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Abstract 
While access to essential medicines has become recognised as a human right, problems 
concerning the inappropriate use of medicines have emerged. Medicines lose their 
therapeutic value and can impair both individual health and public health if 
inappropriately used. Inappropriate use of medicines diminishes the quality of healthcare 
and causes resources to be wasted, which is especially serious in under-resourced 
countries. To improve the use of medicines, the introduction of standard treatment 
guidelines (STGs) is suggested as a potential strategy. 
The aim of this DrPH thesis is to study the use of medicines, focusing on adherence to 
new STGs in Community Health Centers (CHCs) in Timor-Leste. The country is now 
trying to establish an equitable and sustainable healthcare system under extremely 
resource-limited conditions. The study used mixed research methods, collecting data 
from randomly selected 20 rural CHCs, 1,799 retrospective samples from patient 
registration books, 583 prospective observations, and 55 semi-structured interviews of 
health personnel were collected. 
Timor-Leste's medicine use was found, in general, to be acceptable. For example, use of 
injections was extremely low. Training, especially clinical nurse training, influenced 
knowledge of, attitudes to, and practical use of medicines and also prescribing 
adherence to STGs. Other factors that influenced the use of STGs were: health 
personnel's agreement with the policy concept and contents of STGs; health personnel's 
positive perception of the changes brought about by the introduction of STGs; 
development of STGs in a health policy framework: the fact that their STGs were easy to 
use repeatedly; and a supportive environment and systems to use STGs. 
Constant socialisation and timely updates of STGs are necessary. Interrelation and 
consistency across policies and programs should be maintained. The position of training 
within the health policy framework should be clearly understood by the all people 
concerned. Follow-up supervision is needed both for individuals and the CHC. 
Anticipated support should be well functioning. 
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Integrating statement about DrPH 
The Doctorate in Public Health (DrPH) programme of the London School of Hygiene & 
Tropical Medicine (LSHTM) is 'a professional doctorate that provides training in the skills 
crucial for leadership roles in public health'. Studying in the programme gave me an 
opportunity to prepare for a future career, which tries to contribute to a linkage between 
public health practice and research. The DrPH programme consists of three components: 
the taught component, the professional attachment, and the research project. 
Taught component 
The course began in October 2003 with the compulsory core units, which are required for 
all DrPH students: Evidence Based Public Health Practice, and Leadership, 
Management and Development. Both of them consider broad aspects of public health 
issues. Evidence Based Public Health Practice taught us integrated skills to deal with 
these issues; from how to identify a problem to how to disseminate research findings and 
how to put evidence into practice. Leadership, Management and Development provided 
theories and practice of management and organisational behaviour, which are vital for 
working in public health. These units helped me develop a way of thinking which was 
useful for conducting both my professional attachment and my research project. 
While taking the compulsory core modules, I acquired basic knowledge of research in 
linear units: Basic Statistics, Extended Epidemiology, and Principles for Social Research. 
With DrPH optional modules, I registered for Qualitative Methodologies and Health Care 
Evaluation to learn research methodologies more deeply. I also occasionally attended 
sessions on Statistical Methods in Epidemiology and Advanced Statistical Methods in 
Epidemiology which were necessary for data analysis of the research project. 
Two more optional study units were Teaching Health Professionals and Ethics, Public 
Health and Human Rights. I took Teaching Health Professionals just before my 
professional attachment at the clinical nurse training program in Timor-Leste. The unit 
developed ideas which helped me to understand the training program during the 
attachment. Unlike other moaules, I did not expect direct, short-term benefits from Ethics, 
Public Health and Human Rights unit, but learned an invaluable life-long theme in the 
unit for my public health career. 
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Professional attachment 
The purpose of the professional attachment is 'to learn how to design, develop and use 
public health organisations to deliver public health goals'. I did my professional 
attachment for five months from August, 2004 at the clinical nurse training program in 
Timor-Leste. I had a contract with the World Health Organization (WHO), Timor-Leste, 
as an intern for 12 weeks. Furthermore, I obtained special permission for an additional 
stay from the WHO Representative, Timor-Leste and continued the attachment until the 
end of 2004. 
I expanded the given purpose of the professional attachment by conSidering the 'public 
health program' as a type of unit to deliver public health goals, and deemed the clinical 
nurse training program the 'host program'. The contract as an intern with the WHO 
necessitated making such modification. The clinical nurse training program is one of the 
national training programs for existing health professionals in Timor-Leste, held by the 
National Training Center for Health Education and Training (NCHET) under the Ministry 
of Health (MoH). The WHO, Timor-Leste, technically supports it. My intern work in the 
WHO was limited to the program. I realised I could observe and analyse the NCHET 
program during my work at the WHO. Therefore, I decided to study the clinical nurse 
training program and NCHET in the professional attachment even though my official 
status was as a WHO intern. 
During the 3-month internship, I was fully involved with the program management team, 
attending training, follow-up visits, related meetings and so on. The main task assigned 
to me in the team was to evaluate the ongoing program. Relevant documents, reports 
and materials were reviewed to summarise the process of the program, and two surveys 
targeting ongoing and past training participants were carried out. At the end of the official 
internship (the end of October 2004), I submitted an aSSignment report, which was 
obligatory for a WHO intern. The report I made for the WHO later became part of an 
official document of the MoH. 
In the professional attachment report, management of the clinical nurse training program 
was examined by using Henri Fayol's 'five activities of management' theory, and general 
organisational issues in the NCHET were analysed by applying the 78 McKinsey 
Framework. In addition to the assigned work, I reaped valuable information for the future 
research project from the professional attachment. Throughout the work, clinical nurses 
sustained me showing their willingness to learn and the potential abilities of local health 
personnel in the community. 
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Research project 
The purpose of the DrPH research project is 'to help the student to learn about the role of 
research in public health practice'. DrPH theses are generally oriented towards public 
health practice. Based on this purpose, I conducted a research project entitled 
'improving the use of medicines in Community Health Centers (CHCs) in Timor-Leste'. 
Before enrolling in the school, I had the chance to work for rural CHCs in this new country 
as an NGO worker and expatriate district medical officer. My research questions 
concerning the use of medicines have been gradually developed since I worked with 
local health personnel. I found prescribing and dispensing medicines by local health 
personnel were vital for patients in rural areas. However, the reality in the CHC was hard. 
Experience during my Professional Attachment persuaded me to focus on their new 
STGs and related training. 
Prior to the DrPH review in October 2005, a pilot project was carried out from the 
beginning of June to mid-August, 2005. The pilot project did not merely give me a chance 
to test preliminary data collection tools, but also provided good opportunities to arrange 
for the main field visit, including managerial affairs and on-the-job-training of research 
assistants. The main field visit started in November, 2005, and lasted for nearly one year. 
This was the first time for me to conduct research that used 'mixed research methods'. 
The research required extensive research knowledge and skills in both qualitative and 
quantitative techniques, and was a great opportunity to integrate all that I have ever 
studied. For the qualitative part, the 'Framework Approach' was employed, and various 
statistical analyses methods were used for the qualitative components. 
What I gained during the research project was not simply expertise in practising research. 
For example, I experienced tough negotiations as an independent researcher, and I also 
played a role as a manager in the research team that consisted of ten members of 
research staff. Teaching young people research knowledge, attitudes and skills was one 
of the most laborious tasks during the research project, but it was essential. The situation 
in a country where it was hard to obtain experienced data collectors did not allow me to 
escape from training staff members myself from the beginning. 
Moreover, I had to overcome many contingencies during the research in a brand-new 
country where everything was still unpredictable. Above all, two events almost destroyed 
my plans for the research proposals. One was the MoH's sudden change in human 
resource allocation in my research target facilities, which forced me to revise the data 
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collection and analysis plans. The second was a time of social unrest during the data 
collection, which made the government stop functioning for a while and many people, 
including my staff members, were internally displaced. Fortunately, we were able to 
complete the data collection. However, these unanticipated events later affected the 
research both directly and indirectly. 
Results of the research will provide useful information for the MoH in maintaining the 
quality of the health services in Timor-Leste, which will ultimately be beneficial to people 
in the community. 
For me, the DrPH program has not been an easy course to finish. I often experienced 
very hard times during the process. Nevertheless, I can say the time I spent was precious. 
The program has equipped me for future work in a public health area. 
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CHAPTER 1 Introduction 
Modern medicines have become indispensable in our lives and healthcare. While the 
concept of 'essential medicines' has been introduced worldwide and access to essential 
medicines is now considered a human right, problems concerning the inappropriate use 
of medicines have emerged. The use of medicines is only one facet of a comprehensive 
healthcare activity. However, both healthcare service providers and users often expect 
medicines that are unnecessary and continue their needless and occasionally 
dangerous consumption. Improving the use of medicines is an issue of the quality of 
healthcare and effective use of limited resources. Although it is a relatively new research 
area, efforts to improve the use of medicines in under-resourced countries have been 
reported. 
A new health system is now being established in the Democratic Republic of Timor-Leste 
(former East Timor, hereafter Timor-Leste). It reconstructed a nation under hard 
circumstances, and restored its sovereignty in May 2002. There are certain aspects of 
the quality of healthcare services in the Primary Health Care (PHC) facilities in this new 
country. For example, prescribing and dispensing medicines inappropriately by 
Community Health Center (CHC) personnel have been described although there is no 
objective data. No health program in Timor-Leste speCifically centers on 'improving the 
use of medicines', but many activities include this component. The notion is incorporated 
in the country's 'drug policy', one of the macro-policy sections in the Health Policy 
Framework. Efforts to improve the use of medicines have been introduced into various 
programs through their training but little about the present situation faced by Timor-Leste 
in this regard is known. 
The thesis aims to study the use of medicines in rural CHCs in Timor-Leste, focusing on 
adherence to their new standard treatment guidelines (STGs). Nurses and midwives 1 
who are working for rural CHCs with limited facilities in difficult conditions are targeted. 
1 In this thesis, 'health personnel' is used as a general term to indicate nurses (including 
'managers') and midwives. Nurse assistants are excluded although they are also included in 
'health personnel' in official documents of the Ministry of Health (MoH), Timor-Leste. 
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The study tries to contribute to the quality of CHC practice by improving their use of 
medicines through STGs for people living in resource-limited areas. The structure of this 
thesis is as follows: 
Chapter 2 reviews the literature concerning the use of medicines and adherence to 
STGs. Chapter 3 describes the background of the research area. It provides information 
on the public health sector in Timor-Leste, including their new STGs. Chapter 4 
establishes the aim, objectives, and research questions of the study. The scope and 
framework of the study are also presented in this chapter. Chapter 5 explains methods 
and data collection. In relation to this, the preparation process of the project and 
unanticipated events during the data collection are presented. Chapter 6 describes the 
use of medicines in Timor-Leste, applying international medicine use indicators. 
'Prescribing indicators' are analysed by prescriber's training. Chapter 7 assesses 
adherence to STGs for three target diseases. Prescriber's individual adherence are 
analysed by prescriber characteristics and CHC's overall adherence are analysed by 
CHC characteristics. Chapter 8 describes health personnel's knowledge of and attitudes 
to the use of medicines and adherence to STGs based on individual interview data, 
which are qualitatively analysed. Chapter 9 integrates the results and discusses the 
study. Chapter 10 summarises the findings and makes recommendations for 
Timor-Leste's health system, other resource-limited areas and future research. 
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CHAPTER 2 Literature review 
This chapter reviews the literature concerning the use of medicines and adherence to 
STGs. 
2.1 Essential medicines 
2.1.1 Concept of essential medicines 
Although only one modern medicine was widely available at the beginning of the last 
century, effective medicines for major illnesses were introduced by the 1970's [1]. In 
1975, the World Health Assembly introduced the concepts of 'essential drugs' as 'those 
considered to be of utmost importance and hence basic, indispensable, and necessary 
for the health need of the population. They should be available at all times, in the proper 
dosage forms, to all segments of society' [2]. The idea is to work with a limited range of 
basic and reliable medicines to meet the most vital needs for the people. The first Model 
List of Essential Drugs was produced in 1977, and has been revised every two to three 
years [3]. 'Provision of essential drugs' is identified as one of the eight basic components 
of PHC in the Declaration of Alma-Ata in 1978 [4]. More than 150 countries now have 
national or provincial essential medicines lists (EMLs) [5]. Access to essential medicines 
is now recognised a human right [6]. 
2.1.2 Access and use 
Initially, access (or supply) was the main issue about essential medicines. However, 
appropriate use of medicines has become another important argument [7,8]. The WHO 
Conference of Experts, Nairobi in 1985 defined 'rational use' as follows: 'the rational use 
of drugs requires that patients receive medications appropriate to their clinical needs, in 
doses that meet their own individual requirements, for an adequate period of time, and at 
the lowest cost to them and their community' [9]. 
'Inappropriate medication use' defined by Trostle is 'the distribution or consumption of 
drugs in ways that reduce or negate their efficacy or in situations where they are unlikely 
to have the desired effect'. The author also notes the concept of 'rational drug use' can 
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limit our understanding as the use of medicines often has a socio-cultural rationality that 
may not be consistent with clinical or scientific rationality [10]. What is rational in a 
medical sense may not be rational for the consumer [11]. It is important to note that 
simply improving physical access to medicines will not of itself solve the problems. In a 
review of the 25-year history of the Model List of Essential Medicines, 'irrational use of 
medicines' is indicated as one of four remaining critical barriers to closing the 'access 
gap' to essential medicines [12]. 
2.1.3 Location of issues 
Problems concerning medicines are widespread. On the one hand, issues of essential 
medicines overflow from the health sector to the economic and political ideologies [13]. , 
Many of the problems surrounding medicine use can be tackled at a global level by many 
agencies, governments and pharmaceutical companies [14]. On the other hand, 
medicines are prescribed, dispensed and used in the community. A recent International 
Conference on Improving the Use of Medicines (ICIUM) divided its discussion into five: 
1) international pOlicies and systems, 2) national policies, systems and programs, 3) 
hospitals and in-patient care, 4) primary care and health providers, and 5) primary care 
and the community [15], which shows the extent of the issues. 
2.2 Issues concerning the use of medicines 
WHO estimates that more than half of all medicines are inappropriately prescribed, 
dispensed, or sold while about half of patients fail to take them correctly [16]. This section 
reviews literature on the use of medicines. 
2.2.1 Examples of inappropriate use of medicines 
Common issues of inappropriate use of medicines have been indicated. Problematic 
patterns of medicine use by healthcare providers can be summarized as follows: 1) over 
indication, especially for unnecessary antibiotics, injections and expensive (branded) 
medicines, 2) multi-drug use (or polypharmacy), and 3) incorrect use in terms of the dose 
and schedule [11, 16-21]. 
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2.2.2 Negative consequences of inappropriate use of medicines 
There is some evidence of the negative impact on health due to the inappropriate use of 
medicines, such as limited efficacy, adverse side-effects, iatrogenic diseases, antibiotic 
resistance. In addition to individual and public health outcomes, the inappropriate use of 
medicines is a threat to household as well as national health budgets [11, 16-20, 22] 
Although people expect much from medicines, their faith is often unconfirmed and 
overvalued. If inappropriately used, medicines lose their therapeutic value, and could be 
harmful to health and an economic burden [19]. Using medicines inappropriately 
diminishes the quality of healthcare and causes resources to be wasted [22]. 
Furthermore, there is a psychosocial impact that makes people believe that there is 'a pill 
for every ill' [18], or to stimulate inappropriate patient demand that leads to reduced 
access due to stock-outs [16]. A previous study shows that prescriptions with more items 
are associated with poorer dispensing practice and patient knowledge, which suggests 
that even bio-medically less harmful medicines, like vitamins, can be risky [23]. 
2.2.3 System,hea Ithcare providers, and users 
Many interrelated factors influence the use of medicines. The health system, healthcare 
providers (mainly prescriber and dispenser) and patients and community are all involved 
in the therapeutic process [17]. Less attention has been paid in previous studies to the 
role of professionals compared to 'patient compliance 2" and research on prescription 
and distribution of medications by health professionals to improve healthcare is 
recommended [10]. 
Although a lack of knowledge of health professionals is sometimes believed to play roles 
in inappropriate use of medicines, a review article on factors influencing antibiotic use 
indicates that evidence to support these assumptions is very limited. [24]. Rather, a 
study shows that knowing aetiology and differential diagnosis of diarrhoea is not 
associated with appropriate prescription of antibiotics [25]. In an ethnoepidemiological 
study, doctors prescribed less antibiotics and anti-diarrhoeal drugs when observed, and 
the authors discuss the variables other than technical skills that are involved in doctors' 
prescribing behaviour [26]. Some studies suggest that the prescriber is more influenced 
2 Nowadays, the word 'adherence' is preferred to 'compliance'; however, this phrase is used in 
this thesis in order to avoid confusion of 'health personnel behaviour to STGs' and 'patient 
behaviour to the prescription'. The difference between 'compliance' and 'adherence' is explained 
in 2.4. 
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by their own perceptions of patient expectations, their own preference, or social 
demands than individual patient expectations [27-32]. 
2.2.4 Steps of the healthcare process 
Medicines are used in both the bio-medical and local social context. Main 'actors', 
prescribers, dispensers and patients, are involved in using them. The process entails 
diagnosis, therapeutic plan, prescribing, dispensing and patient compliance with the 
treatment [18]. 
Five factors are identified to determine community effectiveness: efficacy of the 
treatment, diagnostic accuracy, healthcare provider adherence to appropriate treatment, 
patient compliance with the treatment, and coverage in target population [33]. These 
elements correspond to steps of the healthcare process (see Figure 1-1). Studies of 
Krause et al. in Burkina Faso investigate each of them to identify the steps with the 
greatest need for improvement. Only two percent of the patients received appropriate 
healthcare at every stage of the procedures. The studies find the patient-related steps 
such as drug-buying and drug-taking compliance yielded more satisfactory results than 
the provider-related steps, and improvement in earlier steps may have a particularly 
strong impact [34, 35]. 
2.2.5 Possible interventions to improve the use of medicines 
Interventions intending to improve the use of medicines are reported; educational, 
managerial, regulatory and financial approaches have been implemented [11, 18, 36-38]. 
Although limited research on this issue is discussed as one of their findings, some 
strategies are recommended based on previous studies. STGs, EML, and targeted 
in-service training of health workers have been proven effective in some settings [22]. It 
has been indicated that merely distributing printed materials does not work well [39, 40]. 
Introducing STGs or EML alone is ineffective and needs to be combined with peer group 
development and training [18]. Due to the complexity of factors involved, it is unlikely that 
any single intervention will work in every situation [17]. It is suggested that all groups in 
the medication cycle need be touched in order to obtain meaningful changes in 
improving the use of medicines, not merely targeting one group such as users, health 
professionals, governments, and others [19]. 
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Figure 2-1 Summary of issues surrounding essential medicines 
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'Indicators ' are explicitly defined and measurable items that state the structure, process 
or outcomes of care [41] . Indicators do not provide definitive answers but indicate 
potential problems that might need addressing [42] . 
They have been developed across Europe, primarily for hospital care [42].F or example 
in England and Wales, it has been suggested that up to 400 different prescribing 
indicators have been developed to assess the appropriateness of prescribing in general 
practice [43]. Reasons for the development of prescribing indicators are that prescribing 
is an important issue in quality of care, and is associated with costs. It is necessary to 
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have proxies to give an indication of prescribing performance without examining the 
details [43]. 
In developing countries, however, a lack of agreement on an essential tool for an 
objective method to measure the use of medicines was a problem [44]. To simplify and 
standardise the study of medicine use, the WHO and International Network for Rational 
Use of Drugs (INRUD) produced a manual [3, 45, 46]. This has been developed as a 
first-line measure, intended to stimulate further questioning and to guide subsequent 
action, consisting of 12 core indicators and complementary indicators as shown in Table 
2-1. The intended objectives of a drug use study by these indicators are: 1) describing 
current practices, 2) comparing the performance of facilities or prescribers, 3) monitoring 
and supervising specific behaviours, and 4) assessing the impact of an intervention [44]. 
Table 2-1 INRUDIWHO drug use indicators3 
Core Drug Use Indicators 
Prescribing Indicators 
1. Average number of medicines per encounter 
2. Percentage of medicines prescribed by generic names 
3. Percentage of encounters with an antibiotic prescribed 
4. Percentage of encounters with an injection prescribed 
5. Percentage of medicines prescribed from EML 
Patient care indicators 
6. Average consultation time 
7. Average dispensing time 
8. Percentage of medicines actually dispensed 
9. Percentage of medicines adequately labelled 
10. Percentage of patients with knowledge of correct dosage 
Health Facility Indicators 
11. Availability of EML 
12. Percentage of key medicines in stock 
Source: [44] 
In 1993, the use of medicines in 12 developing countries was assessed by using these 
standardised indicators [47]. Some discussions on the indicators have been published; 
adaptation of indicators in hospital care [48]; questions about 'consultation time' and 
'dispensing time' for investigating the quality of care [49]; a possibility of misleading 
results by drug use indicators to assess improvement of the quality of care [50]; 'labelling 
scores' and 'knowledge score' to be added to the original indicators [51]; usefulness of 
'percentage of patients who received adequate antibiotic doses' as a prescribing 
indicator [52],and so on. 
3 The manual originally uses 'drug' in 1993; however, 'medicine' has been recently used in WHO 
reports that use these indicators. Updated expressions of the indicators are used in this thesis. 
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Original indicators, however, are still used in developing countries. In a 2004 report 
more studies based on the indicators were added [53]. The average number of 
medicines per encounter was 1.3 or 4.4, and antibiotics were prescribed between one to 
three quarters of patients in these countries. In one country, 74 percent of patients 
received injections. In another country, only 27 percent of patients correctly answered 
dosage schedule of the medicines that they had received [53]. 
2.4 Standard treatment guidelines (STGs) 
This subsection reviews previous studies on STGs. Various terms such as 'clinical 
guidelines', 'practice guidelines' and 'treatment guidelines' are used in the literature, and 
they are included in this review. The term 'STGs' is used in this thesis. 
2.4.1 Definition and benefits of STGs 
According to the definition by the Institute of Medicine, 'clinical guidelines' are 
'systematically developed statements to assist practitioner and patient decisions about 
appropriate healthcare for specific clinical circumstance' [54]. STGs have become a 
familiar part of clinical practice across countries since the 1990's. STGs became 
necessary because of issues that healthcare systems are facing: rising healthcare costs, 
variations in service delivery, and the desire of health professionals and of patients to 
provide or to receive the best care [55]. STGs are principally established to improve 
quality of and effectiveness of healthcare [56-58], and to minimise potential harm [55]. 
STGs are known to effect both process and outcome of healthcare [57]. They can benefit 
patients, healthcare providers, and healthcare systems [55, 59]. 
For example, patients can receive improved health outcomes promoted by STGs in the 
same manner wherever they are treated. STGs also have prospects to empower 
patients by providing information and to promote distributive justice by exhorting better 
service delivery [55]. A potential contribution to impact on disadvantaged populations 
and health inequities is advocated, although previous STGs have rarely focused on 
equity issues [60, 61]. An effect of STGs on patient satisfaction is suggested [62]. 
From the healthcare provider's standpoint, they can learn from explicit recommendations 
in STGs when they are uncertain about how to proceed, as well as when health 
professionals feel themselves outdated. STGs also improve the consistency of care [55]. 
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STGs can help health professionals employ evidence-based medicine without 
significantly increasing their workload [63]. 
Countries where resources are limited do need STGs that can be applied to local 
practice. The fact that financial resources are insufficient and there is no money to waste 
requires effective healthcare provision, which can be helped by STGs [64]. Furthermore, 
where information and human resources are scarce, STGs' contribution to 
evidence-based medicine is important [63]. 
2.4.2 Implementation of 5TGs 
Using STGs improves the use of medicines, when they are not merely distributed but 
implemented with educational and/or managerial approaches [11, 22, 36, 57]. 
Introducing STGs with training health personnel has been shown to be effective in 
previous studies [65-71]. Active strategies to introduce STGs, for example, peer group 
discussion, self-assessment and feedback sessions, are suggested [68, 72, 73]. In some 
studies, educational interventions to implement STGs are combined with managerial 
approaches such as supervision [65, 70]. STGs and an EMl should be developed 
together to be actively implemented [22, 59]. As the second ICIUM recommends, what 
are effective strategies to encourage improving adherence to STGs for appropriate use 
of medicines is now one of the key questions that need to be addressed [74]. 
Since interventions in previous studies are dependent on local factors, evidence for an 
effective intervention in one setting is not always useful in another setting [40]. There are 
various impediments to put evidence into practice in developing countries. Strategies 
used in industrial nations are unlikely to be successful in under-resourced countries, and 
locally adapted STGs are required [63]. Although the number of studies from developing· 
countries is increasing, evidence for effective practice is still restricted [11, 40]. More 
evidence from developing world is needed. 
2.4.3 'Adherence' and 'compliance' 
The term 'compliance' has been widely used for a long time to describe patient's 
behaviour; whether the patient follows the prescription given by the health personnel [75]. 
'Compliance' implies the patient takes orders from the healthcare provider [19] and the 
idea entailed blaming patients [76]. 'Adherence' is another term to concern with patient 
behaviour in relation to prescribed medicines. Compared with 'compliance', 'adherence' 
underlies the importance of patient's active attitudes and requires the patient's 
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agreement to the recommendations [19, 75, 76t It is believed that these two terms 
should be differentiated [76], and 'compliance' is being replaced by 'adherence' [75]. 
As recognition of the importance of STGs, these words, 'compliance' and 'adherence', 
are also used in relation to health personnel's behaviour towards STGs; whether the 
health professional follows the recommendations in the STGs5• 
2.4.4 Possible factors influencing adherence to STGs 
It is not always easy for health personnel to adhere to STGs. Various theories I models 
have been developed to understand factors influencing adherence to STGs, which 
mainly try to understand barriers to adherence. 'Putting evidence into practice' is 
considered to be a similar theme with adherence to STGs, and related literature is 
included in the review. 
STGs have tried to change clinical practice for the better. However, change is often 
resisted when it occurs in the workplace [77]. Previous studies have shown that health 
professionals are also resistant to changing their daily practice [78-81] and that this can 
be a barrier to adherence to STGs [82]. Grol discusses the best way of making changes 
in clinical practice. Different phases of the changing process are suggested: 
dissemination, adaptation, implementation and maintenance. Each phase has obstacles 
and appropriate strategies to overcome them [83]. 
The existence of STGs does not guarantee that they are used in practice [84]. Cabana et 
al. identify seven themes of barriers to physician adherence to STGs using a 
'professional perception model', based on a review of 76 studies; lack of awareness, lack 
of familiarity, lack of agreement with guidelines, lack of self-efficacy, lack of expectancy, 
lack of motivation, and external factors are found. The authors then develop a 
'knowledge attitudes behaviour framework'. Awareness and familiarity influence 
knowledge while agreement, self-efficacy, expectancy and motivation mainly affect 
attitudes [82, 85). Schouten et al. apply this framework in their qualitative study to 
4 The term 'concordance' is recognised as a further step, which considers patient believes and 
wishes [19, 75]. 
5 The main theme of this research is health personnel adherence to STGs. Patient adherence to 
prescription is sometimes mentioned in this connection. Although 'adherence' is preferred to 
'compliance' nowadays, the phrase 'patient compliance' is used in this thesis to avoid confusion 
between two topiCS. 
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present factors influencing physician adherence to STGs for community-acquired 
pneumonia, focusing on antibiotic use. They classify their findings into internal and 
external barriers. The internal barriers are further categorised: cognitive components 
(physician knowledge), and affective components (physician attitudes). External factors 
are found in the guidelines themselves, social context and organisational context [86]. 
Espeland and Baeheim use Cabana's model to identify barriers to physician adherence 
to guidelines for ordering plain radiography for back pain. They found some new barriers 
and rearrange the framework categorising into three major types of barriers: 
knowledge-related, attitude/feeling-related, and external barriers. The external barriers 
they identify are: guideline-related, patient-related, and setting-related barriers [87]. 
Barriers to improving clinical practice suggested by Oxman & Flottorp are related to 
practice environment (organisational context), prevailing opinions (social context) and 
knowledge and attitudes (professional context) [88]. Grol & Wensing summarise theories 
and models relating to implementing change in diabetic care. According to this, theories 
/ models are related to individual professionals, social context, or organisational and 
economic context [89]. Studies explain that some features of STGs influence adherence 
to the STGs [82, 86, 90-92]. 
There are some variations in these theories that try to understand factors influencing 
health personnel adherence to STGs. In summary, previous studies tell us that the main 
influential factors of adherence to STGs are: 1) individual professional knowledge, 2) 
professional attitudes, and 3) external factors, including working environment and 
STG-related factors. 
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CHAPTER 3 Timor-Leste 
This chapter provides background information on the research area. The process of the 
health system rehabilitation and development with limited recourses is described. 
Timor-Leste's drug policy and Timor-Leste versions of STGs are explained. 
3.1 Overview of Timor-Leste 
Timor-Leste6 is a small, newly founded country with a population of 924,642, which was 
counted for the first census in 2004, and is 15,410 Km2 in area [93, 94]. Its sovereignty 
was restored on May 20, 2002 after 2.5 years of the United Nations Transitional 
Administration in East Timor (UNTAET) and more than 450 years of occupancy by other 
countries. 
Since 1975, the territory had been unevenly integrated and practically administered by 
Indonesia. People had the chance to vote for independence by Popular Consultation in 
August 1999; however, after the result was announced that 78.5 percent of people 
refused to remain under Indonesian rule, serious violence and destruction occurred in 
every corner of the country. Many East Timorese were killed and as many as 500,000 
were displaced from their homes, about a half them leaving the territory, in some cases 
by force. [95, 96]. In addition to this, the administrative system became dysfunctional7. It 
was reported as 'a complete collapse of state structures' with over 40 percent decrease 
in economic production and over 70 percent destruction of infrastructure [97]. UNTAET's 
mandate was not only to provide security and maintain law and order in the territory, but 
also to establish an administration and to assist in the development of civil and social 
services [98]. East Timor has had to build everything from scratch, and several efforts to 
build a new nation have been made by the Timorese with international assistance. 
6 The nation gives its official name in English as 'the Democratic Republic of Timor-Leste' after it 
restored its sovereignty in May 2002. Before that, documents written in English usually use 'East 
Timor'. This chapter followed each original document that was referred to. 
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3.2 Health system rehabilitation and development after the crisis 
3.2.1 Brief history in rehabilitation phase 
The health sector was not exempt from this serious situation. For example, health 
facilities were targeted and 80 percent of them were at least partially disrupted [99]. Very 
few people had experience in policy making and health administration. The remaining 
Timorese medical doctors numbered only around 25 [100]. The Central Health Authority8, 
which was established for health system rehabilitation, tried to retain ownership and 
keep many of the initiatives going during this rehabilitation process. The process is 
characterised by coordination and management of international assistance [101-103]. 
The sector-wide program supported by the World Bank-administrated trust fund came to 
be centrally located in the rehabilitation and development of the health system [104]. 
In February 2000, the Interim Health Authority, which was composed of Timorese health 
professionals and international advisers, started to coordinate health issues throughout 
the country. The Interim Health Authority was in charge of planning and executing the 
Health Sector Rehabilitation and Development Program (HSRDP), funded by the Trust 
Fund for East Timor (TFET), which became effective in July 2000 [105]. The Interim 
Health Authority changed its name to the Division of Health Services and became one of 
the divisions under the Minister of Social Affairs in the first Transitional Cabinet in July 
2000. Under coordination by the Division of Health Services, the 'leading NGO 
(non-governmental organizations), provided medical and health services as well as 
district health administration, together with local health personnel. These NGOs also 
participated in designing and implementing the first District Health Plans in the HSRDP. 
By August 2001, senior health staff at national and district levels had taken up their 
positions [106] and the first recruitment process for other health personnel including 
CHC level staff was completed [107]. A plan that leading NGOs would continuously 
support newly established District Health Services (DHSs9) emerged at one stage [108], 
7 One of the possible reasons was that many Indonesians who were previously in higher positions 
in the 'provincial government' as well as in the private sector had left. 
8 The Ministry of Health was officially established in September 2001. Central Health Authority 
here refers to the Ministry of Health and its preceding forms (Interim Health Authority and the 
Division of Health Services) as expressed in a monograph by the main members of the Interim 
Health Authority and the Division of Health Services. 
9 DHS is the same meaning with DHO (district health office) in Timor-Leste. When indicating a 
specific office, they write, for example, 'DHS Dili', and when using the term as pleural, they write 
DHSs in their documents. 
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but finally the work was handed over from international staff to the Timorese, and district 
'leading NGOs' finished their missions by December 2001 [109].The Division of Health 
Services was promoted to the Ministry of Health (MoH) when the second cabinet was 
organized in September 2001. 
The people's right to have health and medical care is explicitly stated in the new 
constitution [110]. There are two important documents in the Timor-Leste policy and 
planning principles that relate to healthcare services: the relevant sections of the 
National Development Plan and East Timor's Health Policy Framework. The MoH 
intends to achieve its vision to promote 'Healthy East Timorese people in a healthy East 
Timor'. 'Equity', 'efficiency' and 'sustainability' are emphasised in the process of health 
system establishment [111, 112].The health sector is known for its progress in building 
policy, institutions and management capacity [97]. 
3.2.2 Basic Package of Health Services 
In the Health Policy Framework, the MoH identified a package of services that will ensure 
greater coverage and impact for the majority of the people. The basic package consists 
of 'essential health services and cost effective interventions to prevent and control or 
treat problems causing the highest burden of diseases in the country'. These services 
and interventions are delivered within the district health system at CHCs, Health Posts 
(HPs) and Mobile Clinics (MCs) in order to meet 80-90 percent of the public health and 
curative needs of the people at a cost the government can afford [112]. In addition to 
service delivery, service support and health system development, the basic package of 
health services guides strategic planning and development of protocols, guidelines and 
monitoring of service provision [113]. The framework of the basic package of services is 
shown in Table 3-1. 
Table 3-1 The Basic Package of Health Services in Timor-Leste 
Level of services Intervention Essential and priority Essential but lesser component interventions priority interventions 
Community Level Monitoring Maternal health Environmental health 
Health Post-Level 1 Prevention - nutrition - food handling 
Health Center-Level 2 Health - reproductive health Non-communicable 
Health Center-Level 3 promotion - family planning disease 
Health Center-Level 4 Diagnosis Child health - trauma 
Treatment - immunization - mental health 
Referral -IMCI - oral health 
Rehabilitation Communicable - muscular-skeletal 
diseases - cardiovascular 
- tuberculosis 
- malaria 
-leprosy 
Source: [114] 
32 
3.2.3 Level of health facilities (health service configuration) 
Four levels of public healthcare facilities are available in the district health services as the 
first contact with healthcare. Moreover, there are five referral hospitals and one national 
hospital in the country. Allocation of human and material resources and establishment of 
a clinical referral system are based on this level. A summary of the level of health 
facilities is indicated in Table 3-2. A Level 3/4 CHC (CHC with beds and doctors) or 
hospital is located in the main town of every district, and a few exceptions apart, each of 
remaining SUb-districts has a Level 2 CHC (CHC without beds and doctors) 10. 
Table 3-2 Summary of the level of health facilities in Timor-Leste 
Facility Level Staff Location No. of No. of beds locations· 
Mobile Clinic Level 1 from HP or CHC remote 114 (outreach) communities ---
Health Post Level 1 1 - 2 sub-district 0 177 sites 
Community Level 2 5-7 sub-district 0 59 Health Center center 
Community Level 3 10 -14 district capital - 20 8 Health Center or4 incl. GPs 
Referral Hospital 40-50 district capital 24 4 incl. specialists·· 
Baucau Referral 137 center of the 114 1 Hospital incl. specialists eastern region 
Dili National 330 capital 260 1 Hospital incl. specialists 
• Minor variations in these numbers can been In different documents (sometimes In different 
sections in the same document) . 
•• limited specialities 
Source: [113] 
3.2.4 Human resources 
A major imbalance in the workforce was a serious problem for re-building the nation; in 
general, there were few senior (decision-making level) officers and specialists while 
there were so many ex-junior employees that the new government could not afford to 
employ all of them. The problem was seen across all sectors. 
The Health Policy Framework from the newly established MoH indicates 'undersupply in 
certain types of health personnel' or 'loss of senior professional in the health services' 
[112]. It implies a scarcity of medical doctors was one of the major concerns for the new 
10 The source of Table 3.2 was published in May 2005. However, a substantial change was made 
in human resource allocation plan later in the end of 2005, during data collection for this thesis. 
This issue will be explained in 5.6.1. 
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healthcare system at its inception. Other documents indicate the shortage of doctors with 
actual numbers: the number of remaining East Timorese doctors after the crisis in 1999 
was around 25 [100]; only 14 doctors delivered direct healthcare services in 2002, with 
half of the physicians working at Dili National Hospital [115]; a report in 2002 estimated 
doctor/patient ratio by 2005 at 1:13,000 [116]. However, employing expatriate medical 
doctors caused a financial burden; it was reported in 2005 that 50% of the total budget 
would be personnel costs, which was 'skewed by the relatively high salaries' paid to 
expatriate doctors [113]. 
The National Health Workforce Plan published in May 2005 indicates there were 73 
doctors posted in 2005, of which only 27 were Timorese 11. The plan projects one doctor 
for every 8,000 people by 2015 from 1: 12,666 in 2005, which will require 185 Timorese 
and 23 expatriate doctors 10 years later [113]. Since 'a doctor cannot reside in every 
CHC at the sub-district level' with the planned numbers, it is suggested that doctors 
make regular clinical visits to the sub-districts (Level 2 CHC), and the role of the clinical 
nurse practitioners are discussed as 'doctor substitutes' in the plan [113]. 
Unlike the low number of physicians, Timor-Leste had an 80 percent retention rate of 
nurses and midwives after the crisis, which amounted to 2,000 people [117]. Among 
them, 850 were employed at public healthcare facility levels for the first recruitment in 
2002 [118]. The MoH document of May 2005 shows that 820 nurses, including 119 
assistant nurses, and 274 midwives are in post [113]. Nearly all nurses and midwives 
were educated under the Indonesian educational system. 'Basic nursing school', 
'midwifery school' and 'academy' were the main educational courses for them during the 
Indonesian time 12. Basic nursing school was a vocational high school, which required 
three years after compulsory education. The majority of nurses in Timor-Leste are basic 
nurses. To be a midwife, a basic nurse studied for one more year at midwifery school. 
Academy was a 3-year diploma course after high school (either vocational or general), 
which was considered higher education. There was a nursing academy in East Timor for 
a short period during the Indonesian time, but no midwifery academy. Apart from a small 
number of doctors and dentists, very few health professionals graduated from 
universities in Indonesia. 
11 The document, however, mentions nine of these 27 Timorese doctors were on study leave 
then. 
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3.2.5 Training for existing health personnel 
Human resource development is listed as one of six policy areas in the Health Policy 
Framework and is identified as 'one of the biggest challenges in ensuring health for all in 
East Timor' [112]. The MoH's guideline for training and development for health personnel 
addresses the priority development needs of the health services [119]. 
Because of the scarcity of doctors, the roles of nurses and midwives in clinical work have 
had to be expanded when compared with the Indonesian time and UNTAET time. 
However, their 'under-qualified and lower-skilled clinical practices with inadequate 
supervision and direction' was pointed out and training of nurses and midwives to fulfil 
their new roles was recommended. The MoH once suspended pre-service training 
(formal education) for new nursing students after the remaining students graduated, and 
prepared for a new educational system. Instead, it focused on in-service training for 
existing nurses and midwives [113]. Many training programs for nurses and midwives 
have been conducted against this background. At the beginning, implementing training 
relied heavily on international aid agencies. Some of them were thought 'ad hoc', not 
focusing on prioritized health service needs, and were therefore of questionable 
long-term benefit [113]. The National Center for Health Education and Training (NCHET) 
was established in 2002 under the MoH, and since then it has managed health 
professional training in collaboration with international assistance. Among various kinds 
of training managed by NCHET, clinical nurse training and training for Integrated 
Management of Child Illness (IMCI) were organized on a particularly large scale 13. 
An idea of clinical nurse training occurred in an early stage of health system 
development although the name was changed several times, such as Nurse Practitioner, 
Public Health Nurse or Clinical Nurse [115, 120, 121]. The clinical nurse training program 
is a six-month 14 certificate program to develop human resources to manage basic 
illnesses and conditions in PHC facilities. It started in February 2003, and every CHC had 
one nurse trained in the program by mid-2005 [113]. The training consists of 17 modules 
12 Assistant nurses have a shorter educational background than basic nurses. The MoH is 
planning to discontinue this position in 2013 [113]. 
13 'Clean and safe delivery' training was also implemented on a large scale, with 2-week training 
for 338 members of health personnel [113). As the training was speCifically for delivery, this thesis 
does not discuss this training. 
14 Trainees gather in the training center for three months and study by themselves at their own 
CHC (self-learning component) for three months. 
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including management of 11 illnesses or health conditions and essential medicines for 
the illnesses. It also includes 'comprehensive patient management'. An overview of the 
clinical nurse training is shown in Table 3-3. 
Table 3-3 Clinical nurse training in Timor-Leste and 'comprehensive patient 
management approach' 
Contents 
Illnesses Ihe alth conditions Other modules 
- Acute respiratory tract infection - Introduction 
- Malaria - Health promotion 
- Diarrhoea - Immunization 
- Tuberculosis - Infection prevention 
- Intestinal parasites - Essential medicines 
- Dengue - Nurse's code of ethics and clinical 
- Skin infections nurse's scope of works 
- Malnutrition 
-Anaemia 
- Pregnancy 
- Wound and trauma (incl. first aid) 
Comprehensive patient management approach 
(1) General danger signs 
(2) General information and history 
(3) Physical examination 
(4) Clinical decision making and classification 
(5) Therapy 
(6) Consultation with doctors and referral 
(7) Counselling 15 and follow-up 
(8) Health education and promotion 
Source: [122] 
IMCI has been internationally developed and promoted by the UNICEF and WHO to 
assess the most common symptoms among children under five years old; cough I 
difficulty breathing, fever, diarrhoea and ear problems as well as nutritional status and 
immunization status [123, 124]. In Timor-Leste, the program was locally adapted and 
implemented at a very early stage of the rehabilitation of the country [125, 126]. In 
contrast to the clinical nurse training, the training period per person for IMCI is short (two 
weeks), while much larger numbers of health personnel were targeted; by May 2005, 
319 members of health personnel had been trained in the IMCI program [113]16. 
15 In Timor-Leste's STGs in, it does not mean 'psychotherapy' as usually used, but is considered 
to have a similar meaning to 'patient education' or 'information given to the patient'. 
16 According to the presentation given by an IMCI program officer in June 2005, 381 people had 
been trained [126]. 
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3.3 Drug policy 
The drug policy in Timor-Leste also appeared in the Health Policy Framework paper as 
one of six macro-policy areas. The framework paper indicates that East Timor had 
'frequent problems of supply at the delivery point and inappropriate use' during 
Indonesian time and 'has relied initially on the contribution of NGOs and UN agencies 
through donations' during the transitional period to independence. In 2001, an 
Autonomous Medical Supply System was introduced and the first national EML was 
drafted [112]. 
When International 'leading NGOs' handed over district work to the DHSs, it was 
required that medicines be provided and procured by the MoH and managed by DHSs 
and CHCs. Withdrawing from separate international donations, provision and 
management of the medicines for public health facilities eventually shifted to AMSS at 
the end of 2001 [105]. The Autonomous Medical Supply System became the 
Autonomous Drug and Medical Equipment Service by a decree in 2004, and is planned 
to be a public enterprise [127]. 
The second national EML was published in 2004 and advocates that the EML is 'the 
precursor for the revised Standard Treatment Guidelines'. This second version of the 
EML is characterized by four points. Firstly it was developed in collaboration with vertical 
programs such as IMCI, clinical nurse training program and so on. Secondly, each 
medicine in the list indicates the level of health facility (e.g. CHC Level 2) to be used 17. 
This levelling of medicines corresponds to the referral system. Thirdly, it considers the 
costs of treatment and each medicine has a price indicator18 . Finally it recommends 
'rational drug use' [128]. 
17 For example, co-trimoxazol indicates all facility level (Level 1 , Level 2, Level 3/4 and Hospital), 
but chloramphenicol tablet only indicates Level 3/4 and Hospital. Some medicines specify 
specialist use only. 
18 such as'S', 'M', 'L' 'XL', XXL' and 'XXXL' 
37 
3.4 STGs in Timor-Leste 
In its 2002 Health Policy Framework paper, the MoH planned to issue 'National 
Treatment Guidelines' to ensure rational use of available medicines by all health workers 
[112].N ationwide standardization of practice was applied in the policy. 
3.4.1 Timor-Leste versions of STGs 
Timor-Leste MoH seldom uses the term 'standard treatment guidelines' in its official 
documents. Standard treatment guidelines do not appear in a publication entitled 'STGs'. 
Instead, standard clinical practice is recommended in several kinds of 'textbook', 
'manual', 'guidebook' and 'protocol'. They have been developed for and disseminated 
through various national health programs for disease control I patient management, for 
example, the clinical nurse training program, the IMel program, the malaria 
management program, the safe motherhood program and so on. National standard 
treatment or management of an illness is usually indicated in flowcharts or classification 
tables (occasionally in statements) in the material of a program. They are developed 
based on the Basic Package of Health Services policy. The medicines used in these 
STGs are listed in the national EML. All of them were introduced during training for health 
professionals [113]. 
3.4.2 Extracts of STG contents 
This study will target acute respiratory tract infections (ARTis), malaria and diarrhoeal 
diseases and focus on clinical nurse training textbooks and the IMel chart-book as 
Timor-Leste versions of 'STGs'. Key flowcharts and classification tables in the training 
textbooks and chart-book used for this study are attached in Appendix 1. The following 
are extracts from the contents. 
ARTls.1.i 
Three points are key to ARTI management. 1) The illness should be clinically classified 
between categories: the upper ARTis or lower ARTis (adults); or severe pneumonia, 
pneumonia or 'no pneumonia' (children). 2) An antibiotic is needed for lower ARTis and 
19 based on flowcharts and classification tables in the clinical nurse training textbook for ARTis 
(p17, 18. 34. 35) and the IMel chart-book (p2) 
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pneumonia. 3) No antibiotic is recommended for most types of upper ARTis and 'no 
pneumonia'. 
Malaria~ 
Both the clinical nurse training textbook for malaria and IMCI chart-book are based on 
the National Protocol of Malaria Management. Malaria management where a blood 
smear test was not available (in most of Level 2 CHCs) is based on clinical decision. 
Treatment for clinically suspected malaria patient needs to cover both P. falciparum and 
P. vivax, which are reported to be equally present in Timor-Leste. Giving chloroquine and 
sulfadoxine + pyrimethamine (hereafter Fansidar) at the same time for a clinically 
suspected malaria patient is recommended. 
Diarrhoeall 
For diarrhoeal patient management, two kinds of classification are recommended: 
severity of dehydration (mild dehydration, moderate dehydration and severe 
dehydration) and type of diarrhoea (a'cute diarrhoea without bloody stool, dysentery and 
persistent diarrhoea). Key recommendations for diarrhoeal patient management are as 
follows. 1) Acute diarrhoeal patients without bloody stools with moderate or milder 
dehydration is that they be orally rehydrated and do not need an antibiotic. 2) Antibiotic 
therapy is only recommended for dysentery. 3) Treatment for persistent diarrhoea is 
based on the possible cause: diet for children with malnutrition, anti-helminthic for 
suspected parasitosis and metronidazole for suspected giardiasis. 
Antibiotics 
Fourteen kinds of antibiotic, ten oral forms and four injections, are listed in the 
Timor-Leste EML for the Level 1-2 facility 22. Injections, which are principally for 
20 based on National Protocol of Malaria Management, Timor-Leste, 1.3 Malaria without 
complications (pp. 4-5), 1.5 Treatment failure (pp. 6-7), and flowcharts in Appendixes (pp. 14-15, 
17) 
21 based on classification tables in the clinical nurse textbook for diarrhoea (pp. 13-15 and 21) and 
the IMel chart-book (p. 3) 
22 Listed oral antibiotics are amoxicillin, cloxacillin, phenoxymethilpenicillin, azithromycin, 
ciprofloxacin, co-trimoxazol, doxycycline, erythromycin, metronidazole, and nalidic acid. Listed 
injectable antibiotics are ampicillin, procaine benzylpenicillin, chloramphenicol, and gentamicin. 
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emergency use before referring the patients with a serious condition to the upper level 
facility, are indicated 'E' in the list. 
Vitamins 
In the EML for the Level 1-2 facility, only vitamin A and multivitamins are listed in the 
'vitamins and mineral' section and folic acid in the 'anti-anemia medicines' section. 
Clinical indications of these medicines in Timor-Leste's STGs are limited23 . The STGs for 
the three target diseases of this study (ARTis, malaria and diarrhoea) do not recommend. 
a vitamin prescription. 
23 According to the STGs in the clinical nurse textbooks and IMel chart books, indications for 
these vitamins are as follows; vitamin A for children with complicated measles, and vitamin A. 
multivitamin and folic acid for cases with moderate malnutrition. ('below red line' of growth 
monitoring chart but more than 70% of the median weight for height). The STGs for the three 
target diseases of this study (ARTis, malaria and diarrhoea) do not recommend a vitamin 
prescription. 
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CHAPTER 4 Aims and objectives 
This chapter establishes the aims and objectives of the thesis as well as the research 
questions to be studied. The scope and framework of the study are also explained 
4.1 Aims 
To study the use of medicines in rural CHCs in Timor-Leste, focusing on adherence to 
the standard treatment guidelines (STGs). 
4.2 Objectives 
The objectives of the planned research are: 
To describe the use of medicines in rural CHCs in Timor-Leste; Objective 1. 
Objective 2. 
Objective 3. 
To assess health personnel's adherence to the newly introduced STGs; 
To describe health personnel's knowledge and attitudes in relation to 
their use of medicines and adherence to their new STGs; 
To identify factors that influence the use of the STGs; and Objective 4. 
Objective 5. To make recommendations to improve the use of medicines in rural 
CHCs through the STGs. 
4.3 Research questions 
The following research questions are based on the objectives of the study: 
(Objective 1) 
(1) What are the characteristics of Timor-Leste's medicine use in CHCs? 
(2) Is there a difference in prescribing indicators by prescriber's training? 
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(Objective 2) 
(3) How much do health personnel adhere to the newly introduced STGs? 
(4) What prescriber characteristics and CHC characteristics are associated with 
prescribing adherence to STGs? 
(Objective 3) 
(5) How well do health personnel know the newly introduced STGs? 
(6) What do they think about their own practice regarding the use of medicines and 
adherence to their new STGs? 
(7) What do they think has changed since the introduction of their new STGs? 
(8) What are the difficulties in using their new STGs in the local context? 
(Objective 4) 
(9) What are the factors that influence the use of medicines and adherence to STGs? 
4.4 Scope and framework of the study 
This research studies the use of medicines, focusing on adherence to STGs. As stated in 
chapter 2, there are several healthcare steps in the use medicines and adherence to 
STGs. The main focus of this research is the prescribing step. 
In previous studies, using STGs is suggested as one of the key interventions to improve 
the use of medicines. In this research, however, looking into the cause and effect 
association between the use of STGs and the use of medicines is not the main purpose. 
Rather, this research considers adherence to STGs as a part of the use of medicines. In 
particular, when addressing the prescribing step, terms like 'prescribing practice ' and 
'prescribing adherence' are used, and the latter is considered as a part of the former. The 
research is investigating factors that influence the use of medicines, focusing on 
adherence to STGs, both of which are a part of CHC practice. Figure 4-1 presents the 
scope of this study. 
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Figure 4-1 CHC practice , use of medicines and adherence to STGs 
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This study assumes that the two kinds of training in Timor-Leste, clinical nurse training 
and IMCI training, that have introduced their new STGs, influence the use of medicines 
and adherence to STGs. In the quantitative analysis, the use of medicines and 
adherence to STGs is quantified. Adherence to STGs is analysed by prescriber 
characteristics and CHC characteristics, including individual training and CHC's overall 
training input. To understand the context, health personnel's knowledge and attitudes 
are described based on the interview data, which are analysed qualitatively. Quantitative 
and qualitative data are then integrated to identify factors that influence the use of 
medicines focusing on adherence to STGs, and based on all of these findings, 
recommendations are presented. The figure below shows the framework of this study. 
Figure 4-2 Framework of the study 
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CHAPTER 5 Methods and data collection 
This chapter explains the study methods, data collection techniques, and analysis 
methods used in the study. In relation to this, the preparation process for the project and 
events that took place during the field visits are also described in the sub-sections,. 
5.1 Study methods 
This study relies on both quantitative and qualitative data. The use of medicines and 
adherence to STGs isquan tified using retrospective sampling and prospective 
observation to outline the situation. The results are then analysed statistically to 
investigate an association between prescribing adherence and health personnel 
characteristics and facility characteristics. Health personnel's knowledge and attitudes 
are derived through individual interviews using semi-structured interview topics, and 
then qualitatively analysed to describe the context. Factors that influence the use of 
STGs are identified, thus converging findings from both methods. 
One of the rationales for mixing quantitative and qualitative data is 'to better understand 
the issue by converging numeric trends and the detail' [129]. Some believe that their 
philosophical and methodological origins cannot be combined effectively [130, 131]. 
However, after a long debate between quantitative and qualitative methods in social 
research, pragmatically oriented researchers now refer to 'mixed methods' recognizing 
the limitations of single method research [132, 133]. Designs that combine qualitative 
and quantitative methods are increasingly being used [134-136]. It has becomes an 
important approach to consider when a researcher selects a study design, and can 
expand the scope of enquiry by accessing a wider range of data [131, 137]. Although 
there are many practical and theoretical barriers to combining qualitative and 
quantitative research, Borkan suggests mixed methods research is an essential tool in 
primary care practice and research, and the power of the process can be seen in several 
dimensions. In particular, it has the potential to address practice and policy issues from 
the point of view of both numbers and narrative [137]. 
According to Stange, the goal of mixed methods is to integrate and objectify a 
phenomenon while retaining an understanding of local meaning [138]. This is an 
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important aspect of mixed methods research for this study. As a brand new country, 
information is still scarce in Timor-Leste. Quantifying a phenomenon while 
understanding local context was beneficial. Creswell et al. identify five criteria of mixed 
methods research design: a rationale, the types of data and their prioritisation, 
implementation and integration. They then classify design models of mixed methods 
research based on these criteria [139]. How and when to integrate the data is suggested 
in the different research design models. [140]. Applying Creswell's classification, a 
design model of this research was triangulation. Quantitative data and qualitative data 
were collected during the same time period and equally prioritised. Both sets of data are 
analysed separately and compared and constructed at the interpretation stage in the 
discussion. 
5.2 Sampling methods and sample size 
Two-stage sampling was used for this study. The first stage was random sampling of 
CHCs. The second stage, in a selected CHC, was sampling cases for the quantitative 
data and choosing interviewees from health personnel for the qualitative data. 
5.2.1 First stage sampling 
Twenty CHCs were randomly sampled 24 by using a random table from 44 Level 2 CHCs 
that met the inclusion criteria. In order to meet the international standard, the number of 
facilities was decided based on an international manual for medicine use indicators [44]. 
The locations of CHCs are shown in Figure 5-1. 
There are 65 CHCs in the whole country, of which 56 are Level 225. Apart from a few 
exceptions, there are neither laboratory nor inpatient facilities in Level 2 CHCs, and there 
had been no doctor or plan to appoint doctors for at least 10 years at the end of 200526. 
24 Data could not be collected in two CHCs that were originally selected. The data collection team 
could not reach one CHC because of the extremely difficult road conditions and could not obtain 
CHC consent in another. After withdrawal of these two CHCs, two more CHCs were randomly 
sampled from the rest of CHCs. 
25 These numbers are based on the CHC name list for sampling which was obtained from the 
MoH on February 3, 2006. They are different from Table 3.2. 
26 The change in the human resource allocation plan at the end of 2005 is explained in 5.5. 
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Level 2 CHCs are principally allocated in sub-district centers where there is no district 
centre. Twelve Level 2 CHCs were excluded from this study: four in the enclave district, 
five in the capital city, two where the pilot project had been conducted, ar:ld three where 
the pre-test had been conducted (two of pilot and pretest CHCs are in the capital city)27. 
Figure 5-1 Location of CHCs 
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5.2.2 Second stage sampling 
Quantitative data 
In every CHC, 100 retrospective cases were randomly sampled from patient registration 
books in 2005, and 30 consecutive cases were prospectively observed during the visit. 
All collected data were used to investigate the use of medicines (objective 1). For 
assessing adherence to STGs (objective 2), only cases recorded with at least one of 
three target diseases (ARTis, malaria and diarrhoea) were used. 
The sample sizes for quantitative data collection also referred to the WHO/INRUD 
27 The enclave was excluded because of transportation difficulties, and the capital city was 
excluded because living conditions and other situations are very different from rural areas. 
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manual, but the feasibility of data collection was also taken into account. For practical 
reasons, sample sizes in each facility were fixed and were not weighted based on the 
workload I annual visit. 
Qualitative data 
For objective 3, three members of health personnel in three different kinds of groups 
were interviewed in each CHC; the manager (head nurse), clinical nurse and one 
member of 'other health personnel'. 'Clinical nurse' was defined as a member of the 
health personnel who had attended clinical nurse training even if she was employed as a 
midwife. 'Other health personnel' was defined as a member of staff who was neither 
manager nor clinical nurse, and was either nurse or midwife28. Nurse assistants were 
excluded from sampling. 
Qualitative research usually uses non-probability sampling, and the sample is not 
intended to be statistically representative [141]. 'Redundancy', which means no new 
information from new samples, is recommended as the primary criterion to terminate 
sampling qualitative data [142]. In this study, however, two-stage sampling was used, in 
which the first stage was random selection. The sample size was decided in advance. 
Due to geographical difficulties in accessing the target, quantitative data collection and 
qualitative data collection were conducted during the same visit, and the sampling 
strategy designed for this study was the most feasible in the situation. Systematic or 
random selection can be used in a purposive sampling strategy to increase credibility by 
avoiding personal, ad hoc selection of cases [143]. Moreover, subgroups in stratified 
purposive sampling can be compared to display variation in a particular phenomenon 
[143], and they are 'informationally representative' [144]. Thus, the sampling method 
used in these circumstances can be justified. 
Second stage sampling methods are summarised in Table 5-1: 
28 Although midwives are basically involved with maternal health (deliveries and antenatal or 
postnatal care), some of them are doing consultations, mainly child consultations, if they attended 
IMel training. 
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Table 5-1 Objective, sampling methods and analysis methods 
Objective and theme Sampling methods Analysis methods 
Retrospective, 
Objective 1 random 
Use of medicine Prospective, 
consecutive Quantitative Retrospective, 
Objective 2 Random· 
Adherence to STGs Prospective, 
Consecutive· 
Objective 3 Purposive Qualitative Knowledge and attitudes 
• The cases recorded with three target diseases In the same datasets with objective 1 were used. 
5.3 Data collection 
The following data were collected at each CHC: 1) retrospective data, 2) prospective 
data, and 3) individual interviews. Furthermore, health personnel data and CHC data 
were collected to link the main datasets so that data could be analysed by health 
personnel characteristics or CHC characteristics. Each data collection method is 
explained in this section. 
5.3.1 Retrospective data collection (Quantitative data) 
One hundred cases were selected from the cases in the patient registration books in 
2005 by systematic random sampling. As patient registration books were not available in 
the form we needed in two CHCs, and one case collected was invalid, the total sample 
size was 1,799. The exclusion criteria were as below: 
antenatal care and pregnancy 
parturition and post-parturition 
abortion and post-abortion 
normal neonatal care 
child health program only (immunization, vitamin A, antihelminthics, growth 
monitoring) 
family planning 
'control' or 'follow-up' without specific diagnosis 
empty in the diagnosis column 
referral 
Data collected were: the date of visit, patient's age (or age group), patient's sex, 
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diagnosis (or symptom), and prescription. In cases where symptom(s) were recorded 
instead of diagnosis, the case was categorised according to criteria that had been 
determined in advance (criteria are given in Appendix 2). The number of medicines was 
counted29 and whether the prescription included an antibiotic, vitamin or injection was 
checked 30. 
Sampled cases were hand-copied into the sampling form (Appendix 3) by data collectors. 
For the cases of any of the three target diseases, prescribing adherence to STGs was 
classified by the author based on Timor-Leste's STGs. The data were inputted into Excel 
spreadsheets by assistants, then checked twice by the researcher. 
5.3.2 Prospective data collection (Quantitative data) 
Thirty consecutive cases in each CHC were observed. Consent was obtained both from 
the health personnel and from the patient. In two CHCs, 30 cases were not collected 31 • 
Therefore, the final sample size was 583. None of the Timorese health personnel 
refused to be observed or interviewed. However, foreign medical doctors in some CHCs 
did not consent to being observed, and in such cases only the nurse's consultations were 
observed. 
Exclusion criteria for prospective data collection were the same as those for 
retrospective data collection. Data collectors were allocated three different points; 
consu'ltation room(s), dispensing counter and exit. Checklists used are attached 
(Appendix 4). 
In the consultation rooms, the data collector(s) sat away from the health personnel and 
patient and filled in the checklist, observing the process of consultation: asking chief 
complaints, taking a history, conducting a physical examination and explaining the 
29 Vitamin A for a child under five years old and anti helminthic for a child under 14 years old were 
not included in the number of medicines as they are given to a healthy child as part of the child 
health program. 
30 Vitamin A given to a child under five years old was not counted as a vitamin prescription for the 
reason above. 
31 In one CHC the foreign doctors initially accepted the research team if only nurses' consultations 
were observed, however, they later began to show their reluctance. The team withdrew from the 
CHC in the middle of the data collection. In another CHC, the team had to stop data collection 
halfway due to the country's crisis. 
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illness / treatment to patients. The date of the visit, patient's age, patient's sex and health 
personnel's name were also recorded. After finishing the observation, diagnosis (or 
symptoms) and prescription were copied from the patient's medical chart. As in the 
retrospective data collection, any case recorded without a diagnosis was categorised 
based on criteria. The number of medicines was counted, and whether the prescription 
included an antibiotic, vitamin or injection was checked. 
At the dispensing counter, the following issues were checked using a checklist: how 
many medicines had been dispensed, how many medicines were explained to the 
patient, how many medicines were taken at the counter under health personnel's 
supervision, and whether the patient asked the health personnel a question. The 
dispenser's name was also recorded. 
At the exit, the label and the patient knowledge of each medicine were then checked 
using the checklist. Each label was examined to see if it contained dosage schedule, 
duration of the treatment, name of the medicine, and the name of the patient. Then the 
patient was asked if he/she knew the dosage schedule, duration of the treatment, the 
name of the medicine of each medicine as prescribed. Reason(s) for the prescription 
was also asked. The label and patient knowledge about the duration of the treatment 
was not checked for external medicines, oral dehydration salt (ORS) and one dose 
medicines (mainly Fansidar and antihelminthic). Sometimes prescribed medicines and 
dispensed medicines were not consistent; however, the medicines that the patient 
actually took were checked. Questions to patients were usually asked in Tetum. If the 
patient was not fluent in Tetum, the local language was used. For minor languages that 
none of data collectors could speak, local help was requested. 
Records in checklists were transferred to summary sheets by the data collectors after the 
observation. Data collectors reviewed each other's summary sheets, which were then 
checked by the researcher twice. For cases of the three target diseases, adherence to 
STGs was classified by the researcher based on Timor-Leste's STGs. Assistants 
inputted data into Excel spreadsheets in two different datasets: by case and by medicine. 
Data input was checked by the researcher twice. 
5.3.3 Interviews (Qualitative data) 
Three individual interviews of health personnel in each CHC were conducted using the 
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semi-structured topic guide. In some CHCs, planned interviewees could not be found 32• 
Therefore, a total of 55 interviews were conducted. 
A pair of data collectors conducted the interviews: one interviewer and one note taker. 
Where possible, the interview took place in a closed room where privacy could be 
guaranteed. However, for logistical reasons, it was difficult to find a closed space near 
the CHC in the rural community, so the interview was usually held inside the CHC or the 
accommodation of the research team, such as a health post. 
Based on the research questions listed in 4.2, the topic guide consisted of five topics: 1) 
standard treatments, especially about treatment of target diseases and indications of 
vitamins33, 2) present practice, 3) changes after introduction of STGs and related training, 
4) difficulties in using STGs, and 5) requests to improve STGs. Sample questions for 
each topic are given in Appendix 5. Data collectors were instructed in their training that 
they did not have to follow the topic guide and sample questions very rigidly, but they 
needed to cover all the topics. 
Interviewing and note taking were conducted in Tetum, occasionally mixed with 
Indonesian, especially for technical health terms or jargon. Original transcripts were 
transcribed using Word word-processing software and translated into Indonesian and 
English by two assistants. 
5.3.4 Health personnel and CHC data 
Information on health personnel and CHCs were obtained to be linked with the main 
datasets for the analysis. Details of health personnel's demographical characteristics 
were recorded in a small questionnaire (Appendix 6), which was put on the back page of 
the informed consent form. CHC data was gained from secondary data, observation and 
interviews with the manager. Data were collected on; geographical characteristics, 
32 Four managers were absent from CHCs during the data collection period due to their 
management duties elsewhere. The clinical nurse was not in post in two CHCs. Another member 
of 'other health personnel' was interviewed in one CHC instead. In another CHC, a replacement 
could not be interviewed. 
33 In CHCs where quantitative data could be collected before the interview, interviewees were 
asked for comments on the results of key indicators (mainly average number of medicines per 
case, percentage of cases when an antibiotic was prescribed, and percentage of cases when a 
vitamin was prescribed) as a cue for interviewing. 
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workload, human resources, including staff's previous training, and availability of key 
essential medicines, the national EMl, and STGs. Observation checklists for material 
resources are given in Appendix 7. 
5.4 Analysis methods 
This section explains the methods of data analysis and which data were used for each 
objective. 
5.4.1 Use of medicines (Objective 1) 
5.4.1.1 Medicine use indicators 
Analysis methods 
Assessment of the use of medicines in Timor-leste was based on the INRUDIWHO's 
medicine use indicators (see 2.3), Of the 13 'core indicators,34, nine indicators were 
applied in this study: three 'prescribing indicators', three 'patient care indicators' and 
three 'facility indicators'. One further prescribing indicator was added, specifically for this 
study. 
Data used 
Due to the nature of the data, 'prescribing indicators' can be measured by both 
retrospective and prospective data, which complement each other while 'patient care 
indicators' use only prospective data [44]. The prospective data consisted of two 
datasets: encounter data and medicine data. Use of one or the other of these datasets 
depended on the indicator. 
Procedures 
Prescribing indicators 
34 Although there were 12 original 'core indicators' in the INRUDIWHO manual in 1993, 'the world 
medicines situation' in 2004 suggests one more facility indicator. 
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Four indicators were measured. Two indicators in the manual were not included in this 
study. 'Percentage of medicines prescribed by generic names' and 'percentage of 
medicines prescribed from EML' which were not measured as they were estimated to be 
100 percent in rural CHCs, due to the medicine procurement system in Timor-Leste. 
'Percentage of encounters with a vitamin prescribed' was added in 'prescribing 
indicators' for this study since a high level of vitamin prescriptions was observed in the 
pilot project. Measurement was as suggested in the manual. 
Patient care indicators 
Three indicators were measured. 'Average consultation time' and 'average dispensing 
time' were omitted for practical reasons 35. 
Regarding 'labelling' and 'patient knowledge', some modification was made on how to 
present the results. The INRUDIWHO manual indicates that dosage schedule, duration 
of the treatment, name of the medicine, and name of the patient for 'adequate labelling', 
and dosage schedule and duration of the treatment for 'patient correct knowledge' 
should be checked' [44]. However, previous studies have sometimes used different 
criteria for these indicators. [53]. In order to ensure precision of the results, percentage of 
labelling or knowledge of each element of information was separately measured, in 
addition to measuring the indicators based on the criteria from the manual. For example, 
'percentage of medicines with dosage schedule labelled' or 'percentage of medicines 
with patient's knowledge of correct duration of the treatment' was also measured and 
displayed. 
As a part of 'patient knowledge', 'reason(s) for the prescription' were also asked. It is 
counted as a criterion of 'correct patient knowledge' in some previous studies [51, 53]. In 
this study, 'reason(s) for prescription' was neither included in criteria of 'correct 
knowledge' nor assessed to ascertain if it was correct or incorrect, but a number of 
patients' answers about reasons for prescription are presented, focusing only antibiotics 
and vitamins. 
35 The main reason was quality control of measuring time, which was considered difficult with 
limited data collectors. For example, in the consultation room, observation for adherence to STGs 
was conducted at the same time. Another reason was that using a stopwatch in the consultation 
room or dispensing counter was not appropriate in rural CHCs. 
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Facility indicators 
Three indicators were measured as suggested in the manual. 
Availability of clinical nurse textbooks was assessed in 18 CHCs where a clinical nurse 
was in post. Availability of an IMCI chart-book was checked in all the target CHC. 
Availability of EML and key medicines in stock was assessed in 19 CHCs where they 
could be checked 36. 
5.4.1.2 Comparison of prescribing indicators by prescriber's training 
Analysis methods 
Indicators can be used to compare the performance between prescriber or facility groups 
[44]. In this study, three 'prescribing indicators' were compared by prescriber's training. 
As the percentage of encounters with an injection prescribed was very small, it was 
excluded from this analysis. The Wilcoxon's rank-sum test was used for the statistical 
analysis. 
Data used 
As prescriber's name was available only in the prospective data, this analysis relied on 
the prospective data. The data were then linked to health personnel data. 
Procedures 
Prescriber's individual results for each indicator were calculated. The median of each 
indicator was then compared between prescribers who had trained and those who had 
not. Clinical nurse training and IMCI training were analysed separately. 
When including foreign doctors' cases, they were counted in the 'no training' group for 
both clinical nurse and IMCI training since the foreign doctors were given STGs without 
the introduction that the local health personnel received. The results excluding and 
including doctors are presented separately. 
36 Data could not be obtained in one CHC as the research team withdrew from data collection 
before seeing the person in charge of the medicine management. 
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5.4.2 Adherence to STGs (Objective 2) 
5.4.2.1 Adherence to STGs for four healthcare steps 
Analysis methods 
Adherence to STGs for four healthcare steps was described: taking a history, conducting 
a physical examination, making I recording the clinical decision, and prescribing 
medicines. 
Data used 
The prospective data were used. The datasets were the same as those used for 
medicine use indicators, but only cases recorded with a target disease were included. 
Procedures 
Assessment of adherence was based on Timor-Leste's STGs. As described in chapter 3, 
practice guidelines in Timor-Leste comprised materials developed by patient 
management programs such as the clinical nurse training program, IMCI program, or 
malaria management program. For this study, reference was made to clinical nurse 
textbooks (volumes for ARTis, malaria and diarrhoea) and the IMCI chart-book. The 
proportion of cases that adhered to STGs to all target cases was calculated. When a 
case was recorded with more than two target diseases, the worst result was taken as the 
case's result for each step37. 
Taking a history 
Questions that health personnel asked to the patient were checked. Patient's answers 
were not taken into account. When all recommended questions were asked, it was 
categorised as 'adhered' to STGs in terms of taking a history. 
37 For example, if a patient was diagnosed as malaria and diarrhoea and the treatment adhered to 
the malaria STGs but a medicine contraindicated in the diarrhoea STGs was prescribed, the 
cases result was considered as 'not adhered'. 
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Conducting a physical examination 
Examinations of patients that health personnel conducted were checked. Results of the 
examinations were not taken account. When all recommended examinations were 
conducted, it was categorised as 'adhered' to STGs in terms of conducting a physical 
examination. 
Recording clinical decision 
The way to record clinical decision was checked. Diagnostic accuracy based on a history 
and a physical examination was not assessed in this study. For example, STGs for adult 
ARTis recommend classifying the illness if a patient is suspected of having an upper 
ARTI, a lower ARTI, or suspected tuberculosis. For child ARTI cases, the IMel 
chart-book shows how to differentiate a child with cough or dyspnoea between a case of 
pneumonia and non-pneumonia. When a case was recorded as explained above, the 
case was categorised as 'adhered' to STGs in terms of recording clinical decision. 
Prescribing medicines 
Whether treatment was given in accordance with STGs was checked. When a medicine 
that is indicated in STGs was not prescribed or a medicine that is contraindicated in 
STGs was prescribed, the case was categorised as 'did not adhere' to STGs, otherwise it 
was categorised as 'adhered' to STGs in terms of prescribing medicines. In cases where 
a proper clinical decision was not recorded as indicated in STGs, its prescription could 
not be assessed, and the case was counted as 'not adherent' in prescribing adherence. 
5.4.2.2 Individual prescribing adherence and prescriber characteristics 
Analysis methods 
Focusing on prescribing adherence, prescriber's individual adherence was analysed by 
prescriber characteristics. Two kinds of statistical methods (Wilcoxon's rank-sum test 
and logistic regression analysis) were used. 
Data used 
Prospective data were used for the analysis as prescriber's name was available only in 
the prospective data. Only cases recorded with a target disease were included. The data 
were then linked to heath personnel data. 
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Procedures 
Prescriber's individual prescribing adherence was calculated. The median prescribing 
adherence, including only local health personnel's data, was compared by prescriber's 
age, sex, occupational category, civil service level, and work experience, and training. 
Comparison of the median was also performed by combination of prescriber's training. 
Including foreign doctors' data, the median was compared by training. Like the 
comparison of prescribing indicators, which was explained in 5.4.1.2, doctors were 
counted in the 'no training' group for both IMCI and clinical nurse training. 
To investigate an association between individual prescribing adherence and prescriber's 
training (clinical nurse training and IMCI training), a logistiC regression analysis was 
conducted. Firstly, the crude odds ratio for each variable was calculated taking account 
of prescriber clustering. Next, to find possible confounders, the odds ratio for the training 
adjusted by each of other variables was calculated. Whether there was evidence of the 
effect of modification by the variable was also checked. Possible confounders found 
were put in the final model, and the odds ratio for the training adjusted by the possible 
confounders was calculated, taking account of prescriber clustering. The above 
mentioned analysis was performed separately for each training (clinical nurse training 
and IMCI training). 
5.4.2.3 CHC's overall adherence and CHC characteristics 
Analysis methods 
Focusing on prescribing adherence, CHC's overall adherence was analysed by CHC 
characteristics. The Wilcoxon's rank-sum test was used for the statistical analysis. 
Data used 
Both prospective data and retrospective data were used for the analysiS to complement 
each other. Each dataset was then linked to the CHC data. 
Each of the prospective data and retrospective data contained a weakness to link to the 
CHC data.The most of the CHC data were obtained during the CHC visit, so linkage of 
the CHC data to the prospective data, which was obtained at the same time, was 
appropriate. However, for all practical purposes, prospective data that included newly 
arrived foreign doctors' cases were considered unlikely to represent the CHC's situation 
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and remained unreliable for analysis by CHC characteristics. Therefore, retrospective 
data were also used for this analysis although time discrepancies between the two 
datasets (the retrospective data and CHC data) were unavoidable. 
Procedures 
CHC's overall prescribing adherence was calculated. The median was statistically 
compared by CHC's sub-district population, annual workload, number of health 
personnel, percentage of members trained, total period of training, and availability of 
resources. 
5.4.3 Knowledge and attitudes (Objective 3) 
Analysis method 
To describe health personnel's knowledge and attitudes qualitatively, the Framework 
approach was used. This approach was developed specifically for applied or 
policy-relevant qualitative research [145-147]. Although inductive analysis is more 
common in qualitative analysis, the objectives of the study are set in advance in the 
Framework approach [148]. Qualitative analysis in this study tried to study the 'context', 
identifying 'the form and nature of what exists', which is one of the four categories of 
possible research questions to be addressed for the Framework approach research that 
Ritchie and Spencer suggest [145]. 
Data used 
The interview notes were used for the analysis. Of the three versions of interview notes, 
original, Indonesian translation, and English translation, the Indonesian versions were 
mainly used for data analysis supplemented by reference to the original transcripts 38 . 
38 Citations in this thesis were translated by the author from the original transcripts. The italic font 
inside the parentheses shows the expression in the original transcripts regardless of language. 
Translation was based on the 'Standard Tetum-English Dictionary' 3fd edition (Hull, 2002) and 
'Kamus Indonesia Inggres' 3fd edition (Echols & Shadily, 1989). 
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Procedures 
Key stages of the Framework approach [145] were followed. Firstly, all transcripts were 
read through to become familiar with the range of diversity and to overview the contents. 
Key ideas and recurrent themes were listed and the general atmosphere was noted. 
After the 'familiarisation' stage, the following thematic indices were identified. Some 
index categories were identical to the topic, and others emerged from the data, as 
Ritchie and Spencer indicate [145). 
1. Knowledge 
1.1 Knowledge of standard treatments of target diseases 
1.2 Knowledge of antibiotic use and vitamin use 
2. Perceptions of STGs and related training 
2.1 Perceptions of their new STGs 
2.2 Perceptions of the training 
3. Positive perception of changes 
4.1 Changes in own practice 
4.2 Perceived changes in patient satisfaction 
4. Desire for improvement 
5. Self-confidence 
6. Attitudes to others 
6.1 Attitudes to patients 
6.2 Attitudes to colleagues 
6.3 Attitudes to foreign doctors 
7. Attitudes to present difficulties / problems 
8. Working conditions 
Some themes directly responded to a specific topic. For example, knowledge of standard 
treatments of target diseases was almost one-to-one correspondence to each sample 
question in the topiC 1 ('standard treatments'). Some other themes were observed 
across the topics such as comments on antibiotic use, which were found throughout. 
Issues related to difficulties/problems also arose from various parts of the interview 
although 'difficulties' were mainly asked in topics 2 (,present practice') and 4 
('difficulties'). Comments on 'changes' were also given outside topic 3, in which 
questions specifically asked about changes after STGs and related training were 
implemented. 
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Moreover, some themes emerged from data gained although they were not directly 
asked for by questions in the topic guide: attitudes to others, in particular to doctors, were 
emergent issues raised by the respondents themselves. On the other hand, answers that 
responded to questions of topic 5 ('requests') showed a wide range of variety, and were 
considered more meaningful if categorised into other themes rather than being put into 
one category of 'requests'. 
For the next stage, the transcripts of the interview notes were indexed according to the 
thematic indices identified. Sometimes one passage could be categorised into more than 
two themes. 'Indexing' was followed by the 'charting' stage, which involves abstraction 
and synthesis. To build up a picture of the data as a whole, data were rearranged 
according to the thematic indices. 
Indexing, sorting and charting were performed in computer-assisted qualitative data 
analysis software (NVivo 7). Findings are presented according to the thematic index in 
chapter 8. The last stage ('interpretation') is presented in the discussion chapter. 
5.5 Preparations 
This section describes the process before the data collection for the main project to 
provide information on the research environment. 
5.5.1 Pilot project 
Prior to the main project, a pilot project was conducted from June 5 to August 9, 2005. 
The objectives of the pilot project were; 1) to understand local conditions, 2) to establish 
contact with the local authority including obtaining official approval from the proposal 
panel in the MoH (Appendix 8), 3) to check the availability of information at several levels 
in the health system, 4) to establish research logistics, and 5) to develop data collection 
tools (eg. the sampling form, observation checklists, summary sheets, interview topic 
guide, and informed consent forms). For the last objective, pilot data collection was 
carried out using preliminary data collection tools in two purposively selected CHCs. 
Another purpose of the pilot was on-the-job training for assistants I translators (hereafter 
assistants). 
For the pilot data collection, the researcher and one assistant visited two CHCs for five 
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days each. One of them was located in a rural sub-district in the most eastern district 
where the local language is dominant. Another CHC was located relatively near the 
capital city where the majority of people speak Tetum. In each CHC, retrospective cases 
were sampled from patient registration books, prospective cases were observed at three 
observation points using preliminary observation checklists, and finally a focus group 
discussion among personnel was conducted. Availability of secondary data in each CHC 
was also checked. During the pilot project some problems were found that needed to be 
solved. 
Firstly, it was necessary to overcome the irregularity of patient registration books. The 
pilot data collection revealed some variation in recording methods between CHCs. For 
example, it depended on the CHC if cases for a specific program, such as antenatal care 
or immunization, were included in the general books or in special books for the program. 
It also depended on the CHC whether they recorded adult consultations and child 
consultations separately or together. Therefore, inclusion and exclusion criteria of 
sampling had to be created. Furthermore, in one of the two CHCs, they recorded chief 
complaints instead of clinical diagnosis, and this necessitated rules being made to define 
diseases from chief complaints when records did not show a diagnosis. 
Secondly, it was necessary to consider how many days would be needed for the 
observation in each CHC. Daily patient visits varied according to the weather, local 
market day or a program implemented on the day, and there were only a few patients on 
the least busy day. Moreover, it was found that health personnel might be rotating their 
tasks. In such a case, data collected for one or two days would be influenced by the 
person in charge of the day and might not represent the general situation of the CHC. At 
least a one-week (five working days) visit for each CHC was considered ideal for the 
quality of prospective observation. For practical reasons, however, fixed sample size per 
CHC, not fixed observation days per CHC, was finally used in the main data collection. 
Another problem was with the focus group discussions. It was observed that members 
with more experience or in higher positions tended to dominate the discussion, and other 
members hesitated to speak. Senior members, especially the manager, also tended to 
show viewpoints from their position, not their personal views. This may have happened 
because they needed to maintain a position in front of the junior staff. Therefore, 
individual interview techniques were used for the main data collection, taking account of 
these weaknesses of group interviews. 
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5.5.2 Data collector training 
Multiple data collectors were essential for this research because it required cases to be 
observed at different points simultaneously. Another reason to employ several members 
of staff was to prepare for the complexity of the language situation in Timor-Leste. Two 
different types of staff were recruited: assistants and data collectors. Assistants were 
expected to speak Tetum, Indonesian and English and to work both in the field and in the 
office including translation and data input, while data collectors worked in Tetum and 
Indonesian in the field. The three major local languages besides Tetum were covered by 
staff members. 
Health professionals were not recruited for the research staff. Because of the small size 
of the country and limited numbers of health professional schools in the area during the 
previous regime, the majority of existing health professionals knew each other, which 
was thought to influence the data collection. Younger people were intentionally chosen 
for the project so that they would make respondents feel at ease when being observed or 
answering questions. 
Eventually, two assistants39 and six data collectors were employed for the main project40 , 
and they were trained on the minimum knowledge and skills for the data collection. The 
process of the data collector training was as below: 
(1) development of training module 
(2) classroom training for basic knowledge, quantitative data collection skills, and 
qualitative data collection skills 
(3) pre-tests 
Training modules were developed by the researcher with two assistants in November 
and December, 2005 followed by the training which started on January 5, 2006. The list 
of contents of the training module and training schedule is given in Appendix 9. The 
classroom training consisted of lectures and role-plays and took 8.5 days in total, 
including a 2.5-day session for qualitative data collection skills by an invited lecturer from 
a research institute in Indonesia. Finally pre-tests were conducted in three CHCs for 9.5 
39 One of them helped in the pilot project. One more assistant, who was an overseas medical 
student, temporarily helped for the data collector training. 
40 Furthermore, two drivers were hired. 
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days. During the process, data collection tools were revised several times based on staff 
feedback, and a review session was held before starting data collection. 
5.5.3 Arrangement of the field visit 
A request letter was distributed to each head of DHSs, asking for collaboration with the 
research. A copy of the approval letter from MoH's Proposal Review Panel (See 
Appendix 8) was attached to the letter. The head of DHS was asked to distribute letters 
to managers of selected CHCs in each district. Since none of the CHCs had a landline 
and the majority of them were without a mobile phone network, DHSs were always the 
first contact to communicate issues related with the research to CHCs. Using the 
organizational structure for the arrangement worked well. The request letter (to DHSs 
and to CHCs) is given in Appendix 10. 
5.6 Unanticipated events during data collection 
Two unexpected events, which affected the research project, emerged during the 
process. One was a fundamental change in the MoH's human resource allocation plan at 
Level 2 facilities. Another was social unrest in the capital city, which made the 
government stop functioning for a while and also forced many people to move away from 
the violence. This section describes these events and explains how they affected the 
project. 
5.6.1 Allocation of foreign medical doctors in Level 2 CHCs 
As described in 3.2.4, the scarcity of medical doctors had been one of the major issues in 
health system rehabilitation and development in Timor-Leste [100, 115, 116]. Policies 
had been planned and implemented with this presupposition. However, a massive 
deployment of nearly 300 Cuban medical doctors was announced on December 2005 
[149]. It was planned that the Cuban Doctors Brigade would stay until young Timorese 
medical students who were studying at medical school in Cuba graduated from school 
and Cuban doctors started to be post in every CHC 41. 
41 Personal conversation with an MoH officer in March 2006 implied that allocating doctors at 
Level 2 had not yet become an official policy amendment and would be modified again. However, 
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The original plan of this research was targeting local health personnel in CHCs where 
there is no doctor in order to improve rural health services in the resource-limited 
situation. Deployment of foreign doctors might influence both the aim and data collection 
of the study. First of all, if the allocation of expatriate and Timorese doctors at Level 2 
was permanent, non-physician consultations would be stopped, and the aim of this 
research would have little meaning. Another concern was whether observation data of 
local health personnel could be gained as planned. Little information about the change of 
local health personnel's work after the foreign doctors' deployment was available before 
the data collection started. Therefore, 'consecutive' samplings were finally planned to 
observe for prospective data, including the foreign doctors' cases. 
After starting the data collection, another issue emerged; many foreign doctors did not 
consent to participate in the research, which made it difficult to collect planned cases. It 
was assumed that the doctors were not well informed about the research and did not 
understand its aim. It was probably because the Doctors Brigade has a different 
organizational structure in the MoH. To establish collaboration with the Doctors Brigade, 
the data collection was suspended and an official letter to Cuban doctors in CHCs, as 
well as the national coordinator of Cuban Doctors Brigade, from a higher official in the 
MoH (Appendix 11) was requested by the author. The situation improved after that. 
5.6.2 Recent crisis in the capital city 
During the data collection, Timor-Leste experienced another crisis. Compared with the 
previous crisis after the Popular Consultation (referendum) in 1999, the scale of the 
incident this time was much smaller and limited to the capital city and some specific 
areas. However, the unstable social and political situation made traumatised people 
frightened again. The incident, which could be traced back to the beginning of 2006, 
peaked with street fighting late in May, and largely (but not completely) settled down in 
mid-July [150]42. 
discussing the background and future possibilities in this change in the human resource allocation 
is beyond the scope of this study. 
42 The origin was the discrimination problem in the military alleged by soldiers from the western 
region. However, the issue was not confined to within the military; rather it was interconnected 
with politics and spread to the daily life of ordinary people. This led to demonstrations, violence by 
hooligans, confrontation among people in the community, and finally street fighting between the 
armed forces and the breakaway group, which started on 23 May, 2006. Members of the national 
police were involved and some were killed or injured. This new outbreak of violence resulted in 
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As the serious situation was geographically confined, it did not affect the data directly. 
Nevertheless, the nationwide emotional conflicts between westerners and easterners 
made field visits for this research difficult, and civil unrest in the capital required the data 
collection to be suspended for a while. From the end of April, 2006, members of the 
research staff originally from the eastern region refused to work in western areas and 
vice versa. During the street fighting in the capital, rural CHCs functioned normally and 
data collection could be continued. In reality, however, members hoped to suspend work 
to escape to their hometown with their families. Finally, field visiting was interrupted for 
one and a half months from May 27 to July 16, 2006, which meant the data collection 
took 5.5 months in total. Fortunately, none of the staff and their family members was 
involved in the violence and field visits could be resumed with the same staff members. 
5.7 Ethical considerations 
The research was approved by the Proposal Review Panel in the MoH, Timor-Leste and 
the Ethics Committee at the London School of Hygiene & Tropical Medicine. (The 
approval letter from the MoH is attached in Appendix 8). 
Informed consent was asked of both health personnel and patients. Oral and written 
information was given to the health personnel, and written consent was obtained from 
those who consented. For patients, oral information was given, and oral consent was 
obtained. The informed consent form used for the health personnel and a sample of the 
oral explanation to the patients is given in Appendix 12. 
On the first day of the visit, the purpose of the research, the procedure for confidentiality, 
and how to respect the respondent's consent were explained to health personnel. 
Respondents were told that they were free to withdraw if they did not feel comfortable 
being observed or interviewed. The informed consent form was then distributed to be 
signed individually. 
absence of law and order in the capital city, and communal fighting as well as looting and burning 
of houses and governmental buildings. The majority of foreigners were evacuated from the 
country. UNHCR reported that 100,000 people were internally displaced. Deployment of 
international forces and the police response to the government's official request on 25 May, 2006 
led to a reduction in serious fighting. [150]The situat ion calmed down after the ex-prime minister 
resigned on 29 June and the new cabinet was formed on 8 July, 2006. However. the situation 
continued to be unstable for several months. 
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Oral information was given to patients by data collectors. Gaining written consent from 
patients was difficult in rural Timor-Leste. The health profile of Timor-Leste indicates 46 
percent of the population of 11 years or older have never attended school, and cannot 
read or write [118]. Even if a person could write his/her name, he/she sometimes 
hesitated to write it in front of others. This was true especially among females in rural 
areas. Asking them to sign their names might have made them uncomfortable even they 
were willing to participate in the study. Therefore, oral consent was considered suitable 
for patients. 
To avoid a patient going home without sufficient information and understanding of the 
dosing schedule, interviewers were instructed to give feedback to CHC personnel if a 
patient did not know the dosing schedule. Although no medical emergency for either 
respondents or staff members happened during data collection, the research team could 
have responded to a case. The location of the data collection is a primary health care 
facility, and the researcher is medically qualified with clinical experience and knew the 
local health system. 
5.8 Researcher's position 
The researcher visited most of the selected CHCs with staff members to supervise them. 
It was necessary in the research circumstances, as mentioned in previous sections, in 
order to control quality of data as well as to manage contingencies. including potential 
risks. However, the researcher did not collect primary data (prospective observations for 
quantitative data and individual interviews for qualitative data) directly for several 
reasons. Firstly, although the researcher could communicate with respondents, 
especially with health personnel, in a common language (Indonesian), it is the third 
language for both parties. The quality of interviewing might have been impaired if 
Indonesian was used43• Secondly, having worked together in the past, many members of 
health personnel knew the researcher, which might have influenced their answers. In 
particular, the researcher's background as a medical doctor could have made health 
personnel feel pressured. 
43 However, Indonesian is still used as an auxiliary language and is the only foreign language for 
many people, so the researcher'S ability to speak and read Indonesian was an advantage. 
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CHAPTER 6 Use of medicines 
This chapter describes the use of medicines in Timor-Leste, using the INRUDIWHO 
'core indicators': prescribing indicators, patient care indicators, and facility indicators. 
The results of prescribing indicators are then compared by prescriber's training. 
6.1 Description of data used 
Retrospective data 
A total of 1,799 cases were obtained. Among them, 26 percent (468/1,799) of samples 
were child cases (under five years old). In two CHCs, child consultation books were not 
found, and all sampled cases were from adult consultation books. Therefore, this might 
underestimate the proportion of child consultations. Male and female cases were almost 
equally distributed. Patient's age group and sex in the retrospective data are shown in 
Table 6-1. 
Table 6-1 Number of cases by patient age group and sex - retrospective data 
male female Total 
under 248 220 468 5 years (26%) 
5 years 620 711 1,331 
and above (74%) 
Total 868 931 1,799 (48%) (52%) (100%) 
From 1,779 encounters, 2,175 illnesses were recorded. The number of recorded illness 
was one to four per encounter. The majority of encounters (1,454/1,799) were recorded 
with only one illness. Among 2,175 recorded illnesses, 1,231 were target diseases 
(ARTis, malaria and diarrhoea). At least one of the three target diseases was recorded in 
1,145 encounters, and these cases were further analysed for adherence to STGs in the 
next chapter. Of the remaining illnesses, 471 were diagnosed with diseases besides the 
three target diseases counted and 473 'no diagnosis'. The majority of records without 
clinical diagnosis (336/473) were for four common complaints (headache, 
musculo-skeletal pains, anorexia and stomach ache). 
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Prospective cases 
The total number of prospective observations was 583, among which 29 percent 
(168/583) of the cases were child consultations. There were more female cases than 
male, but the difference was small. Patient's age group and sex for retrospective data 
are shown in Table 6-2. 
Table 6-2 Number of cases by patient age group and sex - prospective data 
male female total 
under 92 76 168 5 years (29%) 
5 years 183 232 415 and above (71%) 
total 275 308 583 (47%) (53%) 1100%1 
For 583 encounters, a total of 759 illnesses were recorded. The number of recorded 
illnesses per case varied from one to four; however, 74 percent (429/583) of cases were 
recorded with one illness. Among all 759 recorded illnesses, 444 were the three target 
diseases. At least one of the three target diseases was recorded in 380 encounters, 
which were also studied further to investigate adherence to STGs (see chapter 7). Of the 
remaining recorded illnesses, 180 were other clinical diagnosis besides the three target 
diseases, 135 were 'no diagnosis' records. Four common complaints (headache, 
musculo-skeletal pains, anorexia and stomach ache) also accounted for the majority of 
records without clinical diagnosis (111/135). 
Medicines 
All 583 patients were prescribed at least one medicine. One patient left the CHC before 
the medicines were dispensed. The remaining 582 patients received medicine(s) in the 
CHC. In total, 1,461 medicines were dispensed as prescribed, 42 medicines were 
excessively dispensed without being prescribed. Sometimes single dose medicines 
were taken at the dispensing counter under the supervision of health personnel. 
Therefore, 1,482 medicines were taken home by patients, which were assessed in this 
study at the CHC exit. 
68 
Table 6-3 Number of medicines prescribed by health personnel , dispensed at the 
counter, and taken home by patients 
no of cumulative no of medicines 
medicines 
medicines prescribed 1,537 1,537 (prescribed) 
medicines not dispensed - 76 1,461 
medicines excessively 
+42 1,503 (dispensed) dispensed 
medicines taken at the 
- 21 1,482 (taken home) dispensing counter 
Medicines were given to the patient in three types of dosage form : tablets or capsules 
(1 ,205/1 ,482), suspension / syrup (179/1,482) , and external medicines (98/1 ,482) . In 
terms of medicines classifications, 91 percent (1 ,344/1 ,482) of medicines could be 
categorised into any of nine groups44. More than a quarter (383/1 ,482) were analgesics; 
20 percent of which were paracetamol and 6 percent of which were other analgesics. 
Antimalarials and antibiotics represented 17 percent (257/1,482) and 15 percent 
(226/1,482) respectively. Vitamins ranked third and represented 17 percent (254/1 ,482) 
of the total. Forms and categories of medicines are shown in the following charts . 
Figure 6-1 Dosage form of medicines checked 
suspension J syrup 
12% 
extemal use 
7% 
tablet J capsule 
61% 
44 These groups are analgesics, anti-malarials, vitamins, antibiotics, topical medicines, ferrous, 
oral rehydration salts (ORS), anti-helminthics, metronidazole. Medicines in Timor-Leste EML 
categorised in these groups are shown in Appendix 13. 
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Figure 6-2 Category of medicines checked 
metronidazole 
anti-helminthics 1 % others 
2% I 9. ~%:---r-_ 
ORS 
2% 
4% 
topical medicines 
7% 
";tamins 
17% 
6.2 Medicine use indicators 
6.2.1 Prescribing indicators 
Average number of medicines 
Retrospective data showed that 2.4 medicines (95%CI : 2.4 - 2.5) were prescribed per 
encounter, with the lowest CHC result being 1.6 and the highest 3.4 . Sixteen out of 18 
CHCs showed an average of less than three medicines prescribed per encounter. 
Figure 6-3 Average number of medicines and number of CHCs - retrospective data 
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Using prospective data, an average of 2.6 medicines (95%CI : 2.5 - 2.7) were prescribed 
per encounter, which was slightly higher than the result of the retrospective data. The 
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lowest average in the CHCs was 1.6 and the highest was 4.7. Sixteen out of 20 CHCs 
showed an average of less then three medicines per encounter. 
Figure 6-4 Average number of medicines and number of CHCs - prospective data 
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Percentage of encounters with an antibiotic and a vitamin 
Retrospective data showed that an antibiotic was prescribed for a total of 44 percent of 
the encounters (95%CI : 41 - 46) . In five CHCs, more than a half of the cases were 
prescribed an antibiotic. A vitamin was prescribed for 39 percent of the all encounters 
(95%CI : 36 - 41) . CHC's antibiotic prescriptions and vitamin prescriptions varied 
considerably. 
Figure 6-5 Percentage of encounters with an antibiotic and a vitamin and number of 
CHCs - retrospective data 
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Prospective data showed that an antibiotic was prescribed for a total of 39 percent of the 
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encounters (95%CI : 35 - 43), which was sl ightly lower than the results for the 
retrospective data. In six CHCs, more than a half of the cases were prescribed an 
antibiotic. Forty two percent of the all cases observed were prescribed a vitamin (95%CI : 
38 - 46). This number was slightly higher than that for retrospective data. Ranges of 
CHC's antibiotic prescriptions and vitamin prescriptions were wider than those for the 
retrospective data. 
Figure 6-6 Percentage of encounters with an antibiotic and a vitamin and number of 
CHCs - prospective data 
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Percentage of encounters with an injection 
An injection was prescribed in only eight of 1,799 encounters (0.4 percent) in the 
retrospective data, and two of 583 (0.3 percent) in the prospective data. 
6.2.2 Patient care indicators 
Percentage of medicines dispensed 
Of 1,537 prescribed medicines, 1,461 medicines, including those that were taken at the 
counter, were dispensed to patients. Therefore, 95 percent of the medicines prescribed 
were actually dispensed. 
Assessing by case, not by medicine, 86 percent (500/582) of patients were then given 
exactly the same medicines as the prescription without any shortage or excess, including 
medicines taken at the counter. 
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Percentage of medicines label/ed 
Only six (8811,482) percent of medicines were adequately labelled if applying the 
suggested criteria in the INRUOIWHO manual. 
The tables below show the percentage of medicines labelled with each element of 
information (Table 6-4). Although all four elements of information were written on a small 
proportion of the mediCines, 69 percent (1,019/1,482) of medicines were labelled by 
dosage schedule. 
Table 6-4 % of medicines labelled 
% of medicines labelled 
dosage duration· name of patient name of 
schedule medicine 
(N=1,482) (N=1,200) (N=1,482) (N=1,482) 
Total 69% 28% 15% 48% 
(95%CI) (66 - 71) (25 - 30) (14 -17) 145- 501 
lowest CHC's 4% 0% 0% 6% result 
highest CHC's 98% 84% 90% 100% result 
.. .. 
* not asked for Single dose medicines and topical use medicines 
When assessing the label by case, not by medicine, 63 percent (365/582) of patients 
received medicines, all of which were labelled with the dosage schedule. However, all 
four elements of information (dosage schedule, duration of the treatment, name of the 
patient and name of the medicine) for all medicines were provided on the label for only 
two percent (141582) of patients. 
Percentage of patients with knowledge of co"ect dose 
A total of 77 percent of the patients (445/582) correctly answered questions on medicine 
dose (dosage schedule and duration of the treatment) for all the medicines received. 
Checking dosage schedule only, 85 percent (506/582) of the patients knew when to take 
the medicines they had received. 
Table 6-5 shows patient correct knowledge of each element of information (dosage 
schedule, duration of the treatment, and name of the medicine) for each medicine. In 
terms of dosage schedule and duration of the treatment, quite a high percentage of 
medicines were understood by patients while less than a third of medicines were 
understood about name of the medicine. Patient knowledge of dosage schedule and 
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duration of the treatment were higher than the results of labelling of these elements of 
information. 
Table 6-5 Patient correct knowledge 
% of patient correct knowledge 
dosage duration· name of 
schedule medicine 
(N=1,482) (N=1 .200) (N=1 .482) 
Total 93% 88% 27% 
(95%CI) (92 - 95) (86 - 90) (25 - 30) 
lowest CHC's 86% 77% 34% 
result 
highest CHC's 100% 100% 54% 
result 
.. 
• not asked for single dose medicines and topical use medicines 
Reasons for prescription (additional information of patient knowledge) 
Antibiotics and vitamins were thought to be effective for a variety of symptoms. Many 
patients notably misunderstood that vitamins would relieve respiratory symptoms and 
anorexia . 
Figure 6-7 Reasons for antibiotic prescription understood by patients 
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Figure 6-8Reason s for vitamin prescription understood by patients 
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6.2.3 Facility indicators 
A vailability of EML 
I, 
The national EML was available in 15 out of 19 CHCs (79 percent) . 
Availability of guidelines 
The IMCI chart book was available in all but one out of 20 CHCs (95 percent). Among 18 
CHCs where a clinical nurse was in post, text books were fully available in 10 CHCs and 
partially available in 5 CHCs (83 percent in total) . 
Availability of key medicines 
On average, 86 percent of 30 key medicines were in stock. Availability ranged from 57 to 
100 percent. In 11 CHCs, more than 90 percent of key medicines were available. 
6.3 Comparison of prescribing indicators by prescriber's training 
Fifty three prescribers were included in the observation . Of these 53 people, 32 were 
local health personnel and 21 were foreign doctors. The total numbers of cases 
prescribed by local health personnel and by foreign doctors were 350 and 233 
respectively. The number of consultations per person varied from one to 30. The range 
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of the individual result of each indicator was: from 1.6 to 5.9 for the average number of 
medicines, from 0 to 100 for the percentage of encounters with an antibiotic, and 0 to 100 
percent for the percentage of encounters with a vitamin . Seven prescribers prescribed 
vitamins for all cases observed (one or 14 cases) while seven preseribers did not 
prescribe vitamins for any observed case (one or 15 cases). The distribution of the 
prescriber's individual result , both excluding and including doctors, is displayed below. 
Figure 6-9 Prescribing indicators and number of prescribers (excluding doctors) 
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Figure 6-10 Prescribing indicators and number of prescribers (including doctors) 
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Among 32 local health personnel , 15 had attended clinical nurse training, and 22 had 
attended IMCI training . Among 32 local members of health personnel, clinical nurses 
prescribed significantly less antibiotics than non-clinical-nurses. However, two other 
prescribing indicators for the average number of medicines and vitamin prescriptions did 
not show a significant difference between prescribers who had attended clinical nurse 
training and those who had not. None of three prescribing indicators showed a significant 
difference between prescribers who had attended IMCI training and those who had not. 
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Table 6-6 Comparison of prescribing indicators by prescriber's training (excluding 
doctors) 
n median Inter-quartile p-value* 
range 
average number of medicines 
prescribed per encounter 
clinical nurse training 15 2.3 2.0 - 2.8 0.15 
no clinical nurse training 17 2.8 2.2 - 3.2 
IMel training 22 2.5 2.2 - 3.0 0.78 
no IMel training 10 2.6 2.2 - 3.2 
% of encounters 
with an antibiotic prescribed 
clinical nurse training 15 17% 0-27% 
<0.01 
no clinical nurse training 17 54% 36- 89% 
IMel training 22 33% 20- 54% 0.71 
no IMel training 10 39% 17 - 83% 
% of encounters with 
a vitamin prescribed 
clinical nurse training 15 33% 20 - 50% 0.15 
no clinical nurse training 17 56% 27 -70% 
IMel training 22 33% 23-60% 0.56 
no IMel training 10 45% 27 -67% 
* Wilcoxon rank-sum test 
After including foreign medical doctors in the 'no training' group, the same results were 
obtained: among three prescribing indicators tested, only the percentage of antibiotics 
was significantly different between clinical nurses and non-clinical-nurses. 
Table 6-7 Comparison of prescribing indicators by prescriber's training (including 
doctors) 
n median Inter-quartile p-value* range 
average number of medicines 
prescribed per encounter 
clinical nurse training 15 2.3 2.0 - 2.8 0.19 
no clinical nurse training 38 2.7 2.2 - 3.2 
IMel training 22 2.5 2.2 - 3.0 0.83 
no IMel training 31 2.5 2.2 - 3.2 
% of encounters 
with an antibiotic prescribed 
clinical nurse training 15 17% 0-27% 0.01 
no clinical nurse training 38 45% 33 -76% 
IMel training 22 33% 20- 54% 0.39 
no IMel training 31 36% 22 -75% 
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(continued) 
% of encounters with 
a vitamin prescribed 
clinical nurse training 15 33% 17 -62% 0.17 
no clinical nurse training 38 51% 23 -69% 
IMCI training 22 33% 23-60% 0.51 
no IMCI training 31 50% 17 - 67% 
* Wilcoxon rank-sum test 
6.4 Summary of the chapter 
Using retrospective data, an average of 2.4 medicines were prescribed per encounter 
and 2.6 medicines per encounter using prospective data. An antibiotic was prescribed to 
44 percent (retrospective data) or 39 percent (prospective data) of the patients, and a 
vitamin was prescribed to 39 percent (retrospective data) or 42 percent (prospective 
data) of the patients. Prescription of an injection was extremely rare (0.4 percent of 
. retrospective cases and 0.3 percent of prospective cases). Ninety five prescribed 
medicines were actually dispensed. Recommended information was labelled on only six 
percent of the all dispensed medicines. However, among four elements of recommended 
information, a dosage schedule was labelled on nearly 70 percent of the medicines. In 
spite of poor labelling, 77 percent of patients knew how to take the medicines that they 
received correctly. 
Comparing prescribing indicators by prescriber's previous training, health personnel who 
had attended clinical nurse training prescribed significantly less antibiotics. When the 
foreign doctors were included in the 'no training' group, the same result were obtained. 
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CHAPTER 7 Adherence to STGs 
This chapter assesses adherence to STGs for three major diseases (ARTis, malaria, 
and diarrhoea). Adherence to STGs for four healthcare steps (taking a history, 
conducting a physical examination, recording clinical decision, and prescribing 
medicines) is described. The remaining sub-sections focus on the prescribing step, and 
adherence to STGs is then analysed by prescriber characteristics and CHC 
characteristics. 
7.1 Description of data used 
Retrospective data 
Of 1,799 retrospective cases sampled, 1,145 cases were recorded with at least one of 
the conditions: ARTis, malaria and diarrhoea, which were selectively used. The 
proportion of child consultations (under five years) and adult consultations (five years 
and above) was nearly 1:2 and female and male consultations were approximately 
equally distributed, as shown in Table 7-1. Among these target cases, 93 percent of 
cases (1,060/1,145) were recorded with only one target disease, and seven percent of 
cases (85/1,145) were diagnosed with more than two target diseases. Counting each 
disease separately (if a case was recorded with more than two target diseases, each of 
them was counted separately), the numbers of ARTis, malaria and diarrhoea were 793, 
351 and 87 respectively. 
Table 7-1 Patient age group and sex among target cases - retrospective data 
male female total 
under 205 173 378 5 years (33%) 
5 years 358 409 767 
and above (67%) 
total 563 582 1145 (49%) (51%) (100%) 
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Prospective data 
From all 583 prospective cases, the 380 cases that were recorded with at least one of 
ARTis, malaria and diarrhoea were selectively used. The proportion of child 
consultations and adult consultations was approximately 1 :2, and there were more 
female consultations than male consultations, as shown in Table 7-2. Among them, 84 
percent of cases (320/380) were recorded with only one target disease, and 16 percent 
of the cases (601380)) were diagnosed with more than two target diseases. Counting 
each disease separately, the numbers of ARTis, malaria and diarrhoea were 275, 142 
and 27 respectively. 
Table 7-2 Patient age group and sex among target cases - prospective data 
male female total 
under 73 66 139 5 years (37%) 
5 years and 103 138 241 above (63%) 
total 176 204 380 (46%) (54%) (100%) 
7.2 Adherence to 5TGs for four healthcare steps 
Using the 380 prospectively observed cases that were diagnosed with at least one of the 
three target diseases, adherence to 8TGs for four healthcare steps was assessed as 
follows: 
Taking a history 
Thirty seven percent of patients (141/380) were asked questions about the history of 
their present illness during their consultation, as recommended in 8TGs. The highest 
CHC result was 61 percent (11/18) and the lowest was 15 percent (2113). Assessing 
each disease separately, adherence to 8TGs about taking a history of ARTis, malaria 
and diarrhoea was 50 percent (138/275),31 percent (441142) and seven percent (2127) 
respectively. 
Conducting a physical examination 
Twenty four percent of patients (93/380) were given a physical examination based on 
8TGs, with the highest CHC result of 64 percent (7/11), and the lowest of zero percent 
(0/20). Assessing each disease separately, adherence to 8TGs conducting a physical 
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examination of ARTis, malaria and diarrhoea was 46 percent (127/275), 0.7 percent 
(11142) and zero percent (0/27) respectively. 
Recording clinical decision 
Seventy seven percent of the total cases (292/380) were recorded as recommended in 
STGs, with the highest result of 100 percent in four CHCs (11/11, 16116, 19/19 and 
20/20) and the lowest of 25 percent (4/16). Of the three diseases, ARTis showed the 
lowest result with 70 percent (192/275). Many inappropriate records of ARTis were 
merely written as 'ARTI' but did not differentiate upper ARTis and lower ARTis or 
pneumonia and non pneumonia. Most malaria and diarrhoea cases were recorded with 
clinical diagnosis; however, six out of 142 malaria cases and one out of 27 diarrhoea 
cases were recorded with only symptoms. 
Prescribing medicines 
The overall prescribing adherence was 56 percent (213/380), with the highest CHC 
result being 96 percent (24/25) and the lowest being 19 percent (3/16). Among patients 
in which the decision was recorded properly (292 cases), 73 percent (213/292) of 
prescriptions adhered to STGs. Nearly 80 percent (110/142) of malaria patients received 
medicines in accordance with STGs while less than half (134/275) of ARTI cases 
received recommended medicines. 
7.3 Prescribing adherence using retrospective data 
Among 1,145 retrospective samples with at least one of the target conditions, 83 percent 
of the cases (949/1, 145) were recorded in the recommended manner. Other cases were 
recorded with symptoms only or with clinical diagnosis but no further classification. 
Among the appropriately recorded cases, 641 cases were recorded with recommended 
medicines. Therefore, prescribing adherence to STGs was 56 percent of the all target 
cases (641/1,145) and 68 percent (641/949) of the cases that were appropriately 
recorded. 
Assessing each disease separately, prescribing adherence to STGs for ARTis, malaria 
and diarrhoea was 51 percent (406/793) , 72 percent (252/351) and 34 percent (30187) 
respectively. 
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7.4 Prescribing adherence and prescriber characteristics 
In this section, prescriber's individual prescribing adherence is analysed by prescriber 
characteristics using prospective data. 
7.4.1 Prescriber characteristics 
Fifty two prescribers were responsible for the management of 380 target cases. Thirty 
two members of local health personnel were observed in 240 consultations and 20 
foreign doctors in 140 consultations. 
Detailed prescriber information was obtained from 32 local members of health personnel. 
Male members were observed more than female members of health personnel. The 
majority of local prescribers had graduated from basic education, and resided near the 
CHC. Fifteen of 32 personnel were clinical nurses. More than two thirds of the observed 
prescribers had been trained by the IMCI program. A summary of the results is shown in 
Table 7-3. 
Table 7-3 Summary of prescriber characteristics 
prescriber characteristic n 
age 35> 16 
(years) >=35 16 
male 22 sex female 10 
residence· inside 29 
outside 3 
occupational manager 3 
nurse 22 
category 
midwife 7 
civil service level junior 18 
senior 14 
work experience 15> 19 
Jyears) >=15 13 
pre-service basic·· 29 
education higher 3 
IMel training no 10 yes 22 
clinical nurse no 17 
training yes 15 
• whether respondent reSided inSide or outSide the sub-district where the CHC was located . 
•• nursing high school +/- one year diploma for midwifery 
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7.4.2 Comparison of individual prescribing adherence by prescriber 
characteristic 
Of 52 prescribers, including foreign doctors, an average of 7.3 (max 25; min 1) target 
cases was observed. The highest individual result was 100 percent for 11 prescribers 
and the lowest was 0 percent for seven prescribers. Individual prescriber's adherence 
and the number of prescribers are presented in Figure 7-1. 
Figure 7-1 Prescriber's individual prescribing adherence and number of prescribers 
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Table 7-4 shows a comparison of the median and inter-quartile range of individual 
prescribing adherence by prescriber characteristic and p-value of the Wilcoxon rank-sum 
test. Of 32 local members of health personnel , whose 240 consultations were observed, 
prescribers who had attended clinical nurse training showed significantly higher 
prescribing adherence to STGs than those who had not attended the training «0.01). 
Prescribers who had attended IMel training showed a slightly higher prescribing 
adherence than those who had not attended the training ; however, it was not significant. 
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Table 7-4 Comparison of prescribing adherence by prescriber characteristic 
prescriber characteristic 
age 
(years) 
sex 
occupational 
category 
civil service level 
work experience 
(years) 
• 
IMel training 
clinical nurse training 
* Wilcoxon rank-sum test 
** including managers 
35> 
>=35 
male 
female 
nurse* 
midwife 
junior 
senior 
15> 
>=15 
no 
yes 
no 
yes 
n median inter-quartile 
range 
16 65% 46-85% 
16 68% 42 -100% 
22 68% 43 -100% 
10 62% 44-80% 
25 67% 43-96% 
7 67% 44-80% 
18 62% 50 - 80% 
14 79% 43 -100% 
19 67% 50 - 92% 
13 67% 40 -100% 
10 47% 20 - 90% 
22 68% 57 - 96% 
17 50% 33 -67% 
15 90% 64 -100% 
p-value* 
0.62 
0.36 
0.71 
0.21 
0.94 
0.13 
<0.01 
Prescribing adherence in relation to prescriber's previous training was examined further, 
as shown in Table 7-5. Five of 32 local prescribers had attended neither clinical nurse 
training nor IMCI training, and their prescribing adherence was significantly lower than 
those who had attended at least one of two training sessions (p<O.01). Prescribing 
adherence for those who had attended both clinical nurse training and IMCI training was 
the highest with a median of 92% although it was not compared statistically. 
Table 7-5 Comparison of prescribing adherence by prescriber's training 
prescriber's training n median Inter-quartile p-value* range 
any tralnlng** no 5 20% 20-40% <0.01 yes 27 70% 57 - 100% 
none 5 20% 20-40% 
IMClonly 12 62% 42 - 80% 
type of training clinical nurse 5 90% 60 -100% NA*** only 
both 10 92% 67 - 100% 
* Wilcoxon rank-sum test 
** any of IMCI or clinical nurse training 
*** Wilcoxon rank-sum test is not applicable for binominal variable. 
Including foreign doctor consultations and counting them in the 'no training' group for 
both IMCI and clinical nurse training for the purpose of the analysis, clinical nurse 
prescribers still showed a significantly higher prescribing adherence than the others 
(p<O.01). IMCI trained prescribers also showed significantly higher prescribing 
85 
adherence than the others (p<0.01). Prescribers who had not attended either training, 
including 20 foreign doctors, showed significantly lower prescribing adherence than 
those who attended at least one of the two kinds of training (p<0.01). 
Table 7-6Compa rison of prescribing adherence by prescriber's training (including 
doctors) 
prescriber's training n median inter-quartile p-value* range 
IMCI training no 30 38% 20 -60% <0.01 yes 22 68% 57 - 96% 
clinical nurse training no 37 40% 20-67% <0.01 yes 15 90% 64 -100% 
any training no 25 25% 14 - 50% <0.01 yes 27 70% 57 -100% 
* Wilcoxon rank-sum test 
7.4.3 Logistic regression analysis of prescribing adherence 
Analysing 240 target cases that were managed by local health personnel, the crude odds 
ratio of prescribing adherence for each prescriber characteristic suggested there was a 
strong association between prescribing adherence and prescriber's clinical nurse 
training. A weak association between prescribing adherence and prescriber's IMCI 
training was also indicated. 
Table 7-7 Crude odds ratio of prescribing adherence for each prescriber characteristic 
after taking into account prescriber clustering 
prescriber characteristic crude 95%CI p-value* n OR 
age 35> 136 1 
(years) =>35 104 1.3 0.4 -4.0 0.61 
male 168 1 
sex female 72 0.5 0.1 - 1.4 0.17 
occupational nurse** 197 1 
category midwife 43 0.5 0.1-1.9 0.34 
civil service level junior 149 1 senior 91 1.5 0.5 -4.8 0.47 
work experience 15> 159 1 
(years) =>15 81 0.9 0.3 - 2.8 0.89 
IMCI training no 79 1 yes 161 2.8 0.9 - 8.0 0.06 
clinical nurse training no 111 1 yes 129 5.4 2.1 -13.8 <0.01 
* Wald test 
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** including manager 
The odds ratio of prescribing adherence for prescriber's clinical training was investigated 
after adjusting for another factor. Prescriber's work experience, civil service level and 
sex were found as possible confounders for the association between prescribing 
adherence and prescriber's clinical nurse training. There was no evidence of effect 
modification between clinical training and each of these three variables. 
Table 7-8 Adjusted odds ratio of prescribing adherence for prescriber's clinical nurse 
training after taking into account prescriber clustering 
adjusted for adjusted 95%CI OR 
age 5.6 2.2 - 14.7 
sex 5.0 1.9-13.0 
occupational 5.3 2.0-13.9 category 
civil service level 5.9 2.3-15.2 
work experience 7.1 2.7 -18.5 
IMel training 5.4 2.3 -12.6 
The final logistic regression model demonstrated that there was an association between 
prescribing adherence and prescriber's clinical nurse training at a Significant level 
«0.01) after taking into account confounders (prescriber's work experience, civil service 
level and sex) as well as prescriber clustering. The adjusted odds ratio for prescribing 
adherence in the final model was 6.6 (95%CI: 2.5 -17.6). 
Investigating the adjusted odds ratios for prescribing adherence for prescriber's IMCI 
training, only adjusting for prescriber's clinical nurse training made a change from the 
crude odds ratio. The odds ratio for prescriber's IMCI training adjusted for clinical nurse 
training was 2.9 (95%CI: 1.2 - 6.8) at a significant level (p=0.02). 
7.5 Prescribing adherence and CHC characteristics 
CHC's overall prescribing adherence was compared by CHC characteristics using both 
retrospective and prospective data. 
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7.5.1 CHC characteristics 
Complete information was obtained at 16 CHCst but four CHCs had some missing data. 
A summary of CHC characteristics is shown below. 
Table 7-9 Summary of CHC characteristics 
CHC characteristicn 
east 5 
region south 8 
south-central 2 
west 3 
sub-district 10000> 10 
population 
>=10000 10 (people) 
annual 1000> 8 
workload * ** 
(case/person) >=1000 10 
no of 6> 10 
health personnel·· 
>=6 (people) 10 
total members 70> 11 
tralned*· 
(%) >=70 9 
total period of 3> 9 
training ** •• * 
>=3 11 (weeks/person) 
availability of 90> 8 
key medicines···· 
>=90 11 (%) 
availability of EML •••• 
yes 15 
no 4 
availability of yes 19 
IMel chart book no 1 
availability of complete 10 
clinical nurse partial 5 
textbooks····· no 3 
* Data was obtained in 18 CHCs where retrospective data was collected 45. 
** excluding nurse assistants46 
45 In CHCs where information was missing in patient registration books, the count was adjusted 
according to missing days. 
46 Although nurse assistants are counted as health personnel in official documents in the MoH, 
they were not included in the number of health personnel here. They are mainly working for 
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*** The IMCI training and clinical nurse training were counted for two weeks and twelve weeks 
respectively. 
**** Data was obtained in 19 CHC. 
***** Data was obtained in 18 CHCs where a clinical nurse in post. 
7.5.2 Comparison of CHC's overall prescribing adherence by CHC 
characteristic 
Retrospective data 
Based on the retrospective data, the average number of target cases per CHC among 18 
CHCs was 64 (max 78, min 51) . The CHC's highest prescribing adherence was 88 
percent (64/73) and the lowest was 12 percent (8/67). The distribution of the results is 
presented in Figure 7-2. 
Figure 7-2 CHC's overall prescribing adherence and number of CHCs - retrospective 
data 
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There was no significant difference in CHC's overall prescribing adherence compared by 
each CHC characteristic, as presented in Table 7-10. CHCs with more members of 
health personnel showed a higher prescribing adherence than other CHCs, but it was not 
significant. The total number of members trained and total period of training did not show 
a difference in prescribing adherence. 
registering patients or dispensing medicines and are unlikely to be involved in consultations and 
prescriptions. Moreover, they usually do not attend clinical training. 
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Table 7-10 Comparison of CHC's overall prescribing adherence by CHC characteristic-
retrospective data 
CHC 
n median Inter-quartile p-value* 
characteristics range 
sub-district 10000> 9 56% 35 -64% 
population 0.16 
(people) >=10000 9 63% 59 -70% 
annual 1000> 8 62% 48 - 77% 
workload 0.45 
(case/person) >=1000 10 60% 40 - 65% 
no of 6> 10 58% 35 - 64% 
health personnel 0.08 
(people) >=6 8 66% 57 - 77% 
total members 70> 10 60% 54 - 63% 
trained 0.53 
(%) >=70 8 64% 38 - 75% 
total period of 3> 8 58% 40 - 67% 
training 0.56 
(weeks/person) >=3 10 62% 54 - 70% 
* Wilcoxon rank-sum test 
Prospective data 
Based on the prospective data, the average number of target cases among 20 CHCs 
was 19 (max 25, min 11). The CHC's highest prescribing adherence was 96 percent 
(24/25) and the lowest was19 percent (3/16) . The distribution of the results is presented 
in Figure 7-3. 
Figure 7-3 CHC's overall prescribing adherence and number of CHCs - prospective data 
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There was no significant difference in CHC's overall prescribing adherence when 
compared with each CHC characteristic, including total inputs of training (total members 
trained and total period of training). 
Table 7-11 Comparison of CHC's overall prescribing adherence by CHC characteristic-
prospective data 
CHC median inter-quartile p-value* 
characteristic n ranae 
sub-dlstrlct 10000> 10 48% 41 -63% 
population 0.88 
(people) >=10000 10 59% 36 - 82% 
annual 1000> 8 48% 33-77% 
workload 0.93 
(case/person) >=1000 10 51% 40-63% 
no of 6> 10 53% 41-63% 
health personnel 0.85 
(people) >=6 10 54% 36- 83% 
total members 70> 11 50% 36-79% 
trained 0.54 
(%) >=70 9 55% 45- 82% 
total period of 3> 9 40% 29-63% 
training 0.16 
(weeks/person) >=3 11 62% 45- 82% 
availability of 90> 8 57% 43- 80% 
key medicines 1.00 
(%) >=90 11 55% 40- 83% 
* Wilcoxon rank-sum test 
7.6 Summary of the chapter 
Using prospective data, adherence to STGs for each step: taking a history, conducting a 
physical examination, recording clinical decision, and prescribing medicines, was 37 
percent, 24 percent, 77 percent and 56 percent respectively. Prescribing adherence 
based on the retrospective data was also 56 percent. 
Individual prescribing adherence was strongly associated with prescriber's clinical 
training, and weakly associated with prescriber's IMCI training assessed by univariate 
analysis. After taking into account prescriber clustering, the adjusted odds ratio of 
prescribing adherence for prescriber's clinical nurse training was 6.6 (95%CI: 2.5 - 17.6), 
and for IMCI training was 2.9 (95%CI: 1.2 - 6.8). None of the CHC characteristics was 
associated with CHC's overall prescribing adherence. 
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CHAPTER 8 Knowledge and attitudes 
This chapter describes health personnel's knowledge and attitudes regarding the use of 
medicines, especially prescribing adherence to STGs. It looks at individual interview 
data obtained from health personnel. In this chapter, the results are displayed according 
to thematic indices identified (See 5.4.3) 
8.1 Respondents 
As explained in 5.2.2, stratified purposive sampling was employed to target three groups 
of local health personnel: managers, clinical nurses, and other health personnel. The 
final sample size was 16 managers, 18 clinical nurses and 21 members of 'other health 
personnel'. Younger and less experienced people were purposively selected for 'other 
health personnel' in order to collect wider views as well as to compare them with 
managers and clinical nurses. However, the youngest or least experienced member was 
not always chosen. Selection of the members of 'other health personnel' was sometimes 
influenced by availability of members on the interview day or manager's 
recommendation. 
Table 8-1 summarises respondent attributes. Of all 55 respondents, 36 had attended 
IMCI training. Twelve respondents had both clinical nurse and IMCI training. Thirteen 
respondents had neither. Although it was expected in the original plan to choose 
interviewees from those who were observed, eighteen respondents (10 managers, three 
clinical nurses and five other members) were involved in neither prescribing nor 
dispensing medicines during data collection 47 • 
47 In some CHCs, after the arrival of the foreign doctors only a few cases (or even no cases) were 
managed by local members of health personnel and it was difficult to interview exclusively local 
health personnel who had done consultations. 
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Table 8-1 Interviewee characteristics and sampling group 
sampling group 
other total 
characteristics manager clinical nurse health 
personnel 
(n=16) (n=18) (n=21) (n=55) 
35> 2 5 11 18 
age 
>=35 14 13 10 37 
male 16 16 10 42 
sex female 0 2 11 13 
occupational nurse 16 17 16 49 
category midwife 0 1 5 6 
civil service level senior 16 
13 3 32 
junior 0 5 18 23 
work experience 15> 
4 6 15 25 
>=15 12 12 6 30 
pre-service basic 14 17 21 51 
education higher 2 1 1 4 
clinical nurse yes 0 18 0 18 
training no 16 0 21 37 
IMel training yes 13 12 11 36 
no 3 6 10 19 
8.2 Knowledge of standard treatment 
This section describes respondent knowledge of standard treatment. The first· 
sub-section (8.2.1) considers the use of medicines for three target diseases (ARTis, 
malaria and diarrhoea), and answers questions of the topic 1 ('standard treatments'). In 
the last sub-section (8.2.2) collected interviewee comments in relation to antibiotic use 
and vitamin use, which were found more widely across the questions, are analysed. 
8.2.1 Knowledge of standard treatments for ARTIs, malaria and diarrhoea 
ARTis 
All the three key pOints of ARTI management (see 3.4) were referred to by more than a 
third of interviewees. Half of the clinical nurse interviewees suggested that certain types 
of upper ARTis also required antibiotic therapy, which the clinical nurse textbook 
indicates. 
Apart from a few exceptions, statements given in clinical nurses' answers did not 
contradict recommendations in STGs. The exceptions were: one clinical nurse said that 
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all ARTis required an antibiotic and another clinical nurse suggested that the 
seriousness of the illness determined antibiotic indication. 
On the other hand, several non-clinical-nurse interviews indicated antibiotic therapy for 
all ARTis or upper ARTis. Their criteria for antibiotic indication are seriousness of the 
illness, duration of the illness, type of sputum, and presence of a high fever. None of 
these criteria are recommended in STGs. One nurse indicated chloramphenicol, which is 
not listed as a daily use oral antibiotic in Timor-Leste's EML for Level 1-2 facilities. 
Malaria 
Treatment for clinically suspected malaria without a blood smear test was well known 
among respondents. Some people, who worked for the CHCs with a laboratory, 
indicated procedures based on a blood smear test. Only one respondent suggested that 
treatment for clinically suspected malaria was chloroquine, which is not recommended in 
STGs because chloroquine resistant P. falciparum had been reported in Timor-Leste. 
Although the majority of respondents specified recommended malaria management, 
some suggested treatments that STGs do not recommend. For example. using two kinds 
of medicine (Fansidar and chloroquine) for a specific type of malaria diagnosed by a 
blood smear test was suggested. However, it is unnecessary to combine them if the 
malaria type is known. One respondent gave the recommended medicines for P. 
falciparum and P. vivax the wrong way round. Misunderstandings of primaquine use 
were also detected. Some respondents stated that primaquine was the second line 
medicine after the first line treatment failure, and others believed that quinine could be 
used as an alternative to primaquine. 
Diarrhoea 
While nearly all clinical nurses knew that oral rehydration was the principal treatment for 
simple acute diarrhoea and that an antibiotic was not necessary, less than half of the 
non-clinical-nurses indicated these points. Treatment of dysentery was shown by nearly 
half of the respondents. However, nobody clearly explained treatment of persistent 
diarrhoea as recommended in STGs. 
Some of the respondents seemed to be confused with how to use an antibiotic or 
metronidazole for diarrhoeal patients. Some indicated an antibiotic or metronidazole 
without mentioning blood in the stool. Others indicated only metronidazole for treatment 
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of dysentery although STGs recommend the use of an antibiotic (cotrimoxazole or 
nalidixic acid) first. for suspected shigellosis, and then metronidazole for suspected 
amebiasis. Quite a few interviewees specified incorrect criteria for antibiotic indication 
such as seriousness of diarrhoea and duration of the illness. Apart from one exception, 
all respondents who answered in this way were non-clinical-nurses. Antibiotics that were 
not recommended in the diarrhoea STGs were occasionally listed by interviewees. 
Several members indicated chloramphenicol, which is registered as an emergency 
injection for Level 2 CHCs. 
8.2.2 Knowledge of antibiotic use and vitamin use 
Antibiotic use 
As described in 8.2.1, respondents, in general, understood well when to use antibiotics 
for patients. More accurate knowledge was shown by clinical nurses than others. 
Some interviewees suggested that 'serious (berat), illness or a long history of illness 
(sometimes specifying a period which was different from that in STGs48) were criteria for 
antibiotic use for ARTis and diarrhoea. Nobody indicated an antibiotic as treatment for 
suspected malaria 49 • Aside from a small number of exceptions, the antibiotics that 
interviewees indicated in their answers were those in the EML for Level 1-2 facilities. 
In many comments, respondents did not merely cite the indications of the antibiotic use 
but also specified when they did not use antibiotics; ego common colds, no pneumonia, 
and acute simple diarrhoea. Some suggested their antibiotic use had been improved 
after STGs were introduced. 
'Before training, antibiotic use was too high, but now we do a comprehensive 
examination [and] we do not give antibiotics random/y .... for example, we give 
antibiotics for pneumonia but we give only paracetamol for a common cold. ' 
(Clinical nurse) 
48 The clinical nurse textbook for tuberculosis, which is based on the National Tuberculosis 
Program, only indicates a trial antibiotic to the patients with more than 3-week cough and negative 
sputum smear. 
49 1n the transcript of one respondent, who was 'other health personnel', the phrase 'malaria 
antibiotics (antibiotika malaria)' was used, but considering her context, she intended to say 
'anti-malaria Is' . 
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'I feel there are differences, for example, we only gave antibiotics for only 
one day for severe diseases, but after training, we give antibiotics for five 
days to patients with ARTIs.' (clinical nurse) 
Although interviewees demonstrated their knowledge of inappropriate overuse of 
antibiotics, they rarely gave the reasons. Only one respondent pointed out antibiotic 
resistance as below. 
' .... overuse of antibiotics is not very good for health. If antibiotics are used too 
much, resistance can emerge. For example, [suppose] I have an ampicillin 
injection everyday, if I get gonorrhoea, ampicillin cannot cure [it).' (other 
health personnel) 
Vitamin use 
A few respondents said that vitamins did not cure diseases. A few indicated that vitamins 
were contained in food, especially in vegetables, and usually vitamin tablets were not 
necessary. A couple of respondents acknowledged that they prescribed vitamins to 
satisfy patients or to avoid being criticised for doing nothing when the patients actually 
did not need medication. However, the majority believed vitamins were effective for 
certain types of patient condition. Some interviewees said they prescribed a vitamin for 
all cases. 
The most frequently cited answer was that vitamins worked for appetite loss. Some of 
them indicated more specifically that vitamins could improve or restore the appetite after 
recovery from a certain disease, ego ARTis or malaria. 
The second most frequent comment was that vitamins could improve anaemia, 
sometimes mentioning 'vitamin iron' or 'vitamin SF (sulphate ferrous)'. One possibility for 
this answer was that they mistook iron for a vitamin. 'Vitamins for pregnancy' might lead 
to the same misunderstanding. 
Malnutrition as a reason for a vitamin prescription was also evident in many answers: 
'malnutrition (malnutris/)', or 'shortage of nutrition (kurang giz/)'. Some believed vitamins 
were effective for general conditions, such as regaining 'energy (forca)" 'stamina 
(stamina)" or 'spirit (semangat)', and so on. 
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Quite a few respondents thought that vitamins were needed for ARTI patients or were 
effective against respiratory symptoms such as a cough. Many of these answers 
specifically indicated vitamins for upper ARTis or common colds, for example, 'there is 
no indication of an antibiotic for a common cold but it needs vitamins'. Early recovery or 
relief from respiratory symptoms were believed to be reasons for vitamin use. Vitamins 
for malaria were also referred to. As mentioned before, the context of many of the 
answers suggests that respondents mistook iron for a vitamin. Some interviewees said 
vitamins could stimulate appetite lost by malaria infections. Vitamins for diarrhoea were 
indicated although it was less frequent than vitamins for ARTis or malaria. One 
respondent said that a vitamin could function as fluid replacement, and another 
suggested it should be given to a patient with recurrent diarrhoea. 
Unlike knowledge of antibiotic use that showed a clear contrast between clinical nurses 
and others, misunderstandings of vitamin use were given by respondents regardless of 
their previous training. 
8.3 Perceptions of 5TGs and related training 
In this section, respondent perceptions of STGs and the training that introduced standard 
treatments are described. They were mainly made in responses to topic 3 ('changes'). 
However, comments on what they thought of their new STGs were found across the 
questions. 
8.3.1 Perceptions of their new 5TGs 
All of the respondents were aware of the existence of their new STGs 50 such as the IMel 
chart-book, clinical nurse training textbooks and National Protocol of Malaria 
Management. Health personnel perceived STGs positively. None of the respondents 
expressed negative perceptions although a few of them, who had not yet attended 
training, answered that they had not yet read them because they were busy, The most 
50 Respondents used several terms to describe their STGs: protocol (protokol), manual (pedoman 
or manual) or guidelines (petunjuk) in Indonesian. They used Indonesian terms probably because 
they had been familiar with these Indonesian vocabularies since the Indonesian occupation 
period and did not have the equivalent terms in their own language, yet. In this chapter, 'STG' was 
used to translate these terms whatever their original expression. 
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commonly used word to describe STGs was 'advantage (manfaat)' or 'useful 
(bermanfaat), 51. They said that STGs could 'help (ajuda)', 'support (melindugl)' or 
'facilitate (facilita), them, and also could 'increase capacity (aumenta kapasidade)' or 
'add concepts (aumenta wawasan)'. 
'STGs are useful, they help us to give treatment and [they] support nurses. ' 
(clinical nurse) 
'All STGs here can facilitate us to carry out treatment.' (manager) 
The role of STGs was described as a 'teacher (mistre,gu ru)' or 'path (dalan)' to follow. 
'STGs have a great advantage because they resemble a teacher if we have 
difficulties. ' (clinical nurse) 
'These STGs are very good because they can give a good path for us and 
our staff [so that] they can give treatment for patients.' (manager) 
The fact that they could open STGs repeatedly appeared beneficial for respondents. 
They found their new STGs useful because they could look at them again when they 
forgot something or faced a problem. 
'STGs are useful because when we forget [something] or have difficulties in 
giving treatment, we can open STGs that we have again. ' (clinical nurse) 
Interviewees positively perceived standardisation of treatments after the introduction of 
STGs. No one disagreed with or refused to accept the concept of STGs in general or a 
specific STG. 
'Treatment in this CHC is the same although the nurse is different because 
all [nurses] use STGs, and because STGs form criteria for treatments. ' (other 
health personnel) 
51 These two Indonesian words have the same stem. All of them were found in Indonesian in the 
original transcripts, a total of 58 times from 39 respondents. 
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They seemed to believe that they needed to comply with the instructions in STGs, and 
used the word 'should (tenkl), quite often. Two directions of thinking were identified in 
their answers to support this attitude that they 'should' follow STGs. Firstly, they were 
aware of themselves as frontline workers in the community. They realised that nobody 
else could treat people and felt the need to improve the quality of their services. 
'Sick people should come to [see] the nurse because there is nowhere else 
they do (=receive) treatment. Importantly, we, as the nurses, are ready and 
can do something for the Timorese.' (clinical nurse) 
Secondly, it was found that they were obedient to the authorities as peripheral civil 
servants. Some respondents believed STGs were reliable because they were developed 
by experts in the MoH and WHO so then health personnel should 'just follow (halo tuir 
deit)' any decision indicated by STGs. Several interviewees, all of them categorised in 
'other health personnel', used 'big people (boot sira)' or 'superiors (atasan)' 52 to 
describe the authorities or a 'small person (ema kiik)' for themselves. 
'These STGs are something good because, as I know, intelligent people 
made them.' (manager) 
'This is the Ministry policy, they worked together with WHO when making 
STGs. So, there have never been negative effects for us so far.' (manager) 
' .... we have STGs from international [organisations] that we just follow.' 
(other health personnel) 
'We follow what big people give'. (other health personnel) 
8.3.2 Perceptions of training 
Respondents also positively perceived the training that introduced STGs. They said 
training had been 'useful (bermanfaat), and 'helpful (ajuda)' to make them understand 
the contents of STGs and to be able to give treatment according to STGs. Training could 
increase their capacity, and health personnel could acquire knowledge they had not had 
before they attended the training. 
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'Good. The training that we got (=attended) was very good because [it] can 
help our services as well as increase our capacity .... what we did not know, 
we could find out through training.' (other health personnel) 
'The advantage of the training [is that we] are able to give treatment 
according to STGs.' (clinical nurse) 
They valued getting actual 'experiences (esperiencia, penga/aman), during training, for 
example, how to use a stethoscope, following instructions in STGs. They could share 
experiences with other participants during training. 
'Attending training is the same as giving (=getting) more experience for us. ' 
(other health personnel) 
' .... and with training, we could also share our experience with colleagues. ' 
(clinical nurse) 
Some of them had doubts. Respondents who had been trained hoped that they could 
feedback the results of training to their colleagues but their comments implied it did not 
work well. One clinical nurse had wished to share his new knowledge but he implicitly 
stated it had been difficult. On the other hand, a junior nurse who had not yet attended 
training accused her senior colleague of not feeding back the results of the training to 
co-workers in the CHC. Both sides, however, did not specifically indicate what kind of 
feedback they expected to offer or receive, and exact expectations of training feedback 
in the CHC were not known. One manager complained that supervision was not 
adequate after the training. A few respondents raised the question of whether training 
really matched the situation in CHCs. 
'Regarding the training, [although] the training uses a lot of money, 
sometimes they do not do anything, so [I] just hope there is more supervision 
about (=after) the training, for example, 6 or 7 times . . (manager) 
52 These words are sometimes used to indicate a person in an upper position in the workplace. 
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'Here, only Mana53 IMCI attended [training], but [after] she came [back], she 
did not tell us [what she had learnt).' (other health personnel) 
8.4 Positive perception of changes 
'Changes after STGs and related training' was the main issue of topic 3. However, a 
contrast between 'before (uluk, sebelum) , and 'now (agora, sekarang)' or 'after (depois, 
setelah)' was observed quite often beyond the answers in topic 354. Some respondents 
compared their present practice with before, and others showed what patient changes 
they perceived as a consequence of their change. 
8.4.1 Changes in own practice 
Having standard treatments seemed to bring differences to their daily work. Some 
interviewees viewed the change as being connected to the restored sovereignty 
(independence) of the nation. 
'Before, we gave treatment based on experience, but [now, after] 
Timor-Leste independence, we are using STGs.' (Clinical nurse) 
'There are differences. Before we had the training, we used experiences 
during the Indonesian time. Now is better. There are good results, and after 
attending the training, better.' (clinical nurse) 
'From 2001 to 2003, we did (practices) according to [what we had learned 
during the time of] Indonesia, from 2004 to the present, we are doing 
according to STGs - STGs gave a big change to us. ' (manager) 
After the international NGOs left, local health personnel needed to do consultations by 
themselves (See 3.1 and 3.2). However, before the introduction of STGs and related 
training, they lacked confidence in their own practice because they had been relying only 
53 A courtesy title to call an elder woman 
54 Forty seven passages (including some equivalent expressions) described this contrast from a 
total of 29 observed respondents. 
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on their own experience. They had perceived their previous practices were 'random 
(arbiru)', 'perfunctory (asa/-asa!)', 'uncertain (ragu-ragu)', or 'disordered (naran deit)'. 
'Before IMCI training, we were following what we learnt in school, after IMCI, 
we follow the IMCI chart-book that [we] have already had. ' (manager) 
'Before, [we] worked perfunctorily, but now, with adequate STGs, [we] 
satisfy patients.' (clinical nurse) 
'Before, [I] gave antibiotic randomly, but there is a big improvement for me 
because after [I] have STGs, I give treatment with confidence.' (clinical 
nurse) 
Respondents expressed their changes not only in general concepts but also in actual 
and concrete examples from their daily practice: they began to give a detailed physical 
examination; not to use injections very much; not to use antibiotics for patients with 
common colds or simple diarrhoea; to use chloroquine and Fansidar at the same time for 
suspected malaria patients; to use age and weight to decide a dose of medicine for child 
cases; and to give advice to patients. 
One interviewee said they could not rely only on their own experience because 
knowledge was updated year by year, and using STGs had advantages. Another 
respondent raised a similar issue but in a different way. He commented that they could 
not follow the present STGs forever because knowledge was always changing. Some 
hoped to have prompt information from the MoH in the case of any update to STGs. 
'When there is a change in health issues, it should not arrive in the CHC too 
late.' (clinical nurse) 
8.4.2 Perceived changes in patient satisfaction 
Patient satisfaction was considered to depend on 'only each patient's idea (idak-idak 
hanoin deit). However, respondents believed patients were more satisfied with their 
practice than before. They thought that they could satisfy patients if patients got well, 
especially in cases when they recovered early. They also believed that a careful 
examination, which they had learnt as 'comprehensive patient management' in training, 
made patients contented. It was said that patients were glad if they were given concrete 
explanations or if they were told they did not have a serious condition. 
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'Patients feel contented with our care because after they take the medicines 
that we give, they feel a difference. Concerning [if they are] satisfied or not, it 
depends on each patient. ' (manager) 
'Patients are contented with our care now because we give an examination 
from head to feet.' (clinical nurse) 
They listed the reasons why they thought that patients were satisfied: the number of 
visits had increased; patients expressed their appreciation; patients did not get angry or 
complain; patients were supportive; and there was no trouble between the CHC and the 
community. 
A few respondents felt that patients could not understand what they had newly learnt. 
Their new practice might have disappointed patients because it did not meet patient 
specific preference. ego injection. capsule. or polipharmacy. 
'A majority of patients understand how to take medicines. They are 
contented, but some of them are not vel}' contented because they hoped to 
get an injection following their own experience.' (clinical nurse) 
'About patients who are not contented, they do not yet understand what 
counselling is.' (other health) 
8.5 Desire for improvement 
Respondents' desire 'to increase capacity (aumenta kapasidade)' was frequently 
observed55 in answers to topic 3 ('changes'), 4 ('difficulties') and 5 ('requests'). Some of 
the interviewees said they felt their capacity had increased after having STGs or 
attending the training, and others said they wished to increase their own or colleagues' 
capacity 'more (tan)'. 
55 Seventeen passages including 'to increase I improve capacity (aumenta / hadia kapasidade), 
and 5 more similar expressions were found. 
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'If possible, [I would like] more training for other colleagues and for us, clinical 
nurses, in order to increase our capacities.' (clinical nurse) 
These answers expressed their feeling that their capacity had increased as a result of 
the training as well as their hope that they would increase their capacity more in the 
future. It was difficult to find directly from the interviews whether they had wished to 
'increase capacity' before the introduction of the new STGs. Since respondents had felt a 
lack of confidence in their practice before, it was assumed that their hope for increasing 
capacity might have developed since they became responsible for consultations. 
In terms of future STGs, some suggested general, non-specific requests such as 'what 
was not included in the current STGs', but others specified certain diseases. 
Hypertension, asthma, sexually transmitted diseases, gastritis, cancer and AIDS were 
referred to by more than two respondents. It was not clear from the interviews why they 
hoped these diseases would be included in future STGs. In particular, cancers and AIDS 
were unlikely to be urgent issues in the rural community based on the morbidity rates, 
and their real intentions of the answers were undetermined. 
Some clinical nurses hoped other members of the health personnel would have clinical 
nurse training. Several of them suggested that clinical nurse training was necessary for 
all nurses. One clinical nurse asked for more clinical nurses so that they could help each 
other. There was a real need for clinical nurses in health posts that were located in 
remote areas. 
'Present training will be better if two or three nurses in a CHC attend it in 
order to help each other.' (clinical nurse) 
'I hope [the MoH] will increase [the number of] clinical nurses in CHC 6 
because [we] have only one clinical nurse, and hope to have clinical nurses 
in the health posts, too'. (manager) 
'If possible, [I hope the MoH] will increase [the number of] clinical nurses in 
this CHC because in this CHC [area] many people live far from CHC.' (other 
health personnel) 
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8.6 Self-confidence 
Although 'self-confidence' was not directly asked about in the interview topics, many 
comments were obtained in this connection. Remarks were mainly found in responses to 
topic 2 (,present practice'). However, relevant comments were given across the topics. 
Respondents in general were confident in their present practice, and described this 
using expressions such as 'good (diak)" 'correct (/oos)', 'sure (ho fir an, yakin)', and so 
on. 
The treatment that they (=my staff) give is good, there is no bad thing (=none 
of them is bad). ' (manager) 
'[IJ don't say [treatments areJ 100 percent con-ect, according to my opinion, 
80 percent of treatments are correct.' (clinical nurse) 
' .... we also feel patients are contented because we treat them well.' (other 
health personnel) 
As mentioned in 8.3.1, they were aware that they were only the people who could treat 
sick people. Self-awareness of their responsibilities could be found in the attitudes 
towards prescribing practice. They said that patients sometimes expected or demanded 
unnecessary medicines. Health personnel believed that they were responsible for giving 
medicines to the patient and should not submit to patient expectations if inappropriate. 
Moreover, they should explain what the patient actually needed and should not prescribe 
medicines inappropriately. Related comments were dominant among clinical nurse 
answers. 
'In reality, patients come to the CHC [as theyJ hope to receive medicines. 
Sometimes a patient comes [andJ says (=complains) that there are not 
enough medicines [prescribed). However, we always tell them that the 
medicine is poison (=medicine can be poisonous if they take 
inappropriately).' (clinical nurse) 
' .... some [patients with a symptom like aJ runny nose hope to get medicines, 
too. [TheyJ become angry if [theyJ do not have (=receive) medicines; 
however, we explain [that it is unnecessary).' (clinical nurse) 
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There are some patients who like only one kind of (=a specific) medicine. 
However, we cannot give medicines according to patients' wishes, but we 
give [it] based on the present STGs.' (clinical nurse) 
Overall, clinical nurses were proud of their clinical nurse status. They said it was a new 
position56, and they were different from other nurses. They were ready to share the 
knowledge they had gained in the training with their colleagues and hoped other 
members would have a chance to attend the training. 
' .... about colleagues, [they] a/ways ask me [about STGs] when they have 
problem.' (clinical nurse) 
8.7 Attitudes to others 
Comments on and explanations of daily work sometimes revealed attitudes to others in 
their working environment. These kinds of remarks were heard across the questions and 
occasionally appeared as a complaint about a situation, a request for solutions, or a 
justification or excuse for what they did or did not do. Although each of topic 2 ('present 
practice'), 3 ('changes') and 4 ('difficulties') was asked not only in relation to personal 
problems but also environmental matters as well as patient side issues (see sample 
questions), 'attitude to others', was not put as an a priori theme. In particular, questions 
about doctors were not asked in the topic guide. Nevertheless, related comments were 
obtained far more than expected. This theme was mainly observed in topics 2, 3 and 4, 
but also found even in answers to topic 1 (,standard treatments') and 5 ('requests'). In 
this section, attitudes to others in the work like patients, colleagues, and foreign doctors 
are separately cited and then analysed. 
8.7.1 Attitudes to patients 
Two different types of view on patient comprehension were found. One was that health 
personnel were responsible for patient comprehension about how to take medicines, and 
good services would enable patients to take medicines. 
56 It is not yet an official job title in the MoH, but a member of health personnel who attended 
training in the clinical nurse training program is called 'clinical nurse', 
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'When an explanation is clear, patients comprehend. Especially about 
antibiotics, the explanation should be correct. This completely depends on 
staff at the dispensing counter.' (clinical nurse) 
'Patients feel satisfied when there are good services and a careful 
examination, and when the services Bre good, [it] helps them (=patients) be 
glad to take medicines.' (clinical nurse). 
Many interviewees said health personnel 'explained repeatedly (esplika fila faIr), how to 
take medicines and checked it by 'asking again (husu fait)' so that patients could 
comprehend it. They thought patients in general understood their explanation. They also 
said patients could 'ask again (husu fall)' health personnel until they understood it. 
'[After] we have explained [how to take medicines], [we] ask (=check it) once 
again to the patient. When [the patientJ does not comprehend it, [we] explain 
it once again.' (clinical nurse) 
On the other hand, other respondents also said that patient comprehension depended 
on each individual, especially on their educational level. Some thought if a patient did not 
get well, it was caused by poor patient compliance. Some respondents complained that 
patient awareness about health in general, not only about how to take medicines, was 
inadequate. 
'We sometimes find patients do not take medicines, because (=as a result) 
they come back with the same sickness. ' (manager) 
'About medicines, we give [them], they (=patients) take [orJ do not take 
[them). Sometimes we give [themJ for 5 days, patients take it for 3 days 
(=patients stop taking them on the third day) when they feel well.' (other 
health personnel) 
57 'Fila fair literally means 'to go back' or 'filafal!, in one word means 'once again' as an adverb. 
'Fila fail (filafali)' or 'fait' in connection with to explain or to ask how to take medicines was 
observed 19 times in total. 
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'Patient awareness is inadequate. Because (=therefore) patients here 
sometimes Dust] use timing of market [day] and come for a consultation at 
the same time.' (clinical nurse) 
As mentioned in 8.6, we were given examples of patient preference that respondents 
believed inappropriate; some patients hoped for a specific medicine like an antibiotic or a 
specific form like a capsule or an injection. They complained about patients who 
preferred receiving medicines to having health education, even if their condition was not 
serious. Therefore, health personnel occasionally needed to give patients unnecessary 
vitamins to satisfy them. 
'In fact, a common cold does not require medicines, but considering our 
situation, [if] patients come [and we] give only counselling, they say the nurse 
is wrong.' (clinical nurse) 
Respondents were afraid that a patient would be disappointed when the medicine given 
in the CHC did not make them well at home, especially in a case where the patient lived 
in a remote area. 
'Some are not very contented because sometimes, for people who [/ive] 
remotely, [we] give medicines that is not suitable to their sickness and they 
[do] not [get] well. They are not very contented. (other health personnel) 
Some interviewees said patients would forget how to take medicines if they received too 
many different kinds, and appropriate services should be based on real patient needs. 
'Sometimes [if] there are too many [kinds of] medicine, patients get confused 
and take them incorrectly. Therefore, [we] should do consultations properly 
and give medicines properly based on their needs, probably only two or three 
kinds of medicine.' (clinical nurse) 
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8.7.2 Attitudes to colleagues 
'To help each other (ajuda malu)' or to do something 'to each other (ba ma/u)' in relation 
to CHC work was observed in many comments58 . 
'If a colleague gives wrong medicine or sometimes an unnecessary 
antibiotic, we always remind each other,to follow STGs.' (clinical nurse) 
According to some respondents, colleagues who had not attended training seemed 
unfamiliar with standard treatments. Interviewees said if they faced difficulties in practice, 
they could ask a colleague who had attended training and knew more. However, as 
mentioned in 8.3.2, contradictory views on feedback of training in the CHC were found. 
While one side said they were not able to attend training despite their wish to do so, the 
other side complained they did not have enough feedback from trained colleagues. 
Some clinical nurses said colleagues could ask the clinical nurse. 
'When [somebody] has not attended training, it is better to ask other 
colleagues who have already attended the training.' (clinical nurse) 
'[If] other members, who have not attended clinical nurse training, face a 
difficulty in treatment, they can check STGs. And when they can not 
understand, they can ask the clinical nurse.' (clinical nurse) 
Several clinical nurses expressed their wish to share the knowledge they had gained in 
training, and others expected (an)other member(s) to have a chance to attend the 
training. Respondents besides clinical nurses, including managers, thought clinical 
nurses knew more about STGs. 
'About STGs, only clinical nurse handles with (=answers) the issues.' 
(manager) 
'About patients, I think only clinical nurse master this (=clinical nurse masters 
patient care more than others) because they attended [training] for six 
months' (manager) 
58 Other expressions were; to ask, to teach, or to share work with each other. 'Malu' or 'ba malu' 
was found 11 times in total. 
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Although 'helping each other' was suggested by many interviewees, one member of 
'other health personnel' mentioned that there was insufficient 'solidarity (kekompakan)' 
among staff. As only one interview was conducted in this CHC (see footnote on page 48), 
other people's views in the same CHC could not be obtained. This minority view should 
not be ignored. He also talked about colleagues' inadequate practice with patients. 
'Some colleagues get angry [at patients] and do not give good services 
because of anger. Sometimes they only shout to patients.' (other health 
personnel) 
8.7.3 Attitudes to foreign doctors 
The word 'doctor (doutour(a), dokter), was very frequently used although it was not put in 
the topic guide. The majority of comments were based on their actual experience of 
working with doctors in the CHC59, mainly the recently deployed Cuban doctors. Most of 
the comments concerning doctors could be organised into four categories. 
In the first category, they explained on several occasions the past and present situation 
at the CHC in terms of availability of doctors. When they had not had Cuban doctors after 
international NGOs' withdrawal, they had done consultations by themselves. Even after 
the deployment, if the doctors were absent from the CHe, local staff had needed to do 
the consultations. Some of them added that STGs were of great help when the doctor 
was not available. One manager mentioned, however, even though they had STGs they 
always needed to ask the doctor for help. 
'Before, [during the Indonesian time and UNTAET time], we only helped 
doctors to give medicines.' (clinical nurse) 
'Before the [Cuban] doctors came, I did consultations, sometimes other 
members of staff did.' (clinical nurse) 
'[When] we did not yet have doctors, we followed our duty, but now we have 
doctors [who are] always going ahead [together]. , (other health personnel) 
59 Seventy four passages from thirty four respondents were found, among which three were about 
specialists who developed their STGs. The others indicated specific doctors or doctors in general 
who had worked or worked together: Indonesian doctors, NGO doctors, UN expatriate doctors, 
and Cuban doctors. 
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'Although doctors are not available, we give treatment as we learnt [in 
training].' (other health personnel) 
The second category consisted of their collaboration with Cuban doctors. They 
appreciated that they could consult the doctor on difficult cases although language might 
be an obstacle in the communication with doctors as a few respondent pointed out. 
'When we have a problem, [we] consult with doctors.' (clinical nurse) 
'Because we attended the training, we can give [prescriptions], but when we 
have a problem, [we] consult with doctors. The consultation is good, but the 
language becomes a barrier. ' (manager) 
In the third category, some respondents implicitly or explicitly complained that doctors 
did not follow recommendations in STGs. However, they recognised the doctor have 
more knowledge than the nurse. Although one clinical nurse blamed doctors for not 
adhering to STGs, he mentioned that they could not change the doctor's prescriptions 
due to his position. Instead of making a complaint, some of them raised this issue as a 
request to the MoH that they would make doctors use STGs or develop the doctors' 
version of STGs. This was probably also caused by the respondents believing their 
positions to be low. 
'[We] hope the Cuban doctors will follow the treatment in STGs.' (clinical 
nurse) 
'Doctors do not follow STGs, but we cannot change the medicine they 
prescribe because when (=if) we change the medicine and the patient has a 
problem, I will be sent to jail. Because (=For) knowledge that doctors have 
learnt is more than nurses. ' (clinical nurse) 
'If possible, [we hope the MoH] make uniform STGs for us and the doctors. ' 
(clinical nurse) 
'We ask [the MoH], if possible, to provide STGs in Spanish so that our 
doctors can use them.' (manager) 
The fourth category comprised comments on local health personnel's obedience to 
foreign doctors' prescriptions. 
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'We only follow the doctor's prescriptions, [if we can] not understand a 
prescription, we ask the doctor again. ' (other health personnel) 
The type of comments clearly differed among respondent groups. The majority of 
complaints or requests concerning doctors not using STGs were identified in clinical 
nurse answers. More than two thirds of clinical nurses brought this point up. On the other 
hand, all of the comments that indicated their obedience to the doctor were observed in 
the 'other health personnel' group. More active and concrete suggestions about good 
collaboration with doctors were raised by clinical nurses than others. For example, one 
clinical nurse said that they could show doctors the standard management of malaria 
because the disease is rare in their home country. 
In addition to the four above-mentioned issues, some respondents said that local 
members of health personnel were more intimate with patients than the foreign doctors. 
One clinical nurse added that he got confused about his position as a clinical nurse after 
the foreign doctors came because he did not do consultations any more. 
8.8 Attitudes to present problems I difficulties 
Words such as 'problem (problema, masalah), 'difficulty (difikuldade, kesulitan)', 
'obstacles (hambatan)" and 'lack (kekurangan), were widely found all over the interviews. 
They often appeared in the phrase of 'no problem I difficulty'5O. However, 'no problem' 
was sometimes followed by 'but I however (maibe)' and actually indicated 'a problem'. 
Less frequently, expressions were the other way around (there is a problem, 
but/however ... ) or 'if there is a problem ... ', which suggested a way to solve it. Related 
comments mainly responded to questions which had been asked about existing 
problems or obstacles in topic 2 (,present practice') and 5 ('difficulties'), but they were 
also found across the topics. What they perceived to be existing problems and what they 
thought could be done to solve them are given in this section. 
Nobody mentioned there was a problem with STGs. As described before, one of the 
reasons that STGs were understandable might be that health personnel were familiar 
60 All respondents used one of these words (or other vocabularies with similar meaning) at least 
once. There were 185 passages that included these words were found. 
112 
with the language used for STGs. Among respondents who mentioned the use of STGs, 
all but one did not think them difficult. The person who said 'difficult' was a young midwife, 
and she specifically pOinted to the particular difficulty of an STG for family planning due 
to the complexity of options available. 
Problems or difficulties in applying STGs in real practice were established as an a priori 
issue and related questions were set in the topic guide. Nevertheless few comments with 
this answer were found. Instead of mentioning a problem/difficulty in STGs, respondents 
said that they opened STGs to solve a problem. Collecting comments on 'there is no 
problem' and 'if there is a problem', other possible problem solving measures besides 
consulting STGs also emerged. They suggested they could consult with the doctor or 
ask each other for help when they faced a problem. Some believed they could feedback61 
problems to the central level. A few said they needed to have a meeting among members 
of staff to solve the problems. 
'So far, there is no difficulty in applying STGs, if there is [a difficulty}, we 
consult each other.' (other health personnel) 
There is no difficulty in [giving} treatments because here we have STGs as 
well as Cuban doctors to ask for help.' (clinical nurse) 
'No difficulty because, with a seriously ill patient, we give an injection and 
refer [the patient] to the regional hospital.' (clinical nurse) 
'So far, we just follow [what have been given). If there is any problem, we will 
inform [it} to the MoH.' (manager) 
However, it was unknown from the answers we received if the abovementioned 
problem-solving measures were actually functioning well. 
61 Words for 'to offer (hatoo)" to request (husu), 'to inform (fo-hatene), and 'to consult (konsultast)' 
were used in original transcripts. 
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8.9 Working conditions 
Some of the comments on working conditions. which were found across the interviews. 
are considered in this section. 
'Referral (rujuk)' seemed to support practice in rural CHCs. The term was frequently cited. 
However. nearly two thirds of the passages containing 'referral' just appeared as their 
knowledge of the timing of the referral as indicated in STGs82 • It was not very clear from 
the answers if the referral system was functioning well. Some respondents indicated they 
were allowed to give injections as pre-referral treatment after STGs were introduced. 
One clinical nurse pointed out that transportation was a problem for the referral. Several 
respondents touched on transportation difficulties but not specifically in relation to patient 
referral. Another clinical nurse requested the referral system be improved. 
Many respondents mentioned shortage of medicine. including one answer which 
mentioned the lack of plastic bags for medicine83 . A few answers revealed difficulties in 
the procurement system: calculation for the quarterly request form was difficult; 
sometimes the medicine provided by the district was not the same as had been 
requested; and delivery of medicine to the CHC was delayed. Other majority responses 
just mentioned it as a problem, for example. available medicine was 'little (uitoan), or 
'limited (terbatas), 'not in stock (la iha)'. 'finished quickly (hotu lalais). It was difficult to tell 
from these responses how the shortage of medicine influenced their prescribing practice. 
Some interviewees referred to language issues84 . The language used in STGs did not 
seem difficult for users. Regarding daily communication with patients, while some 
interviewees said a specific local language85 was a problem in their practice. others 
thought speaking in a local language was an advantage for them. This seemed to 
depend on the region. Language barriers with foreign doctors were also pointed out. 
62 Thirty five passages mentioning 'referral (rujuk)' from 24 respondents were found, of which 23 
passages showed their knowledge about the timing of referral. 
63 Twenty passages in relation to the shortage of medicine or supplies (plastic bags) were found 
from 18 respondents. 
84 In total 13 observations about language issues were found; four about the language in their 
STGs, five about communication with patients in local language, two about communication with 
foreign doctors, and two non-specific. 
65 Local languages here mean languages besides Tetum. 
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Deficiencies in staff in terms of both quantity and quality were also raised. A shortage in 
staf numbers f6 was sometimes used as an excuse for not doing what they actually felt 
was necessary, for example, labelling dosage schedule and patient name on a medicine 
bag. Two managers admitted they needed to assign unqualified members to certain 
work, for example, nurse assistants to prescribe medicines in mobile clinics or cleaners 
or security guards to dispense medicines at the counter. 
Working conditions might not yet have been well established, however, one manager 
stated as below; 
'Because our nation just became independent, we are going slowly 
according to our wish. ' (manager) 
8.10 Summary of the chapter 
Responding five topics, eight indexes were identified. Overall, standard treatments were 
well known by respondents. Clinical nurses showed more precise and detailed 
knowledge, especially for antibiotic use. 
Respondents well agreed with STGs and accepted them. They believed they 'should' 
follow them. This feeling of obedience was caused through their self-awareness as 
frontline health workers as well as peripheral civil servants. STGs brought them many 
changes. Three components of the change found were: the concept, daily practice and 
perceived patient satisfaction. They had felt a lack of confidence and hoped to improve 
their capacity, and became confident in their practice using STGs. Self-confidence was 
identified more evidently in clinical nurse interviews, in particular, their answers of 
attitudes to patients, colleagues and foreign doctors. 
Although 'difficulties' in applying STGs were established as a priori issue in the interview, 
few responses were obtained. Instead, respondents suggested how to deal with 
difficulties; opening STGs was one of their problem-solving ways. Needed supports in 
workplace such as mutual help, doctor consultation, referral, and feed-back to the MoH 
were also suggested to solve difficulties. 
66 A shortage in staff numbers was raised by seven interviewees. 
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CHAPTER 9 Discussion 
This chapter integrates the results and discusses the findings. Key findings are 
discussed according to the objective and research questions followed by the strengths 
and limitations of the research and the generalisability of the study. 
9.1 Principal findings 
The principal findings are discussed in sections 9.1.1, 9.1.2, and 9.1.3 which correspond 
to the results in chapter 6, 7 and 8 respectively. In section 9.1.4, all the results are 
gathered to identify factors that influence the use of their new STGs. 
9.1.1 Use of medicines in Tlmor-Leste (Objective 1) 
Medicine use situation in Timor-Leste (Research question 1) 
The table below shows a comparison between the situation in Timor-Leste and 'the world 
medicines situation' published by WHO in 2004 [53], which collects studies using the 
same INRUDIWHO indicators. 
Table 9-1 Comparison between Timor-Leste and previous studies collected in WHO 
report 
indicator 
no of medicines per encounter 
% of encounters with an antibiotic 
% of encounters with an injection 
% of medicines actually dispensed 
% of medicines adequately labelled 
% of patients with knowledge of correct dosage 
availability of EML1%) 
% of key medicines in stock 
* result from retrospective data 
** result from prospective data 
result in 
Timor-Leste 
2.4* / 2.6** 
44* /39** 
0.4* / 0.3** 
95 
6 
77 
79 
86 
WHO report in 2004 
average no of studies in the report 
2.4 35 
45 35 
23 34 
89 12 
54 8 
71 16 
78 9 
67 6 
The number of medicines per encounter and percentage of encounters with an antibiotic 
prescribed in Timor-Leste was similar to the average for the 35 studies reported by the 
WHO. 
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The use of injections in Timor-Leste was extremely low. As unsafe and unnecessary 
injections is reported widely [151] this result in Timor-Leste was encouraging. 
Timor-Leste's EML for Levei 2 lists injections as 'E-medicines' (mainly antibiotics and 
anti-malarials), which can be used as an initial treatment for severely ill patients while 
referring them to a higher level facility [128]. Thus, only limited kinds and numbers of 
injections were procured at Level 2 facilities. Moreover, the second version of the 
national EML specifies that the initial treatment and referral of severe patients should be 
guided by the clinical nurse program and IMCI [128]. It was thought that the low 
percentage of injection use in Timor-Leste was realised by combining EML development 
with the medicine procurement system as well as with the referral system and STGs with 
related training. 
A high percentage of actual dispensing of prescribed medicines was understandable, 
taking into account the fact that medicines are dispensed in the CHC free of charge. Only 
one patient left the CHC before receiving medicines (two medicines). Seventy four 
medicines were not dispensed even though the patients received other medicines. 
Reasons for not dispensing were not investigated in this study. Availability might have 
been a reason. 
The percentage of medicines adequately labelled was low. Essential elements of 
information on the label include: dosage schedule, duration of the treatment, name of the 
medicine, and name of the patient. Investigating each of these four elements of 
information separately, nearly 70 percent of medicines were labelled with the dosage 
schedule while the name of the patient was written on only 15 percent of medicine bags. 
Duration of the treatment was written on fewer medicine bags than dosage schedule 
(28%). Considering that many patients answered that they would take medicines 'until 
finishing,67, there was a possibility that the duration of the treatment was unnecessary 
information on the label for both patients and health personnel. Because previous 
studies suggest that labelling is considered one of the measures to improve patient 
knowledge and compliance [51, 152], a low percentage of adequate labels might have 
influenced patient compliance. Considering the low literacy rate in rural Timor-Leste, 
labelling might not have had an influence. Investigating patient compliance, however, 
was beyond the scope of this study. 
67 STGs usually limit the number of days of initial medication (eg. five-day antibiotics for 
pneumonia) and instruct health personnel to tell the patient to 're-visit' the CHC for follow-up 
during or after the initial medication. 
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The percentage of patients with knowledge of correct dosage was higher than the 
average for previous studies68• Patient knowledge of the correct dosage schedule and 
duration of the treatment is higher than labelling of each element of information. Some 
patients answered them without labelling, which implied they did not always rely on the 
label to recall how to take their medicines. Patient knowledge is considered as an 
essential prerequisite for patient compliance [51, 153, 154], but it does not always 
guarantee patient compliance to the prescription [155]. It was difficult to tell from the 
research results whether a high percentage of short-term patient knowledge in 
Timor-Leste resulted in patient compliance at home. 
Many patients understood that antibiotics were given for their respiratory symptoms 
and/or a fever. It was reasonable if it meant pneumonia. On the other hand, a 
considerable number of patients misunderstood that vitamins could treat various 
symptoms. For example, many patients who received a vitamin answered that it was 
prescribed for respiratory symptoms or anorexia. 
Prescribing indicators and prescribers training (Research question 2) 
Comparison of prescribing indicators by prescriber's training suggested that clinical 
nurse training influenced antibiotic prescription. There were no differences found 
between clinical nurses and non-clinical-nurses in the other two prescribing indicators: 
the number of medicines per encounter and the percentage of encounters with a vitamin. 
There were no differences detected in three prescribing indicators by prescriber's IMel 
training. These results were compatible with the results from the interviews on health 
personnel's knowledge of standard treatments (see 9.1.3). 
9.1.2 Adherence to STGs (Objective 2) 
Adherence to STGs for healthcare steps (Research question 3) 
Adherence to STGs can be measured by looking for four steps: taking a history; 
conducting a physical examination; recording the clinical decision; and prescribing 
medicines. In this study, the results were 37 percent, 24 percent, 77 percent and 56 
percent for each step respectively. These were 'unconditional' proportions that Krause et 
68 Criteria of 'correct knowledge' in the report were not always consistent with 'the world 
medicines situation'. 
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al. suggest, in which adherence to the previous steps was not taken into account [34]. 
Krause et al. also suggested an 'accumulated proportion' to assess adherence for all 
steps of the process, and only three percent of the accumulated proportion of adherence 
were achieved in their study in Burkina Faso study. If applying this in the present study, 
the proportion of patients who received procedures that adhered to STGs for all four 
steps was 11 % (42 out of 380 patients who were diagnosed with at least one target 
disease). Among them, 38 patients were dispensed the same medicines as prescribed, 
and all medicines were explained. Therefore, the equivalent accumulated proportion to 
Krause's study was 10 percent6970 • 
Adherence to STGs about taking a history and conducting a physical examination for 
suspected malaria patients and diarrhoea patients was very low. Almost no patients with 
malaria and diarrhoea were given a complete physical examination. A possible 
explanation of this is STG-related factors, which will discuss in 9.1.3. For prescribing 
adherence, malaria was better than diarrhoea, and ARTis was the worst. These results 
were then compared with the results gained from interviews asking about knowledge of 
standard treatments (8.2). It was found in general that a point better known was better 
practiced by health personnel. 
Prescribing adherence and prescriber characteristics and CHC characteristics 
(Research question 4) 
A critical issue of this analysis was that doctors' cases were unexpectedly included. As a 
result, the number of cases that were managed by local health personnel alone 
decreased. Among the 380 cases with a target disease recorded, only 240 were handled 
by local personnel cases. 
The univariate analysis using Wilcoxon's rank-sum test showed strong evidence that 
individual prescribing adherence was different between clinical nurses and 
non-clinical-nurses (p<0.01). In addition, there was weak evidence that individual 
prescribing between IMCI trained personnel and non-IMCI-trained personnel was 
69 In Krause's study, health personnel steps are; medical history, clinical examination, drug choice 
and explaining about dose. Dispensing in this study was considered equivalent to 'drug buying' in 
Krause's study, which is regarded as a patient step. 
70 The accuracy of diagnosis, whether it was based on a history and/or a physical examination, 
was not assessed in this study. 
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different (p=O.06). For other prescriber characteristics, such as prescriber's age group, 
sex, occupational category, civil service level, work experience, there was no significant 
difference in individual prescribing adherence. Using logistic regression analysis, taking 
into account prescriber clustering and possible confounders, the adjusted odds ratio for 
individual prescribing adherence of clinical nurses compared to non-clinical-nurses was 
6.6 (95%CI: 2.5 - 17.6). The adjusted odds ratio for individual prescribing adherence of 
IMCI trained personnel to non-IMCI-trained personnel was 2.9 (95%CI: 1.2 - 6.8). It 
appeared as if clinical nurse training had more effect on individual prescribing adherence 
than IMCI training. However, simply comparing these two kinds of training was not very 
meaningful since the training aims, type of training input, and target patients were 
different (see 3.2.5). 
When including foreign doctors, only a univariate analysis by prescriber's training could 
be performed. If doctors were classified into the 'no training' group, each variable: 
prescriber's clinical nurse training, IMCI training, and 'at least one training' was 
significantly associated with individual prescribing adherence. 
Analysis for CHC's overall prescribing adherence was complicated. Neither the 
retrospective nor the prospective data was ideal for linkage to the CHC data. (see 9.2.3.) 
However, based on available data, none of the CHC characteristics, including the total 
training input such as the total members trained and total period of training, influenced a 
CHC's overall prescribing adherence. 
9.1.3 Knowledge and attitudes (Objective 3) 
Know/edge of SrGs (Research question 5) 
Overall, the key issues in Timor-Leste STGs for the three target diseases were well 
known among the respondents. All interviewees refer to their new STGs in Indonesian 
terms such as pedoman, petunjuk or protocol, which suggested that these terms had 
already. been known from the previous regime. Existence of their new STGs was 
recognised regardless of whether the interviewee knew the contents. Everyone knew 
what their new STGs were, which suggested that STGs were well disseminated 
nation-wide. Health personnel were well aware of their new STGs. Although everybody 
was aware of STGs, some differences in STG knowledge among respondent groups and 
target diseases were found. 
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In general, clinical nurses referred to STGs more accurately than others. This contrast 
was particularly evident in knowledge of antibiotic use for ARTIs and diarrhoea. Clinical 
nurses far less frequently indicated treatments that contradicted STGs than other 
interviewees. In chapter 6 and 7, clinical nurses showed a difference in prescribing 
practice: a lower percentage of antibiotic prescription and higher percentage of 
prescribing adherence to STGs than others. It was considered that clinical nurse training 
influenced both knowledge and practice and that there was an association between 
knowledge and practice. Even so, some clinical nurses showed their misunderstandings, 
for example, suggesting an antibiotic for all ARTis or acute simple diarrhoea and 
indicating inappropriate anti-malarials for P. vivax and P. falciparum. This implied that 
follow-up was needed to monitor and correct individual misunderstandings after 
completion of training. IMCI trainees and non-trainees did not show very explicit 
differences in accurate knowledge of STGs, compared with the contrast between clinical 
nurses and non-clinical nurses. 
Among the three target diseases, standard treatments of malaria were especially well 
understood. Only one interviewee indicated treatment that contradicted STGs; he 
suggested that the treatment for clinically suspected malaria patients was chloroquine 
alone, which is not recommended in STGs. The majority knew the standard treatment for 
clinically suspected malaria patients without a blood smear test. This result was also 
compatible with the results in chapter 7 that showed a high percentage of prescribing 
adherence to malaria STGs compared with adherence to ARTI and diarrhoea STGs. 
Training for the National Protocol for Malaria Management had been conducted in the 
country in addition to clinical nurse training and IMCI training. It was likely that this 
program had affected the knowledge and practice of malaria treatment. However, since 
this training was not targeted in this study71, its influence on the current CHC practice 
was difficult to ascertain. Another assumption to support the high level knowledge of 
malaria treatments was the simplicity of the instructions. Previous studies have 
suggested that specific characteristics of the guidelines themselves are linked to 
adherence [82,86,90,91]. In comparison, adherence to STGs with reference to taking a 
history and conducting a physical examination for suspected malaria patients was very 
71 This training was initiated by an international NGO at a very early stage of the rehabilitation, just 
after the crisis before the MoH was established. Detailed information could not be gained. For 
example, the number of trainees is not listed in MoH documents. It was also difficult to define who 
was a trainee. 
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low (see 7.2), and this may be due to the complicated instructions provided for these 
activities. 
In spite of good knowledge of STGs in general, many members of health personnel 
misunderstood the functions and clinical indications of vitamins. This was observed 
regardless of respondent group. This health personnel misunderstanding might have 
been linked to the high proportion of vitamin prescriptions regardless of prescriber's 
training and patient misunderstanding of vitamins, which were found in chapter 6. 
Attitudes of present practice (Research question 6) 
The health personnel interviewed were willing to use STGs. No one refused to accept or 
disagreed with the concept of standardising treatments or a specific STG. They stated 
that STGs were 'advantageous' and 'useful'. It was believed that the acceptance of or 
agreement with STGs promoted the use of STGs. 
Respondents thought that they 'should' follow STGs. Two different stances emerged to 
explain this feeling of obedience. They were aware of themselves as frontline workers 
and knew that they were the only people who could treat sick patients and believed 
standard treatments helped them in this situation. At the same time, the health personnel 
thought they had to be obedient to STGs as they were developed and implemented by 
the MoH in collaboration with 'intelligent' people. Extrapolating from some comments 
which used the word 'big people (=seniors)' or 'small people', it was considered that their 
position in the civil service hierarchy influenced their feeling of obedience. 
Respondents in general were confident of their present practice. They demonstrated 
their responsibilities to patients when prescribing medicines. Although previous studies 
have shown that patient expectations and 'perceived expectations' are one of the factors 
for inappropriate prescribing practice [27-32], interviewees in this study indicated that 
they would not submit to patient expectations if this was inappropriate. A few commented 
that they sometimes needed to prescribe vitamins to satisfy the patient or to avoid 
complaints by the patient. Some thought patient comprehension of and compliance with 
the prescription depended on health personnel work while some believed it depended on 
each patient's ability to comprehend and comply with medical explanations. 
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When a patient expected an inappropriate medicine or could not understand how to take 
medicines properly, the health personnel said that they tried to give further explanations 
to the patient. In their STGs, they learned 'counselling (konseling),72. According to 
instructions of 'konseling, the health personnel should tell patients what to do at home, 
how to take medicines, when to revisit the CHC, how to prevent the disease, and so on. 
'Konseling is emphasised both in the clinical nurse textbooks and IMCI chart-books. 
Previous studies suggest that health information affects patient comprehension and 
patient satisfaction [27, 156-158]. The perceived patient satisfaction found in this study 
(8.4.2) has a possible association with their 'konseling' to patients. 
Some clinical nurses directly expressed their pride in being a clinical nurse. Overall, 
clinical nurses showed their self-confidence more explicitly than others. In particular, 
their attitudes to patients, colleagues and foreign doctors showed the difference. For 
example, answers that indicated their attitudes to patient's inappropriate expectations 
were found more in clinical nurse interviews. The majority of complaints in relation to 
doctors not using STGs were also stated by clinical nurses. Meanwhile, merely showing 
obedience to the doctor was found in the answers provided by 'other health personnel'. 
Quantitative data showed that clinical nurse training was associated with prescribing 
practice, and interview data suggested clinical nurses were equipped with more precise 
understanding of STGs than others. In addition, clinical nurse training was considered to 
affect their self-confidence. 
Changes brought about by the introduction of STGs (Research question 7) 
Health professionals are known to resist change in their daily practice [78-81] and this 
can be a barrier to adherence to STGs [82] In this study, however, changes were 
positively perceived by respondents. 
Three components of the change were observed: the policy concept of using STGs, daily 
practice, and perceived patient satisfaction. First, standardising treatments brought a 
change in their work. Although the term 'standard treatment guidelines' had been known 
since Indonesian times, their answers suggested that practicing with their new STGs 
made an epoch. As they had felt a lack of confidence in their previous practice and 
hoped to increase their capacity, their new STGs were of help. Second, they realised 
72 This has a similar meaning to 'patient education' or 'information to the patient' in their STGs, not 
the meaning of psychotherapy as often used (see 3.2.5). 
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actual changes in daily practice. They gave exact examples, in detail, showing a contrast 
between 'before and after' they had received STGs: for example, they prescribed 
antibiotics for a common cold before but are not prescribing them now; they did not use a 
stethoscope before but can use the one now, etc. Third, they perceived changes in 
patient satisfaction after they had started to use STGs. Although actual patient 
satisfaction was not assessed in this study, other studies suggest a positive association 
between patient satisfaction with care and the degree to which physicians implement 
clinical guidelines [62]. 
Changes lead to improved self-confidence, and as a consequence, promoted further use 
of STGs. Many interviewees expected more training and prompt information on any 
change in STGs. It was pointed out that the present STGs could not be used forever 
since knowledge was always changing. This implied that in order to promote use of 
STGs they should not be allowed to become outdated. 
Difficulties in application and implementation of STGs (Research question 8) 
Previous studies have shown that there are barriers to implementing clinical guidelines in 
practice [82, 85, 86, 88, 89). In this study, responses unexpectedly showed that using 
STGs was not very difficult. Many answers indicated 'no difficulty/problem' or suggested 
possible actions 'if there is a 'difficulty/problem'. Respondents said that they simply 'open 
[STGs] again' to solve the difficulties. 
Besides turning to STGs, health personnel indicated other measures to solve a 
difficulty/problem: helping each other, referring a difficult case to a higher level facility or 
to the doctor, and giving feedback about the problems to the MoH. However, it was 
unclear from the interviews whether these supportive factors functioned in actual 
practice. 
Although 'helping each other' was found to be one of the problem solving measures 
when they used STGs, it was not easy to put into practice. A few people complained that 
colleagues who had been trained did not feedback the results in the workplace very well, 
while members who had been trained implied that it was difficult to give feedback to 
colleagues. Some respondents hoped to have more trainees per CHC so that they could 
help each other. However, as shown in chapter 7, total training input in a facility, such as 
the total members trained and total period of training, did not make a difference to the 
CHC's overall prescribing practice. 
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Some difficulties in their work were suggested. They could be categorised in the 'external 
barriers' Cabana et al. identify [82] or 'social context' and organisational context' found in 
other studies [85, 86, 88, 89]. Some of them were patient factors: poor comprehension 
and compliance with taking medicines, insufficient awareness of health issues in general, 
and inappropriate expectations for medicines. Others were environmental factors such 
as difficult transportation for the referral, language barriers between the health personnel 
and patients or foreign doctors, shortage of medicines, and limited staff. Barriers caused 
by 'lack of solidarity' in the CHC were implied. However, further information could not be 
gained from the interviews. 
Although interviewees suggested that a shortage of medicines was a problem, this was 
not supported by the quantitative data (chapter 6). One possibility of this contradiction 
was the assumption that medicine stock was investigated after medicines arrived in 
many CHCs, and they would be short later in the end of every quarter. Another 
assumption was that shortage of medicines was not as serious as they thought, but they 
just believed 'medicines were always short' based on their previous experience. The 
interviews did not suggest what kind of medicine was likely to be out of stock and how 
shortage of medicine influenced their prescribing practice. 
9.1.4 Factors that influence the use of STGs (Objective 4) 
Factors that influence the use of STGs (Research question 9) 
Training 
The results from the quantitative data analysis identified that prescriber's training, 
especially clinical nurse training, was associated with less use of antibiotics and greater 
adherence to STGs. Furthermore, the qualitative data analysis found that clinical nurse 
training influenced knowledge of STGs,a s well as their prescribing attitudes. 
According to the conceptual framework created by Cabana et aI., 'awareness' and 
'familiarity' are factors that influence knowledge [82]. In this study, there was no doubt 
that all health personnel in Timor-Leste were well aware of the existence of their new 
STGs. However, previous studies suggest that awareness does not ensure familiarity 
with the contents [159, 160] and a lack of familiarity was more common than lack of 
awareness [82]. This study showed that health personnel who had not attended training 
less frequently referred to treatments indicated in STGs and were more likely to indicate 
treatments that contradicted STGs. Training made participants familiar with the contents. 
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These results are compatible with previous studies that indicate that distribution of STGs 
through a training course is more likely to be implemented [65-71]. 
Using all the available quantitative data, the total input of training in a CHC was not 
considered to affect CHC's overall prescribing adherence. From the qualitative data, little 
information on facility factors could be obtained. In terms of sharing training results in the 
CHC, contradictory opinions were gained from both trainee side and non-trainee side. In 
sum, how individual training influenced overall performance in their facility was not 
clearly demonstrated in this study. 
Agreement with STGs 
None of the study participants disagreed with a policy to standardise basic treatments or 
a specific guideline. In Cabana's study, 'lack of agreement' is identified as one of the 
barriers to prescriber's attitude to STG adherence [82]. In this study, 'a lack of 
disagreement', in other words, agreement with STGs promoted their use of the STGs. 
It was found that health personnel thought that they 'should' follow their new STGs. This 
expression was broadly found across the topics. The background to this feeling of 
obedience emerged in the study: health personnel were conscious of themselves as 
frontline workers in the community who could only treat patients; and they also thought 
that they should follow the STGs as civil servants since they were developed and 
implemented by the MoH. 
Health personnel's positive perception of the changes 
One of the most prominent findingswas that health personnel positively perceived 
changes after STGs had been introduced. Since previous studies have suggested that 
people resist change in the workplace [77-81], it was a unique result in this study. Health 
personnel listed a variety of changes, which can be summarised in three components: 
health personnel understood that treatments for basic illnesses had been standardised 
nationwide based on the new policy (the policy concept of standardisation); they were 
putting new standards into their work, indicating actual examples of change (daily 
practice); and they believed that their new practice guided by their new STGs made 
many patients more satisfied than before (perceived patient satisfaction). Moreover, 
health personnel hoped for constant changes in the future, if necessary. They especially 
expected prompt information on any change in the present STGs and further training to 
increase their capacity even 'more'. 
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Health personnel had felt a lack of confidence in their previous practice and thought it 
'random'. They hoped to increase their 'capacity'. Their positive perception of the 
changes, therefore, brought self-confidence to their work. This increased self-confidence 
further promoted the use of STGs. Previous studies have indicated different results 
concerning self-assessments and patient perspectives [157, 161, 162], which suggest 
that high self-perceived effectiveness is not always preferable for patients. This research 
found health personnel's self-confidence and perceived patient satisfaction separately. 
However, an association between these two themes was not assessed and is still 
undetermined. 
Development of STGs in a health policy framework 
Development of Timor-Leste's STGs did not rely on a single policy or a single vertical 
program. All of the six policy areas that were established in the Health Policy Framework 
[112] are linked to the development of STGs.ln particular, 'health service configuration' 
and 'basic package of services' (these are part of organization and management policy), 
human resource development policy, and drug policy are the basis of Timor-Leste's 
STGs. Furthermore, STGs exist across various programs, and STGs, training, the 
national EML and health service delivery system were interconnected with each other. 
Training was planned based on the 'basic package of services' policy [113]. This is 
explained in a training module [122]. All medicines taught in training and written in 
training materials (=STGs) are listed in the national EML. Timor-Leste's EML 
emphasises the relation between the EML and training and STGs, and medicines in the 
list are categorised according to the facility level. [128]. 
In the interviews, health personnel answered that they gave an injection before sending 
a severely ill patient to the upper level facility showing their knowledge of referral 
indications. Health personnel understood that only a few injections were really needed. 
Nevertheless, it was difficult to conclude that the extremely low percentage of injection 
prescriptions could be realised only by introducing STGs through training. In the EML, 
majority of injectable medicines were marked as 'emergency medicine' for Level 2 facility 
[128], and procurement for these facilities is minimal. It was considered that the result 
was caused by a combination of STGs, training, the national EML, referral system and 
procurement system. 
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STG-re/ated factors 
Previous studies have suggested that STG related factors influence adherence to STGs 
[82, 86, 90-92]. Although questions on this theme were not directly asked in this study, 
STG characteristics were suggested by the interviews: their STGs were easy to use; and 
they could be opened repeatedly. The quantitative data showed a considerable 
difference in adherence to STGs between speCific instructions. It implied that there might 
have been a difference in features among specific STGs; e.g. simplicity of the contents 
and display of flowcharts or tables. However, the interviews did not suggest which STGs 
were specifically easier than others or which were more difficult than others. Few actual 
suggestions were made in the interviews as to ways of making the present STGs more 
user-friendly. 
Supports 
Some support was expected by health personnel for the use of STGs. These were found 
mainly in responses to the questions about problems/difficulties. Instead of indicating a 
difficulty, health personnel suggested possible measures for solving it such as helping 
each other, referring a serious case to a higher level facility including consultation with 
the doctor, and giving feedback about the problem to the MoH. However, it was unknown 
from the interviews whether this expected support was practically functioning, as 
discussed in 9.1.3. 
9.2 Strengths and limitations of the study 
9.2.1 Situation in Timor-Leste 
One of the strengths of this study was the provision of information for a very new country. 
A study on the use of medicines using internationally used indicators has not yet been 
reported from Timor-Leste, and other public health research is also limited. Nevertheless, 
conducting research in a newly established country meant that unavoidable difficulties 
were encountered during the project. 
Firstly, the health policy and planning for the country was in flux. The most critical issue 
for this study was a change in the human resource allocation plan for rural CHCs. That 
occurred in the middle of the research project (See 5.6.1). This made data collection 
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difficult and data analysis complicated. As the research aim was established based on 
the fact that doctors were extremely scarce, the aim might have been undermined. 
Secondly, the health information system had not been well established, and 
documentation was not yet uniform. This resulted in missing retrospective data, and also 
necessitated developing criteria to prepare for variations in the patient registration books 
among CHCs. This decreased the quality of the data. As the quality of secondary 
information gathered in the MoH from CHCs was considered questionable, this research 
principally relied on primary data. 
Thirdly, 'limited capacity' has been an issue since the early stage of reconstruction of the 
country [111]. This lack of skills had been found in the government, international 
agencies, as well as in NGOs. For an individual researcher, therefore, to find very 
qualified and experienced research staff was difficult. As explained in 5.4.2, one of the 
reasons for choosing young people as research staff for this project was to make 
respondents feel easy about being observed or interviewed. In reality, however, another 
reason was that only a limited choice was available. In these unique circumstances, this 
research project tried to contribute to the 'capacity building' of the nation. 
Fourthly, communication and transportation were still difficult. None of the CHCs 
selected for the research had a landline, and the majority of them were located out of the 
mobile phone network. This meant getting information on the CHC in advance or 
confirming data afterwards was almost impossible. Furthermore, the road conditions in 
rural areas were extremely hard. The research team needed to withdraw from one CHC 
that was originally selected since the vehicles could not get through, and the schedule 
was rearranged for some CHCs to wait for the dry season, which could have biased the 
data collected. 
Finally, the language situation in Timor-Leste was complicated. Tetum, the East 
Timorese lingua franca, has become a national language [110], 86 percent of the 
population above six years old are reported to speak it [94], and the National Institute of 
lingUistics, founded in 2001, has been establishing the structure of the language and an 
official orthography [163]. However, a number of spelling systems are still in use and 
there are substantial grammatical and lexical variations [164]. A previous study on 
traumatic stress among Timorese indicates the language barriers in undertaking 
research in Tetum [165]. In practice, its vocabulary was still limited and sentences were 
contextual. This might have influenced the research, especially the qualitative data 
analysis. 
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9.2.2 Data collection 
Quantitative data collection 
The INRUDIWHO manual suggests that both the retrospective and prospective data 
have advantages and disadvantages but can be used to complement one another. 
Retrospective data are easy to collect if the source is complete and reliable, and they can 
be randomly sampled to minimize bias. However, only information on the prescribing 
step can be found. On the other hand, prospective observation is usually complete, 
providing information on all of the health care steps, but biases due to seasonality, 
peculiarities in staffing and inconsistencies in the supply cycle are unavoidable [44]. The 
presence of observers may stimulate modifications in health personnel practice as in the 
'Hawthorne effect' [166]. 
For the retrospective data collection, misSing registration books and irregularity of the 
documentation were often a concern. Moreover, sources of the retrospective data 
provided only basic information. Including doctors' consultations in the prospective 
observation made data collection difficult as described in 5.6.1. As only the doctors who 
consented to participate in the study were included, doctors' data could have been 
biased. Although the majority of languages were covered by staff and local help, some 
patients were excluded because of their languages. 
Since the INRUDIWHO manual was published, other more detailed indicator-based tools 
have come out [167-170]. In this study, only simple indicators were measured. 
Nevertheless results were important where no objective data on this issue were available, 
yet. Further more, the method was feasible to apply in Timor-Leste's situation. Because 
INRUDIWHO indicators were developed as first-line measures to stimulate further 
questioning and to guide subsequent action [44], it was meaningful to use them in this 
study. 
Qualitative data collection 
Data collectors provided both advantages and disadvantages for the qualitative data 
collection. All of them were fluent in Tetum and Indonesian. They were originally from 
rural areas and knew the situation well. At the same time, they were relatively highly 
educated when compared with the average in the country. Their younger age was 
considered to make respondents more relaxed. However, as already discussed, their 
lack of experience might have influenced the quality of the data. Interviewing and note 
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taking was not always very thorough. Since data analysis relied on their interview notes, 
the quality of note taking had to be taken into account. 
The respondents were informed of the aim of the research in advance. Many 
respondents knew the researcher. Although interviews were not carried out with 
respondents by the researcher directly, she stayed in most of the target CHCs with data 
collection staff. These facts might have resulted in respondents answering in the way 
they believed the researcher was expecting, which would skew the data. 
Finding a location in which to hold the interviews was problematic. Although the ideal 
would have been to interview health personnel away from the health facility, it was 
difficult to find a ctosed space in the rural community. For example, local restaurants or 
private houses usually offered little privacy. Therefore, many interviews were performed 
inside the CHC or the research team's accommodation such as a health post. Being 
interviewed in the health facility might have affected health personnel emotionally even 
though privacy issues were always deliberately considered. 
9.2.3 Analytical methods 
Use of medicines (Objective 1) 
For practical reasons, the sample size of each CHC was fixed, although the number of 
patient visits varied among CHCs. Moreover, the extent of missing registration books 
also differed; from 100 percent missing in two CHCs to completely available in 11 CHCs. 
These facts might have biased the results in both chapter 6 and 7. 
Indicators can be used to compare the performance between prescriber or facility groups 
[44]. Three prescribing indicators in this study were compared by prescriber's training, 
using the prospective data. If possible, the retrospective data would be preferable for this 
analysis for several reasons; they had a larger sample size, were randomly sampled, 
and comprised, almost exclusively, local health personnel cases. However, information 
in the registration books was limited. As prescriber's name was not available in the books, 
further analysis with the retrospective data was impossible. 
Adherence to STGs (Objective 2) 
Including doctors' consultations in the prospective data made the quantitative analysis 
complicated. ConSidering the original purpose, the inclusion of doctors in the analysis 
was questionable, but excluding doctor cases made the sample size smaller than 
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expected. The smaller sample size led to less power. In addition, analysis by CHC 
characteristics was complicated. On the one hand, prospective data that included 
doctors' cases were not considered to represent the CHC's overall situation. On the 
other hand, a time discrepancy could not be avoided between the retrospective data 
sampled from records in 2005 and CHC data obtained in the middle of 2006. Both the 
retrospective data and prospective data were not ideal to be linked to CHC data and 
analysed by CHC characteristics. Finally, this analysis used bofh data. Although the 
actual composition of the staff in 2005 was unknown, the linkage of the datasets (the 
retrospective data and the CHC data) was based on the assumption that the composition 
of health staff in the CHC was static. 
As information from the retrospective data collection was minimal and none of the CHCs 
recorded individual prescriber's name in patient registration books, analysis of 
retrospective data by prescriber was impossible. 
'Prescribing adherence', which was the main focus for the analysis described in chapter 
7, was assessed based only on recorded diagnosis. Accuracy of diagnosis was not taken 
into account in prescribing adherence, which was not enough to assess 'community 
efficacy' [33, 34]. 
Analysis for prescribing adherence was separately carried out by prescriber 
characteristics and by CHC characteristics, using a Willcoxon rank-sum test. If the 
collected data were more suitable, for example prescriber's name was available in the 
retrospective data and precise CHC data in 2005 could be gained, a more sophisticated 
statistical analysis model that took account into prescriber's factors and CHC factors 
could be developed. 
Know/edge and attitudes (Objective 3) 
Living and working in Timor-Leste for several years, the researcher had shared 
experience with respondents. Knowledge of the local context in terms of rural conditions 
as well as the public health system was an advantage for analysing the interviews. The 
ability to speak Tetum and Indonesian, especially the vocabularies used in CHCs, was of 
help, too. Although these issues may have caused a potential risk of subjectivity, 
value-free is not considered valuable in qualitative research [171]. and a researcher can 
be a research instrument [166]. A researcher's personal experience should not impair 
but strengthen the study. 
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As discussed in 5.4.3, the qualitative analysis in this study used the 'Framework 
approach'. This approach is particularly appropriate for policy-oriented research that has 
clear aims at the outset [145-147, 172], and thus suitable for this research. The relatively 
limited time-scale of the approach was also appropriate. The visibility of qualitative 
methods is another feature of the Framework approach [145], and computer software 
can help this visibility [173]. 
The quality of interviewing and note taking might have been a limitation of the qualitative 
analysis. In addition to the quality of interviewers and note takers, the nature and present 
immaturity of Tetum could also have been a problem. Moreover, although interviewing 
the respondents in their own language was an advantage, it necessitated interview notes 
being translated. Birbili indicates that translation-related problems can result from 
difficulties in gaining conceptual equivalence or comparability of meaning, difference of 
grammatical and syntactical structures in two languages, and a way to access and 
understand participants' words [174]. It was considered that all of these issues occurred 
in the translation in this research. Birbilli further notes that there are two techniques 
known to deal with translation-related problems: piloting or pre-test and back translation 
[174]. Due to time constraints, back translation was not done in this study. Instead, the 
researcher translated directly from the original notes, and relied much more on the 
Indonesian translation than the English translation73• 
9.2.4 Mixed methods research 
The rationale for and advantages of mixed methods research were discussed in 5.1. 
Mixed methods fitted the aim of the study as well as the situation in the research area. It 
could quantify a phenomenon while explaining its context, which was one of the most 
important strengths of this research. However, mixed methods cannot supplement 
deficiencies in research design [175]. In this study, limitations of data, some of which 
were unavoidably caused during data collection, meant that the study was unable to 
carry out deeper integration. For example, interviews were originally planned with health 
personnel who were observed for quantitative data so that quantified observational data 
73 Although the grammar and structure of Tetum and Indonesian are different from each other, 
Tetum still borrows conceptual and abstract words as well as technical jargon from the Indonesian 
vocabulary. Two translators had been educated in Indonesian from compulsory to higher 
education, and were nearly native speakers. Therefore, the Indonesian translation was 
considered more reliable than the English translation. 
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and qualitatively analysed interview data could be integrated. However, a third of the 
interview respondents were not involved in consultations or dispensing. 
9.3 Generalisability 
This study randomly sampled facilities from the whole country although there were some 
excluded CHCs. The quantitative data sampled were considered to represent the 
situation for rural Timor-Leste even both the retrospective and prospective data could not 
escape from some defects, as discussed in section 9.2.2. The qualitative data used the 
same random samples at the first stage and then 'purposive sampling was applied in the 
second stage sampling so that selected cases were 'informationally representative [144]'. 
Thus, results of this mixed methods research could be generalised to rural CHCs in 
Timor-Leste. 
Transferability, whether the findings could be transferred outside Timor-Leste, is also 
important to consider. Previous studies discuss 'naturalistic generalisation' or 'inferential 
generalisation' regarding the relevance of findings to other settings and contexts beyond 
the sampled one [176-178]. Timor-Leste experienced a chain of unusual events; serious 
violence, transitional administration by the UN and restoration of sovereignty. In this 
aspect, the context was unique. When the research was conducted, however, a 
'post-crisis' situation was no longer emphasised, at least in the health sector. Rather, the 
country should be viewed as one of the poorest countries in the world [179]. The country 
faced limitations of resources as seen in many other developing countries. In this study, 
the resource-limited situation in Timor-Leste and how the new health system has been 
trying to deal with such a situation were described. The country has been struggling with 
establishing a sustainable system to provide health services equally to the people. The 
findings can be inferentially generalized, and are transferable to other resource-limited 
areas. 
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CHAPTER 10 Summary and recommendations 
In this chapter, key findings are summarised and then recommendations are presented 
for Timor-Leste, other resource-limited areas, and future research. 
10.1 Summary 
This research can be summarised as below, corresponding to the objectives and 
research questions established in chapter 4: 
10.1.1 Use of medicines (Objective 1) 
Medicine use situation in Timor-Leste (Research question 1) 
Timor-Leste's characteristics regarding the use of medicines in public health facilities 
were favourable when compared with previous studies from other developing countries. 
The number of medicines per encounter and percentage of encounters with an antibiotic 
prescribed were similar to the average for 35 previous studies. An extremely low 
percentage of encounters in which an injection was prescribed in Timor-Leste was 
notable. It was believed this low percentage of injection prescriptions could be achieved 
because of a combination of the new policy combining the national EMl, STGs and 
related health systems. A high percentage of medicines actually dispensed and a high 
percentage of patients' knowledge of correct dosage were found. However, the 
percentage of encounters with a vitamin prescribed was measured in this study, and 
shown to be high. 
Prescribing Indicators and prescriber's training (Research question 2) 
Three prescribing indicators were statistically compared by prescriber's training. The 
percentage of encounters with an antibiotic prescribed was lower for health personnel 
with clinical nurse training than for those without the training. Two other indicators (the 
average number of medicines per encounter and percentage of encounters with a 
vitamin prescribed) did not show a significant difference by clinical nurse training. IMel 
training did not make a statistical difference in the three prescribing indicators. The same 
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conclusion was reached when including foreign doctors in the 'no training' group for both 
clinical nurse and IMCI training. 
10.1.2 Adherence to STGs (Objective 2) 
Adherence to STGs for healthcare steps (Research question 3) 
In total, adherence to STGs for the three major diseases studied (ARTis, malaria and 
diarrhoea) for each step (taking a history, conducting a physical examination, recording 
clinical decision, and prescribing medicines) was 37 percent, 24 percent, 77 percent and 
56 percent respectively. The result was remarkable in malaria treatment; nearly 80 
percent of prescriptions for clinically suspected malaria patients adhered to malaria 
STGs. However, the history taking and physical examinations were only performed in 
accordance with STGs in a few consultations. Although reasons for this could not be 
determined directly from the data, one possible explanation was the complexity of the 
instructions in STGs for taking a history and conducting a physical examination. 
Prescribing adherence and prescriber characteristics and CHC characteristics 
(Research question 4) 
Prescriber's clinical nurse training was strongly associated with prescribing adherence to 
STGs for the three target diseases, and prescriber's IMCI training was weakly 
associated with prescribing adherence to STGs. A higher level of prescribing adherence 
was observed among prescribers who attended both kinds of training. Other prescriber 
characteristics, such as age, sex, occupational category, civil service level, and work 
experience, were not associated with prescribing adherence. Adjusted OR for 
prescribing adherence of clinical nurse was 6.6 (95%CI: 2.5 - 17.6) and adjusted OR for 
prescribing adherence of IMCI trainees was 2.9 (95%CI: 1.2 - 6.8). When foreign doctors 
were categorised into the 'no training' group, prescriber's clinical nurse training, IMCI 
training and 'any training (one of two kinds of training), also showed a statistical 
difference in prescribing adherence. Analysis by CHC characteristics was difficult 
because of limitations of the data. Based on the available data, however, facility 
characteristics investigated in the study, including the total input of training such as total 
members trained and total period of training, were not associated with the CHC's overall 
prescribing adherence to STGs for the three target diseases. 
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10.1.3 Knowledge and attitudes (Objective 3) 
Knowledge of STGs (Research question 5) 
Overall, newly introduced STGs were well known to local health personnel in 
Timor-Leste. Clinical nurses referred to STGs more accurately and minutely than others. 
A contrast between IMCI trainees and non-trainees among non-clinical-nurses was not 
very clear. Among the three target diseases, treatment recommendations in malaria 
STGs were understood the most. These results support a higher level of prescribing 
adherence among clinical nurses and a higher level of prescribing adherence to malaria 
STGs, which were found in the quantitative analysis. Despite an overall good knowledge 
of prescribing, health personnel often misunderstood the indications for vitamin 
prescription. This study revealed three facts related to knowledge and prescription of 
vitamins. Firstly health personnel over-prescribed vitamins. Secondly health personnel 
lack knowledge of vitamins. Thirdly patients lack knowledge of vitamins. These three 
facts are probably related, but this can not be inferred directly from the data. 
Attitudes of present practice (Research question 6) 
Health personnel accepted the new policy to standardise basic treatments, and did not 
show any disagreement with STGs in general or specific STGs. They believed that they 
'should' follow STGs. Two stances emerged to explain this feeling of obedience; they 
were frontline workers in the community, at the same time, governmental employees 
under the MoH. Respondents were confident in their present practice in terms of the use 
of medicines. They would not submit to patient expectation for medicine if they 
considered it inappropriate or unnecessary. Self-confidence was more evident in clinical 
nurse interviews, in particular their answers about attitudes to patients, colleagues and 
foreign doctors. These results implied that clinical nurse training could also influence 
attitudes. 
Changes brought about by the introduction of STGs (Research question 7) 
It was a unique finding that changes after the introduction of new STGs were positively 
perceived by health personnel in Timor-Leste. Changes suggested by respondents 
consisted of three different components: the policy concept, daily practice, and 
perceived patient satisfaction. As a background, a lack of confidence and hope to 
improve their capacity had previously existed. Health personnel's positive perception of 
the changes led to self-confidence and the gained self-confidence further promoted the 
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use of STGs. Moreover, they hoped for prompt information in case of any change to 
STGs as well as for more training for themselves and for colleagues. 
Difficulties in application and implementation of STGs (Research question 8) 
Unexpectedly, health personnel did not feel that STGs were difficult to apply. They 
thought that they could open STGs repeatedly to solve difficulties. Other problem solving 
strategies respondents suggested were; to help each other, to refer a severely ill patient 
to a higher level facility or to the doctor, and to give feedback to the MoH. Shortage of 
medicines and other social and organizational issues were indicated as a 
difficulty/problem. However, little information was obtained on how these external 
barriers influenced the use of medicines and adherence to STGs. 
10.1.4 Factors that influence the use of STGs (objective 4) 
Factors that influence the use of STGs (Research question 9) 
Training was associated with health personnel's adherence to STGs. In particular, 
clinical nurses showed clear differences in their knowledge, attitudes and prescribing 
practice. However, the total effect of individual training on overall CHC performance was 
still questionable. Health personnel's agreement with STGs was considered to facilitate 
the use of STGs. They thought they 'should' follow STGs because they were frontline 
workers in the community as well as government employees under the MoH. Health 
personnel's positive perception of the changes brought about by the introduction of 
STGs led to increased self-confidence, and this further promoted the use of STGs. A 
pre-existing lack of confidence and hope for increasing capacity underlay this 
factor. Development of STGs in a health policy framework was important so that related 
policies and programs were interconnected. In Timor-Leste, STGs, training, the national 
EML, and health service delivery system were interrelated and consistency between 
them was maintained, which resulted in favourable practice. STG-related factors were 
suggested by health personnel: their STGs were easy to use and could be opened 
repeatedly. Expected supporls for the use of STGs were identified such as: mutual help, 
referral and consultation, and a feedback system. 
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10.2 Implications in Timor-Leste 
The findings in this study suggest strategies that will improve the use of medicines in 
rural CHCs through the use of STGs. 
10.2.1 Policy implications 
STGs 
Efforts should be made to keep health personnel's ownership of their new STGs. This 
requires maintaining their agreement with the STGs as well as their positive perception 
of the changes after they started using the STGs. It is vital that health personnel 
continuously and clearly understand the need of standard treatment and policy on their 
new STGs. Constant socialisation of new STGs to the all people concerned is important, 
including foreign doctors. 
Interrelation and consistency between related policies and programs should be 
maintained. The development of Timor-Leste's STGs is linked to all policy areas, and the 
STGs, training, the national EML and health service delivery system are interconnected. 
It was considered this caused the favourable results, as seen in the low percentage of 
injections being described. STGs should not be isolated from any related policies and 
programs. 
Favourable features of the present STGs should be taken into account and strengthened 
in future revisions. As health personnel thought that they could easily use their STGs 
repeatedly, revised STGs should be produced based on local need. Prompt information 
is expected to arrive at CHCs when any change in the present STGs is made. 
Training 
A clear strategy should be stated by the MoH so that health personnel who have been 
trained can maximize their gained ability under the ever-changing circumstances. 
Research results showed that the plan for in-service training of local health personnel 
was successful, but clinical nurses are now in a delicate position because of a new 
human resource allocation plan. The position of training should be understood by the all 
people concerned with health policy and planning. 
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Support system 
Health system support for the use of STGs should be well functioning. This includes 
further strengthening of a referral and consultation structure and feedback path. Based 
on observation, availability of medicines is quite good but many health personnel 
complained of shortages of medicines. Investigation into the real meaning of these 
complaints will inform improvements in the medicine procurement system. 
10.2.2 Practice implications 
Follow-up supervision and update sessions are necessary to encourage health 
personnel to practice what they have learnt. Follow-up and updates are also needed to 
monitor trainees' performance, which will address their weakness and correct their 
misunderstandings after completing training. 
It is also necessary for health personnel to know how to share knowledge and skills . 
related to the newly introduced STGs among trainees and non-trainees in a facility. In 
this study, the total training input was not associated with CHC's overall adherence to 
STGs. Training should include a module that instructs trainees on how to transfer the 
new knowledge and skills to colleagues. Follow-up supervision at the facility is also 
important for this purpose. As already planned in Timor-Leste, CHC management 
training for managers may be one strategy to solve this issue. 
Encouraging an organizational culture of mutual support in the CHC and providing 
realistic techniques to support that culture are important because many Level 2 CHCs 
are geographically isolated. In such a circumstance, their mutual help will be crucial. In 
the interviews, health personnel suggested that helping each other would be of help 
when they faced a problem; this, therefore, should work well. 
10.3 Applications in other areas 
What was notable in Timor-Leste was the appropriate use of medicines and good 
adherence to their new STGs in an under-resourced setting with limited facilities and 
health personnel with minimal educational background. Introducing new STGs through 
in-service training showed the potential to empower local health personnel and to 
contribute to a sustainable system of providing health services equally to the people. It is 
important to recognise that, in Timor-Leste,S TGs existed across various programs. It is 
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required that STGs, training, the national EML and health service delivery system be 
interconnected. Consistency between related policies and programs should be kept. 
This study indicates that these strategies would be usefully tried in other 
under-resourced- settings. 
10.4 Further research 
Many issues were beyond the scope of this study, and more and more issues emerged 
from the findings of the study. The following research topics were identified as important 
in helping to understand more about the use of medicines and adherence to STGs in 
rural communities. 
Training-related research 
Training evaluation: This study investigated the effect of training on the use of medicines 
and adherence to STGs, but did not evaluate the content and process of the training. 
Evaluating each training program would provide more information. 
Training effect on facility's performance:ln this study, training did not prove effective on 
CHC's overall performance. To determine what works in a facility will require qualitative 
organisational research. An intervention study to investigate the total input of training in a 
facility and the facility's overall outcome could be usefully conducted. 
Middle- and long-term training effects: In this study, only short-term performance after 
training was assessed. The middle- and long-term effect of training on adherence to 
STGs, taking into account the influence of known and other possible maintenance 
strategies, will be required. 
Different outcome measurements 
Impact on community health: The impact of introducing STGs (with training) on 
community health was not assessed. Where the health information system is reliable, 
the mortality rate of the target diseases can be measured as an outcome. Health facility 
utilisation for the target diseases; medicine consumption; and antimicrobial (antibiotic or 
anti-malarial) resistance are also possible outcome measurements. 
141 
Patient satisfaction: In this study, health personnel perceived changes in patient 
satisfaction after their new STGs had been introduced. To know real patient satisfaction 
as a consequence of introducing the STGs, more research will be needed. 
Costs: The economic aspects of the introduction of STGs were not assessed. When 
training to introduce STGs is planned, both implementation and maintenance costs of 
training need to be considered. A cost-effectiveness study to compare different training 
programs should be conducted. 
Different settings 
Use of medicines in remote areas:This study targeted primary care facilities, which are 
located at sub-district centres and called Level 2. As 85 percent of the population of 
Timor-Leste live in rural areas [112], many people cannot easily access Level 2 facilities. 
The MoH is currently offering some strategies for people in very remote areas, such as 
health posts or mobile clinics (Level 1) and community activities by family health 
promoters. A study on the situation in remote areas is important. 
Use of medicines in the private sector. including retailers: This study was limited to the 
public health system. However, Timor-Leste MoH estimates a regular clientele of around 
125,000 in the private sector with 190 health workers [113]. Although many private 
clinics are located in urban areas, some of them are run by the church and a coffee 
producer cooperative which is located in the same town as the Level 2 CHCs. Moreover, 
although the Pharmaceutical Activities law has been enacted, local grocery stores are 
still selling medicines. Little is known about the use of medicines in the private sector. 
Others 
Why and how factors found worked: 'How much' and 'what' questions were asked in this 
research, but questions as to 'why' the factor worked and 'how' the factor worked were 
not much investigated. Answering 'why' and 'how' questions will help to develop further 
strategies. 
Common misunderstandings shared by health personnel and patients: This research 
showed a high proportion of vitamin prescription and common misunderstandings of 
vitamins were shared by health personnel and patients. Investigating the relationship 
between health personnel knowledge and patient understanding will help to inform on 
strategies to improve the use of medicines in the community. 
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10.5 Conclusions 
This is the first time research on health personnel's use of medicines and adherence to 
their new STGs in Timor-Leste has been reported. Overall, Timor-Leste's characteristics 
of the use of medicines in the CHC were favourable. Clinical nurse training strongly 
influenced knowledge of, attitudes to, and practice of the use of medicines and 
prescribing adherence to STGs. IMel training also showed an association with 
prescribing adherence to STGs. 
Agreement with the policy concept and contents of STGs facilitated the use of STGs. 
Health personnel's positive perception of the changes brought about by the introduction 
of STGs led to increased self-confidence, which further promoted the use of STGs. 
Development of STGs in a policy framework was important to maintain interrelation and 
consistency across related policies and programs. Health personnel thought that their 
new STGs were easy to use and could be opened repeatedly. A supportive environment 
and good support systems are important for health personnel to adhere to STGs. 
Efforts are required to maintain health personnel's agreement with and positive 
perception of their STGs. Constant socialisation and timely updates are necessary. 
STGs should not be isolated from related policies and programs. Revised STGs should 
be more user-friendly based on the local need, and should arrive at CHC promptly. All 
the people concerned need to understand the position of training within the health policy 
framework. Follow-up supervision and update sessions are necessary to encourage and 
monitor their individual practice as well as the CHC's overall performance. It will be 
necessary to ensure that expected support systems are functioning. 
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IMCI Lampiran A 
Pedoman IMCI Anak berumur 2 bulan hingga 5 tabun 
Bagan Alur Demam (IMel) 
Apakah anak menderita Demam? 
35 
• Apakah anak bias minum aBU nelek? 
• Apakah anak selalu memuntahkan semuanya ? 
• Apakah anak menderila kejang 
Bila Yalanyakln 
a Bcrap. lama 7 
a Bil. I.bih 7 hari, ap.kah demam scoap han ? 
a Pemahkan anak mend.pal campak dolo", j 
bulan Ie talchir? 
Liliat d.n Rl ba: 
Q Adakah Kaku Kuduk 
a Tanda-Ianda CAMPAK 
o rasb seluruh rubuh dan 
o sa lah .. ru dan batulr., pilek, rad.1ng ml to 
Tanya, Iihat dan raba 
adanya tanda dan gejala 
CAMPAK 
Tanya, lihat dan raba 
adanyatanda 
dan gejala 
DEMAM BERDARAH 
DENGUE 
• Ad'kah lond. 
bahaya alJu 
• ~.Iru kuduk 
• OEMAM 
poilu 
Anamnesu 
AI>U pad.1 
(>Cl11blAn .lau 
suhu 37.5"C 
Periksa, KIa ifikasikan 
dan Terapi ampak 
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Pengambilan Keputusan Klinis dan 
Klasifikasi 
Derajat Dehidra i 
Yang paling p\.:nlmg adalah menilai dernjal Dchidrasi (lihat label) . Jika ada dua tanda alau 
lebih maka golongankan pasien pada lajur yang sama. Jika tidak ada dua tanda atau leb ih 
maka lanJlllkan ke lajur berikulnya . 
Penilaian Dehidrasi 
Tcrdapat dun a tau Icbih dari tallda-
tanda bcrikul 
Gelisah atau rcwel DEHIDRA I 
Mata cekung RINGAN- EllANG 
Huus atau minumdengan raku~ 
ubi tan kulit kcmbal i lambat ( 0::: 2 
detik) 
Tidak cukup landa unlUk 
diklasifikasikan sebagai dchidrasi TIOAK DEHfDRAST 
ringan-sedang 
Diare 14 hari atau lebih 
RENCANAB 
I 
RENCANAA 
Tanpa dehidrasi OIARE PERSISTEN 
Naschati ibu tcntang ca ra pemb"rian makan 
pad:! anak dcngan OIARE PERSISTEN 
KlInjllngan u lang se tela h 5 hari 
Darah Dalam Tinja 
r D,,,h "I,m 'i"~ DlSENTE~ ' Beri anti biot ika yang se~k[)i;~l Bcrdarah se lama 5 hari (Lihat Tcrapi L>ia re 
I1crdarah) 
Kunjungan ulang setcl ah 2 hari 
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0\ MEMERIKSA TANDA BAHAYA UMUII 
liTANYAKAH • Apakall anal< bias min", .au neteI(/ • Apakah anal< se401u memtJntaIlI<an semuanya? • ADakah anal< rnenderita kejang UHAT l • ApakaI1 anal< tampak IeIaI1lis iIIa1l tidal< sadaI? 
SemuI_ dorom __ bohIya unun _ SEGERA. _priIiIn in din __ • oehinggo rujWn _ t'-
• SucIah befapa "",,,1 
• l.Jt\a1 k.eadaan umum anllt., apaJtlih • 
Letargts atau 1KSak udan 
Gefisah .~u rewe"-modah mal'llh? 
• Adakah darah da1am tinia ? • ltlat apakaI't mati. oekung? 
• Beri."..k rninum. apaQh' 
Tldak Disa ~ ItliU malas minI.m'? 
Haus. minum dengln tlnap? 
• Cubit k";' poNt. ""'"" "'""9N"'" 
1U<p. ~ komboI. Sangol __ da" 2 _ )1 
Llmbet,? 
_. 
Gejala Klaslfikasi 
:or.," 
T ...... _ ... _ 
___H: 
.~--
'-• -CIIoI<nO • T1dIk _ "*""" IlIOU I DEHIDRASI _  IIERAT 
• c.-loIIIporut 
-~-
T-"' __ IoI,;n 
__  hi: 
._-.. DEHlDRASI 
mo .... AINGANI 
.-"""""'l SEDANG 
• Hous. ....... dengon 
-
• c..t>!an IcuIII perut 
--
• T1dIk ..... _ I TA»A -:-~i ~
........ --
- .......... 10 ". 
..... - . 
• T~ dehidTui. 
• Oarah daIMt .. 
DlAftE 
-PERSISTEN 
BERAT 
DlARE 
PERSISTEN 
DlSENTRI 
-~t"" ~t'!'j~ 
Ci~9 
- 0 "0 ~ ~. 
~ == 
Z 
llndakan 
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Crite" f th ta t d d" ria or e rge e Iseases 
diagnosis 
ARTis ISPA, ISPA A, ISPA B, 
ARI, URTI, LRTI, 
salesma (common cold), 
flu I influenza, 
faringitis (pharyngitis), 
tonSillitis, 
sinusitis, 
pneumonia, 
BBP (batuk bukan pneumonial 
Malaria malaria 
or malaria test positive 
Diarrhoea diare 
dysentery 
Criteria for classification and prescription 
ARTI 
classification 1 essential 
URTI 
-----
common cold 
flue I influenza 
cough not pneumonia 
LRTI antibiotic 
_pneumonia 
pharyngitis antibiotic 
tonsillitis 
sinusitis 
suspected antibiotic 
tuberculosis 
Malaria 
classification 1 essential 
malaria (in a facility fancidar 
without laboratory) chloroquine 
suspected malaria 
clinical malaria 
Falciparum (+) fansidar 
Vivax (+) chloroquine 
primaquine 
mixed malaria fansidar 
Falciparum (+), Vivax chloroquine 
(+) primaquine 
malaria with first line quinine 
treatment failure 
Appendix 2 Criteria for data entry 
others 
There is no diagnosis and the chief 
complaint includes at least one of: 
mear (cough) 
inus metin (nasal congestion) 
inus been (running nose) 
kakorak moras (sore throat) 
iis boot (difficult breathing) 
Prescription includes at least one of: 
Fansidar 
Chloroquine 
Quinine 
PrimaQuine 
There is no diagnosis and the chief 
complaint includes at least one of: 
tee been (watery stool) 
kabun moras (abdominal pain I 
diarrhoea) 
category of medicine 
2 if necessaJY 3 unnecessary 
paracetamol or anti-cough 
another antipyretic antibiotic 
paracetamol or anti-cough 
another ant1Qyretic 
paracetamol or anti-cough 
another antipyretic 
paracetamol or anti-cough 
another anti~etic 
category of medicine 
2 if necessary 3 unnecessaJY 
paracetamol or antibiotic 
another antipyretiC 
SF 
paracetamol or antibiotic 
another antipyretic 
SF 
paracetamol or antibiotic 
another antipyretic 
SF 
paracetamol or antibiotic 
another antipyretic 
SF 
paracetamol or antibiotic 
another antipyretiC 
SF 
160 
Appendix 2 Criteria for data entry 
Diarrhoea 
category of medicine classification 
1 essential 2 if necessary 3 unnecessary 
diarrhoea 
simple diarrhoea paracetamol or 
anti-diarrhoea acute diarrhoea ORS another antipyretic 
diarrhoea without antibiotic 
dehydration 
bloody diarrhoea ORS paracetamol or anti-diarrhoea 
dysentery antibiotic another antipyretic 
ORS paracetamol or 
anti-diarrhoea persistent diarrhoea antihelmenthic or another antipyretic 
metronidazone 
Criteria for adherence 
medicine(s) medicine(s) medicine(s) 
in category 1 in category 3 in category 3 
adherent prescribed prescribed or not prescribed 
not prescribed 
not adherent not prescribed prescribed 
remarks 
Priority is the 1 at diagnosis 
If the 2nd diagnosis is also one of 3 targeted diseases, 
o It is acceptable if there is no essential medicine for the 2nd diagnosis (to ignore it). 
o It is unacceptable if there is an unnecessary medicine for the 2nd diagnosis (to 
consider it unnecessary). 
Duplicate of antipyretiC is considered to be unnecessary. 
Duplicate of antibiotic is considered to be unnecessary. 
Duplicate of vitamin is considered to be acceptable. 
Vitamin A for children <5yo is not counted for the number of medicines or a vitamin 
prescription. 
An antihelminthic for children 2 - 14yo is counted for the number of medicines. It is 
considered to be acceptable even if it is prescribed without diagnosis. 
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Form 1 
Sample dari buku registrasi pasien 
Fasilitas: Tanggal pencatatan: 
No serial No fang UD jell diagnosa I klasifikasi group OINIt-oOatan gal umur kel 
m (2) (3) (4) (5) (6) (7) (8) (9) 
1 
2 
3 
4 
! 5 
6 
7 
8 
9 
0 
SUBTOTAL 
TOTAl 
--- ---
ISPA= ___ _ Malaria = ____ _ Oiare = ____ _ Group A = ___ _ 
Data kolektor: 
jumlah anti 
vii inj kfas obat biotik 
(101 (111 (12) (131 (14) 
- --
Others = ___ _ missing= ____ _ 
resep 
(15) 
1 
1 
1 
I 
:b 
:g 
! 
Q. )CO 
w 
:0 
!. 
a 
~ 
~ 
f 
• fit 
III 
J 
cr 
~ 
Appendix 4 Prospective observation checklist forms 
Form 2 I 
Checklist untuk ruang kontultasi 
Fasilitas: Tanggal: 
Data kolektor: 
Persetujuan lisan: ( Va I Ti ~ak ) 
Nama: (No. 10: ) 
(1) No Kartu: 
(2) Umur: 
. 
(3) Jenis kelamin: ( M I F 
141 Keluhan utama 
15) Anamnesis (6) Pemeriksaan fisik 
1 Lamananya I durasi (Tanda vital) 
1 Temperatur I suhu 
2 Deman 2 Tekanan darah 
3 Sakit kepala 3 Nadi 
4 Muall muntah 4 Frekuensi napas 
S Kemampuan minum I maks n 5 Berat badan 
6 Rasa haus '-
(Pemeriksaan fisik lalnnva) 
7 Batuk I sakit tenggorokan I pilek I 6 Kepala 
hiduna tersumbat 7 Mata 
a Sesak napas 8 Muka 
9 Batuk lebih dari 3 minggu 9 Telinga 
10 Dahak dan wamanya 10 MulutlTenggorokan 
11 Dahak berdarah 11 Lehar 
12 Sakit menelan 12 Dada/Paru - inspeksl 
13 Sakit aiai I .akit di muka 13 Dada/Plru -- au.kulasi 
14 Perut 
14 Menaioill gemetar I kerinol ~t 15 Kulit 
16 Turgor 
15 Banyaknya diare perhari 
16 Tinja berdarah I tinja denga ,Iendir 17 Lainnya 
17 Nyeri otot I sendi I punggun:l 
(7) Konseling 
1a Nyari bagian belakano bola mata 1 Penaambllan keputusan I diagnosis 
19 Bercak-bercak kulit 2 Pengobatan 
3 Kunjungan ulana 
20 Volume urin 4 Pencegahan 
21 Warna urin 
- -22 Gejala-gejala lainnya 
23 Pengobatan untuk penyakit 
sekarang 
24 Kehamilan 
OlpfitMksa oleh: 
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Appendix 4 Prospective observation checklist forms 
Form 2 
(1) Prescriber 
(2) Language 
Tetun 
Bahasa daerah ~ 
Bahasa aSing ~ 
(3) Translator 
tidak ada 
ada ~ ( petugan kesehatan, anggota keluargalteman ) 
(4) Diagnosa dan klasifikasi 
Malaria test ( Ya I Tidak) Jika Ya, ~ ( PF (+), PV (+), (-) ) 
(5) Group 
A ( sakit kepala, myalgia/sakit sendi/sakit punggung, kurang nafsu makan, sakit mag) 
B ( ISPA, malaria, diare ) 
C Lain-lain 
(6) Resep: 
(7) ( antibiotic, vitamin, injeksi ) 
(8) Kepatuhan terhadap STG 
anamnesis cukup? 
pemeriksaan fisik cukup? 
dicatat diagnosa dengan kasifikasi? 
peresepan yang patuh terhadap STG? 
ya 
tidak 
ya 
tidak 
diagnosa dengan klasifikasi 
diagnosa tanpa klasifikasi 
gejala-gejala saja 
patuh 
cukup patuh 
tidak 
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Form 3 
Checklist untuk loketJapotek 
Fasilitas: 
Dispenser: 1) 
No. 10 No 0 Lang (ca1atan mediS) 
(1) (2) (3) 
Tanggal: 
2) 
jen jumtah abat 
umur yang kel dir8sePkan 
(4) (5) (6) 
. c ... 
Data kolektor: 
3) 
jI.wnIah abel : minum jumlah obat 
yang diberikan : A~? semua? di:n semua? 
. ill : (7') (8) (9) (10) 
: 
: 
: 
No. 
peItI~n 
dari pasien 
(11) 
~ 
~ [ 
)(' 
.. 
~ ~ 
~ 
:::t. ~ 
~ 
CD 
~ 
:::t. g 
g. 
~ 
! 
0' 
3 (I) 
Form" No. 
Checklist untuk label dan pengetahuan pasien 
Fasilitas: Tanggal: Data kolekor: 
jell btl< label ~~huan oaslen No. 10 R nama Dbat-obatan '*'Ia nama aturan lama· cukup nama aturan lama- cukup No (catatan mediS) umur ket Dbal alasan 
oasien Dbal pakai nva ? obat Dakai ova 1 
(1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (14) (15) (16) (17) (181 
_ .. -
:b 
:g 
CD 
:s 
Q. 
;(' 
... 
~ 0 ~ 
CD 
C") 
=:!' <' 
CD 
0 
0-
til 
CD 
~ g. 
:s 
C") 
:s-
CD 
C") 
:!t 
iii' 
-cr 
~ i 0> 
0> til 
Appendix 5 Semi-structured interview topic guide 
(Indonesian version was used.) 
Interview topic guide 
(1) About treatment 
We hope to ask you about treatment according to your knowledge and experience. 
For what kind of ARTI (ISPA) do you prescribe antibiotics? 
How about for diarrhoea? 
What are diagnostic and therapeutic principles of malaria for you? 
What do you think is the indication of vitamin? 
(2) About present practice 
We hope to ask you about your work, especially about medicine issues. (If quantitative ' 
collection is already completed, show the brief results and ask them comments first.) 
Do you think patients are satisfied with your treatment? Please give us specific reasons 
why you think so. 
Do you think patients understand how to take medicines that you prescribe or 
dispense? Please give us specific reasons why you think so. 
Do you have any problems in prescribing or dispensing medicines? Please think about 
the working condition, your personal issues, and patients' side issues. 
(3) About changes after STGs and related training 
So far, some kinds of national protocols and guidelines have been developed and introduced 
in CHC work: for example, National Malaria Management Protocol (Protocol Tatalaksana 
Malaria Nasional), National Tuberculosis Program Manual (Manual Program Tuberculosis 
Nasional), IMCI, etc. Clinical Nurse Training (Pelatihan Perawat Klinik) textbooks also guide 
decision-making and treatment. 
What do you think has been changed after the introduction of these guidelines or 
protocols? In the workplace, in your personal work, or patients' reaction? 
For example, 'comprehensive patient management' is introduced as you know in IMCI 
training or clinical nurse training. What do you think about this? What in 
'comprehensive patient management' do you think is the most important difference 
from the previous management? What kind of changed do you feel? In the workplace, 
in your personal work, or patients' reaction? 
Many of you have participated in training for these protocols and guidelines. What was 
the most impressive or influential point for you? What has been changed by the training 
that you participated in? What was the most negative point for you? What can not be 
changed regardless of the training? 
(4) About difficulties in using STGs 
Why do you think these protocols and guidelines are introduced? 
You may face something in the protocols or guidelines that are not suitable to your 
daily work or the local situation. Can you give us actual examples? 
When or in what kind of situation do you feel difficulties to use a protocol or guideline? 
You can indicate general issues or give us examples in a speCific protocol or guideline. 
Is there any obstacle for you to use a protocol or guideline? Please think about the 
working condition including your colleagues, your personal issues, patients' side issues, 
or the content itself. 
(5) Requests 
You may continue to use protocols and guidelines although they will be updated or revised. 
Do you have any suggestion for the future use? What do you expect to add in the 
protocols or guidelines? You can indicate general issues or suggestions of a specific 
protocol and guideline. 
How do you want to apply the contents of these protocols or guidelines in your daily 
work? 
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Appendix 6 Questionnaire for health personnel 
(Indonesian version was used.) 
Questionnaire 
Name of district 
NameofCHC 
Birth date 
............ I ............ 119 ......... 
(dd) (mm) 
.Jril Sex 1) Male 
2) Female 
Position 1) Manager 
2) Senior nurse 
3) Junior nurse 
4) Senior midwife 
5) Junior midwife 
6) Assistant nurse 
7) Other health personnel 
81 Other ~ersonnel_( cleaner, securiM 
Civil service level 1) Level 1 
2) Level2 
3) Level3 
4) Level4 
5) Level5 
6) Level6 
Educational background 1) Not completed primary school 
2) Primary school 
3) Secondary school 
4) General high school 
5) Basic nursing high school 
6) Other vocational high school 
7) Diploma (less than 1 year) 
8) Diploma 101 
9) Diploma 102 
10) Diploma 103 
11) University 
121 Postgraduate 
How many years have you been working 
for CHC? (including other CHCs and 
Puskesmas during Indonesian time) 
What language do you use the most 
oftenly at home? 
What language do you use the most 
oftenly in CHC (with patiens)? 
What SUb-district are you currently living? 
How do you commute? 1) Walk 
2) Bicycle 
3) Minibus 
4) Bus 
5) Office motorbike 
6) Private motorbike 
7) Other 
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CHC checklist 
(1) Fcility: 
(3) Investigator: 
(4) Key medicines 
chloroquine 
Fansidar 
quinine 
primaquine 
paracetamol 
ferrous 
cotrimoxazol 
amoxacillin 
erithromicin 
penicillin 
nalidixic acid 
oralit 
albendazole 
pyrantel 
metronidazole 
quinine 
chroramphenicol 
procaine penicillin 
ampicillin 
gentamicin 
(5) EML 
(6) STGs 
Malaria 
IMCI 
Clinical Nurse Training-
(2) Date: 
Tablet 
Syrup 
Tablet 
Tablet 
Tablet 
Tablet 
Appendix 7 CHC observation checkll., 
(Indonesian version was used.) 
Paediatric tablet 
Syrup 
Tablet 
Syrup 
Tablet 
Paediatric tablet 
Suspension 
Tablet 
Suspension 
Tablet 
Suspension 
Tablet 
Tablet 
Powder 
Tablet 
Tablet 
Suspension 
Tablet 
Suspension 
Injection 
Injection 
Injection 
Injection 
Injection 
ARTis, Tuberculosis, Malaria, Dengue, Intestinal parasitosis, Diarrhoea,S kin infection, 
Malnutrision, Anaemia, Injury 
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Appendix 8 Letter from the Proposal Review Panel, Ministry of Health 
........ , .. , ........ 
REPUBLICA Df:MOCRA TICA DE TIMOR·LESTE 
MlINISTERIO DA SAUDE 
Gabincte do Vice-Millistro 
Ref": MS-VM/Prop. Org./05/ ~4f 
! 
Ms. Michiyo Higuchi 
DrPH student 
Public Health & Policy Depar~ment 
London School of Hygiene & trropical Medicine 
Dear Ms Michiyo Higuchi, 
Dili, 13 July 2005 
Thank you for your continuittg interest in Timor-Leste and in particular the quality 
and further development o' health services. Your proposal to support further 
efficient development of the Ihealth service was considered by the proposal review 
panel on 281h une, 2005. . 
The piece of research that ~u propose on 'use of medicines in rural community 
health centre covers a new ard important area of study for Timor-Leste and as such 
the Ministry of Health has I approved your research project proposal with the 
following co ditions. 
We must n te however th t while supporting your research in principle, the 
Government of Democratic epublic of Timor-Leste cannot provide any financial 
support for the study. 
The proposed area of study is on the topic of use of medicines with health staff, 
many whom are newly trai d. In order that the findings of your study arc fully 
understood, considered and ecommendations implemented where appropriate the 
Research Committee reques that your findings are presented to the Ministry of 
Health prior to any publica ·on. It will also be necessary for you to provide the 
Ministry of Health with two opies of the full research document including findings. 
The Ministry of Health wishe you every success in your study. 
Cc: 
1. Dr. Rui Maria de Ara jo, Minister for Health 
2. Dr. John Porter, Read r in International Health Department of Infectious and 
Tropical Diseases and Public Health and Policy, University of London 
Ediflcio dos Sen-iros Celltrais do Milli tlrio tID Sa/ide, Hila de Laicoli, Caixa Postal 374, Oili, Timor·l.este 
Tele/on,: 6 (390) 3313645; Fax: 670 (.190) 3325189 
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Appendix 9 Table of contents of data col/ector training 
(Indonesian version was used.) 
Part I (quantitative data collection) 
Chapter 1. Introduction 
1) knowing each other 
-
Name list 
2) about the research - What is the research that data collectors will work for? 
0 Title of the research 
0 Objectives of the research 
0 Target of the research 
0 Data collection methods 
0 Research team 
0 Schedule of the project 
3) roles of data collectors 
-
What will data collectors do? 
0 Preparation 
0 Arrangement of the field 
0 Data collection 
0 Data entry into summalY forms 
4) important things to know for data 
-
What is the meaning of 'confidentiality'? 
collectors (research ethics) 
-
How should we be careful for respondents? 
- What is the meaning of 'informed consent'? 
Chapter 2. Basic background for medicine use research 
1} about medicines in general 
- What are medicines? 
- Why I how are they im~ortant for us? 
2) about 'essential medicines' 
-
What are 'essential medicines'? 
- Why this idea emerged? 
3) about rational I appropriate use of 
-
What are conditionals to use medicines appropriately? 
medicines 
- What kind of information is needed for the use of 
medicines? 
- What will happen if a medicine is used inappropriately? 
- What is the meanin.-9. of 'rational drug use'? 
4) about 'standard treatment 
- What is the meaning of 'standard treatment guideline'? 
guidelines' 
- What kinds of STGs are there in Timor-Leste? 
- Wh'J are they important? 
5) how to calculate indicators 
-
How to calculate the average number of medicines per 
encounter? 
- How to calculate % of encounters with an antibiotic 
prescribed? 
Chapter 3. Essentials knowledge for data collection 
1) commonly-used terms at CHC 
- What kinds of offices have responsibilities for health 
work system in Timor-Leste? 
- What kinds of health facilities are available at national, 
district. sub-district and village level? 
-
Who are working at CHC or HP? 
2) steps of work at CHC - What do health personnel do when a sick patient visits 
CHC? 
3) work at CHC (1) -- registration - What are contents of the medical chat? 
4) work at CHC (2) -- consultation 
-
What are done at the consultation room? 
0 Checking general risk symptoms & signs 
0 History taking 
0 Physical examination 
0 Decision making I classification (diagnosis) 
0 Treatment including prescription 
0 Counseling 
-
What is difference among 'symptom', 'sign' and 
'diagnosis'? 
5) work at CHC (3) - labeling I - What kinds of information are needed on the label? 
dispensing 
-
What kinds of explanation are needed at the dispensing 
counter? 
6) work at CHC (4) --- recording - What kind of information is recorded in the patient 
registration book? 
7) name of body parts 
8) name of common illness I 
diseases 
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Appendix 9 Table of contents of data collector training 
(Indonesian version was used.) 
'continued) 
Chapter 4. Basic knowledge for target diseases 
1) acute respiratory tract infections - General information 
-
Important symptoms (from history taking) 
-
Important signs (from physical examination) 
-
Classification 
-
Essential medicines for the treatment 
-
Counseling 
2) malaria 
-
General information 
-
Important symptoms (from history taking) 
-
Important signs (from physical examination) 
-
Classification 
-
Essential medicines for the treatment 
- Counseling 
3) diarrhoea 
-
General information 
-
Important symptoms (from history taking) 
-
Important signs (from physical examination) 
-
Classification 
-
Essential medicines for the treatment 
-
Counseling 
Chapter 5. Data collection 
1) sampling and recording cases 
from patient registration books 
2) observation at the consultation 
room 
3) observation at the dispensing 
counter 
4) interview to patients 
51 data entry into summary forms 
Part II (qualitative data collection) 
(by dr. Sri Suryawati from Gadjah Mada University) 
1. Introduction 
2. To be an interviewer I FGD facilitator 
3. To be a note-taker 
4. Guideline for in-depth interview I FGD 
5. In-depth interview 
6. Practice for in-depth interview 
7. Transcription 
8. Practice for transcription 
9. FGD 
10. Practice for FGD 
11. Closing 
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Appendix 10 Master letter to District Health Services and Community Health Center 
(Tetum version was used.) 
Data: February .......... , 2006 
To: '" ................................. , Manager CHC .................... . 
Cc: '" ................................. , Head of District Health Services, .................... . 
Sra. Isabel M. Gomes, District Health Liaison, the Ministry of Health 
From: Michiyo Higuchi, DrPH candidate, London School of Hygiene & 
Tropical Medicine 
Subject: Data collection at CHC .................... . 
I would like to ask for your collaboration for my research. 
I am planning to conduct a research on the use of medicines in Community Health Centers, 
which has been approved by the proposal review panel in the Ministry of Health (Ref MS-
VM/Prop.Org.l05/247, attached). In this connection, my research team hopes to visit 
CHC ..................... for the data collection. 
I would be very glad if you could collaborate with this data collection on someday 
from ..... .1 ...... to ...... I ..... .12006, probably for one or four days. Our data collection methods 
are observation with checklists at consultation rooms and dispensing counter and short 
interview to selected patients. We also hope to interview to 3 nurses individually (manager, 
clinical nurse and one of nurses) on the last day of the visit when you are not busy with 
patients. 
Because our target is 30 patients per one CHC, the duration of the visit at each CHC will 
depend on the total number of patients of the CHC. Therefore, we can only make a rough 
schedule at the moment. We will contact with each CHC about the exact date of our visit at 
least one week before going there. We prepare for accommodation and meals by ourselves. 
I attached informed consent sheets for members of the CHC about this data collection. I also 
put small questionnaire on the back page of the consent sheet. I hope to have them back 
before the data collection on the first day. 
Any question from you directly to the chief researcher would be much appreciated. Thank 
you very much in advance for your collaboration. 
Sincerely, 
Michiyo Higuchi 
Chief researcher 
DrPH candidate 
London School of Hygiene & Tropical Medicine 
Contact numbers: 7252115 (personal HP), 7292732 (office HP), 3322338 (office landline) 
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Appendix 11 Letter from the Ministry of Health to Cuban Doctors Brigade 
~ 
REPUBLICA DEMOcRATICA DE TIMOR LESTE 
MINISTERIO DA SA'UDE 
Gabinete do Secretario P,ermanente 
Ref.MS-S·P/V 106/ ...... Oili. II de Maio tlc 2006. 
Dear all Cuban doctors assigned at the CHe's (lCllitics 
I. would like to inform all of you that Ms tvlichiyo Higuchi is a DrPH student IVlme no\\' 
conducting a research on the usc of medicines ill Community Henlth Centers 
As stated in her letter to the Ministry of Health, th:H she is interesting in nurse!; work nnd 
standard Treatment Guidelines in resource limited situation, however, taking into 
consideration a level 2 facility now has doctors. she is interest to include the doctors 
consultation in the research. 
The Ministry of Health, kindly request doctors <It the facility level to collaborate and 
provide necessary informntion and contribute to tlte resenrch. 
Bf/J'!f;:~' , ' 
·1:liscian:, da C. A. Pir,to, SKp. 
Permanent Secretary for Ministry of HC:llth, 
Timor-Leste 
ce.: Dr Francisco Medina, Cubc\l1 Doctors Brigade Coordinator 
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For health personnel (written consent) 
Dear colleagues, 
Appendix 12 Informed consent forms 
(Indonesian version was used.) 
We would like to ask for your cooperation for the research conducted under the supervision 
of the Ministry of Health, Timor-Leste. 
The purpose of this research is to study the present services of the CHC by observing 
activities and interviewing to patients. We will stay in this CHC for 1 or 4 days. 
Individual performance will be kept confidential. The research does not influence your 
personal evaluation. We do not indicate any name in a report or publication from the results 
of the research. 
If you do not want to be observed, you can refuse. Moreover, if you change your mind after 
you agreed, you can withdraw from the observation at anytime. 
Please check the statements below after you have understood the information on this sheet. 
I would also be glad if you could kindly answer questionnaire on the back page. Any question 
through CHC Manager or directly to the chief researcher would be appreCiated. 
Sincerely, 
Michiyo Higuchi 
Chief researcher 
DrPH candidate 
London School of Hygiene & Tropical Medicine 
•••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••• 0 ••••••••••••••••• 
I agree to be observed in the CHC. ( yes I no ) 
Date 
Your signature 
Your name (in print) 
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Appendix 12 Informed consent forms 
(Tetum version was used.) 
For patients (oral consent) 
Sample explanation for oral consent form a patient 
(about the researcher) 
1) I am a student from London. I am planning to conduct public health research in 
collaboration with the Ministry of Health, Timor-Leste. 
(the purpose of the research) 
2) The main purpose of this research is to know the work of CHC. 
(what will be done) 
3) For this purpose, I hope to ask some questions and to see your patient record, especially 
about medicines that you received right now. 
(about confidentiality) 
4) Nobody except us will ever know your personal answers and the contents of your patient 
record. Your name will never appear in the report. 
(about informed consent) 
5) If you do not want to answer our questions or you don't like we see your patient record, 
you can refuse. We do not ask questions and do not see your patient record anymore. 
(additional information) 
6) It is not a test for you. Even if you misunderstand, nobody criticise you and you can go 
back to the nurse to ask again how to take them. You do not have to feel tension. 
Can you answer our questions? 
Can you agree that we will see your patient record? 
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Appendix 13 Medicines and categories 
Medicin d t esan ca egorles 
category essential medicines in Timor-Leste 
other analgesics 
- paracetamol 
1 (antipyretics or pain killer) - aspirin (ASA) 
- ibuprofen 
antibiotics 
- amoxicillin 
- chloramphenicol 
-
cloxacillin 
2 
- cotrimoxazole (sulfamethoxazole+trimethoprim) 
- erythromycin 
- nalidixic acid 
- penicillin V (phenoxymethil-penicillin) 
anti-malaria Is - chloroquine 
3 - primaquine 
-
quinine 
-
fansidar (sulfadoxine+prynethamine) 
anti-helminthics - albendazole 
4 - mebendazole 
- pyrantel 
vitamin - multivitamin 
-
vitamin 81 (thiamin) 
- vitamin B6 (pyridoxine) 5 
- vitamin 812 (cobalamin) 
- vitamin C (ascorbic acid) 
-
folic acid 
ferrous - SF 6 SF + folic acid -
7 ORS 
8 topical medicines 
9 metronidazole 
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